channel_count
int64
1
1
characteristics_ch1
stringlengths
6
9.77k
contact_address
stringlengths
1
229
contact_city
stringlengths
1
47
contact_country
stringclasses
71 values
contact_institute
stringlengths
2
128
contact_name
stringlengths
4
74
contact_zip
stringclasses
1 value
data_processing
stringlengths
4
10.6k
extract_protocol_ch1
stringlengths
6
14.3k
geo_accession
stringlengths
9
10
instrument_model
stringclasses
13 values
last_update_date
stringlengths
11
11
library_selection
stringclasses
6 values
library_source
stringclasses
5 values
library_strategy
stringclasses
1 value
molecule_ch1
stringclasses
7 values
organism_ch1
stringclasses
1 value
platform_id
stringclasses
13 values
relation
stringlengths
0
2.61k
sample
stringlengths
9
10
series_id
stringlengths
8
29
singlecellprobability
float64
0
1
source_name_ch1
stringlengths
1
253
status
stringlengths
21
21
submission_date
stringlengths
11
11
taxid_ch1
stringclasses
1 value
title
stringlengths
1
120
type
stringclasses
1 value
sra
stringlengths
47
49
biosample
stringlengths
51
51
1
age: 61,tissue: adipose tissue,log10 body mass index: 1.338948892,log10 basal metabolic rate (kcal): 1548,log2 estimated glomerular filtration rate using modification of diet in renal disease (egfr_mdrd): 6.381044137,log10 estimated creatinine clearance rate using cockfcrot-gault formulaa (egcr): 6.333436702,plasma free fatty acids under the curve ogtt (mmol/l * min): 24.3,fat mass (%): 27.4,log10 plasma glucose area under the curve (ogtt) (mmol/l * min): 9.87958325,plasma glucose area under the curve above basal (ogtt) (mmol/l * min): 270,log10 homair (insulin resistance index based on homa): 0.188397198,log10 homais (insulin secretion index based on homa): 1.77120239,log10 insulin area under the curve (ogtt) (pmol/l * min): 4.498186452,insgenin (insulinogenic index): 1.871572936,log10 insulin area under the curve above basal (ogtt) (pmol/l * min): 4.431797842,log10 matsuda insulin sensitivity index: 0.769064012,muscle mass (%): 38.7,lg10 serum c-reactive protein (mg/l): 0.212187604,lg10 plasma adiponectin (mg/l): 0.939519253,ogtt fasting plasma free fatty acid (mmol/l): 0.35,ogtt 30 min plasma free fatty acid (mmol/l): 0.28,ogtt 120 min plasma free fatty acid (mmol/l): 0.05,ogtt fasting plasma glucose (mmol/l): 5.6,ogtt 30 min plasma glucose (mmol/l): 8.6,ogtt 120 min plasma glucose (mmol/l): 7.6,log10 il1 receptor antagonist (pg/ml): 2.595628474,log10 il1 beta (pg/ml): -0.721246399,log10 ogtt fasting plasma insulin (mu/l): 0.792391689,ogtt 30 min plasma insulin (mu/l): 1.63748973,ogtt 120 min plasma insulin (mu/l): 1.753583059,log10 ogtt fasting plasma proinsulin (pm/l): 1.238046103,ogtt 30 min plasma proinsulin (pm/l): 1.596597096,ogtt 120 min plasma proinsulin (pm/l): 1.911690159,log10 bioimpedance: Resistance: 2.748188027,log10 bioimpedance (reactance): 1.73239376,waist to hip ratio: 0.890625,log10 serum bilirubin (umol/l): 1.255272505,log10 serum alanine aminotransfrase (u/l): 2.071882007,log10 creatinine (umol/l): 1.934498451,log10 total cholesterol (mmol/l): 0.800717078,log10 ldl cholesterol (mmol/l): 0.612783857,log10 hdl cholesterol (mmol/l): 0.204119983,log10 total triglycerides (mmol/l): 0.23299611,log10 serum apoa1 (g/l): 0.245512668,log10 serum apob (g/l): 0.136720567,log10 urinary albumin excretion rate (ug/min): 0.755487266
675 Charles E. Young Dr. S. MRL 3220
Los Angeles
USA
University of California Los Angeles
Mete,,Civelek
Illumina Casava1.7 software used for basecalling.,Sequencing files were converted to FASTQ format using a custom Perl script. In order to assign the indexed reads to each METSIM subject, a Python script was used to partition the FASTQ file for each lane into multiple FASTQ files, each of which corresponded to one individual. To be included in the partitioned file, a read had to have an exact match to one of the 48 possible index sequences, unambiguously identifying the individual from whom the read originated. Reads which did not exactly match an index sequence were discarded.,The reads were then aligned to the hg19 version of the genome using the Novoalign tool with the following settings: -l16 -t30 -h90 -rA -R 1 -m -g 200 –k. Novoalign software trims the adapter sequences while aligning.,We used the Bioconductor package GenomicRanges for R (v.2.14.0) to count the number of reads with alignment coordinates that overlap the coordinates of known mature miRNAs. Whenever a read mapped to 'x' genomic loci, the read would contribute a count of 1/x to those regions. The genomic coordinates for known mature miRNAs were downloaded from miRBase version 18.,To enable comparison of counts between samples, we normalized the expression values by dividing the counts for a given mature miRNA by the sum of all the miRNA counts for the corresponding individual. For subsequent analysis, we considered the expression levels of 356 miRNAs that had at least 5 reads in half of the study participants.,Genome_build: hg19,Supplementary_files_format_and_content: tab-delimited text files include unnormalized weighted counts for each miRNA
Abdominal subcutaneous adipose tissue was obtained with needle biopsies. Total RNA was isolated from the adipose tissue using Qiagen miRNeasy kit according to manufacturer’s instructions. RNA Integrity Number (RIN) values were assessed with the Agilent Bioanalyzer 2100 instrument. Samples with RIN values greater than 7.0 were used for transcriptional profiling.,Small RNA libraries were prepared using the Illumina TruSeq Small RNA protocol utilizing up to 48 unique index sequences (Illumina Catalog Number FC-102-1009). For two samples (METSIM490 and METSIM6589) we also prepared small RNA libraries using Illumina Small RNA v1.5 sample preparation protocol (Catalog # FC-930-1501)
GSM1098368
Illumina HiSeq 2000
May 15 2019
size fractionation
transcriptomic
RNA-Seq
total RNA
Homo sapiens
GPL11154
SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX249267,BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN01978195
GSM1098368
GSE45159
0.042174
adipose tissue
Public on Apr 01 2013
Mar 14 2013
9606
METSIM7436
SRA
https://www.ncbi.nlm.nih.gov/sra?term=SRX249267
https://www.ncbi.nlm.nih.gov/biosample/SAMN01978195
1
age: 57,tissue: adipose tissue,log10 body mass index: 1.440479134,log10 basal metabolic rate (kcal): 1472,log2 estimated glomerular filtration rate using modification of diet in renal disease (egfr_mdrd): 6.767579447,log10 estimated creatinine clearance rate using cockfcrot-gault formulaa (egcr): 6.937603777,plasma free fatty acids under the curve ogtt (mmol/l * min): 22.2,fat mass (%): 24.8,log10 plasma glucose area under the curve (ogtt) (mmol/l * min): 9.794415866,plasma glucose area under the curve above basal (ogtt) (mmol/l * min): 228,log10 homair (insulin resistance index based on homa): 0.505451467,log10 homais (insulin secretion index based on homa): 2.117271296,log10 insulin area under the curve (ogtt) (pmol/l * min): 4.910314846,insgenin (insulinogenic index): 2.339503744,log10 insulin area under the curve above basal (ogtt) (pmol/l * min): 4.856789289,log10 matsuda insulin sensitivity index: 0.432215057,muscle mass (%): 41.4,lg10 serum c-reactive protein (mg/l): 0.662757832,lg10 plasma adiponectin (mg/l): 0.544068044,ogtt fasting plasma free fatty acid (mmol/l): 0.35,ogtt 30 min plasma free fatty acid (mmol/l): 0.23,ogtt 120 min plasma free fatty acid (mmol/l): 0.07,ogtt fasting plasma glucose (mmol/l): 5.5,ogtt 30 min plasma glucose (mmol/l): 9.3,ogtt 120 min plasma glucose (mmol/l): 5.5,log10 il1 receptor antagonist (pg/ml): 2.678982471,log10 il1 beta (pg/ml): NA,log10 ogtt fasting plasma insulin (mu/l): 1.117271296,ogtt 30 min plasma insulin (mu/l): 2.180412633,ogtt 120 min plasma insulin (mu/l): 1.977266212,log10 ogtt fasting plasma proinsulin (pm/l): 1.424881637,ogtt 30 min plasma proinsulin (pm/l): 1.868056362,ogtt 120 min plasma proinsulin (pm/l): 1.91750551,log10 bioimpedance: Resistance: 2.753583059,log10 bioimpedance (reactance): 1.770852012,waist to hip ratio: 1.06185567,log10 serum bilirubin (umol/l): 1.176091259,log10 serum alanine aminotransfrase (u/l): 1.380211242,log10 creatinine (umol/l): 1.838849091,log10 total cholesterol (mmol/l): 0.832508913,log10 ldl cholesterol (mmol/l): 0.701567985,log10 hdl cholesterol (mmol/l): -0.075720714,log10 total triglycerides (mmol/l): 0.383815366,log10 serum apoa1 (g/l): 0.093421685,log10 serum apob (g/l): 0.230448921,log10 urinary albumin excretion rate (ug/min): 0.790759615
675 Charles E. Young Dr. S. MRL 3220
Los Angeles
USA
University of California Los Angeles
Mete,,Civelek
Illumina Casava1.7 software used for basecalling.,Sequencing files were converted to FASTQ format using a custom Perl script. In order to assign the indexed reads to each METSIM subject, a Python script was used to partition the FASTQ file for each lane into multiple FASTQ files, each of which corresponded to one individual. To be included in the partitioned file, a read had to have an exact match to one of the 48 possible index sequences, unambiguously identifying the individual from whom the read originated. Reads which did not exactly match an index sequence were discarded.,The reads were then aligned to the hg19 version of the genome using the Novoalign tool with the following settings: -l16 -t30 -h90 -rA -R 1 -m -g 200 –k. Novoalign software trims the adapter sequences while aligning.,We used the Bioconductor package GenomicRanges for R (v.2.14.0) to count the number of reads with alignment coordinates that overlap the coordinates of known mature miRNAs. Whenever a read mapped to 'x' genomic loci, the read would contribute a count of 1/x to those regions. The genomic coordinates for known mature miRNAs were downloaded from miRBase version 18.,To enable comparison of counts between samples, we normalized the expression values by dividing the counts for a given mature miRNA by the sum of all the miRNA counts for the corresponding individual. For subsequent analysis, we considered the expression levels of 356 miRNAs that had at least 5 reads in half of the study participants.,Genome_build: hg19,Supplementary_files_format_and_content: tab-delimited text files include unnormalized weighted counts for each miRNA
Abdominal subcutaneous adipose tissue was obtained with needle biopsies. Total RNA was isolated from the adipose tissue using Qiagen miRNeasy kit according to manufacturer’s instructions. RNA Integrity Number (RIN) values were assessed with the Agilent Bioanalyzer 2100 instrument. Samples with RIN values greater than 7.0 were used for transcriptional profiling.,Small RNA libraries were prepared using the Illumina TruSeq Small RNA protocol utilizing up to 48 unique index sequences (Illumina Catalog Number FC-102-1009). For two samples (METSIM490 and METSIM6589) we also prepared small RNA libraries using Illumina Small RNA v1.5 sample preparation protocol (Catalog # FC-930-1501)
GSM1098369
Illumina HiSeq 2000
May 15 2019
size fractionation
transcriptomic
RNA-Seq
total RNA
Homo sapiens
GPL11154
SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX249268,BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN01978196
GSM1098369
GSE45159
0.257978
adipose tissue
Public on Apr 01 2013
Mar 14 2013
9606
METSIM7482
SRA
https://www.ncbi.nlm.nih.gov/sra?term=SRX249268
https://www.ncbi.nlm.nih.gov/biosample/SAMN01978196
1
age: 50,tissue: adipose tissue,log10 body mass index: 1.498615312,log10 basal metabolic rate (kcal): 1704,log2 estimated glomerular filtration rate using modification of diet in renal disease (egfr_mdrd): 6.601836376,log10 estimated creatinine clearance rate using cockfcrot-gault formulaa (egcr): 7.160711732,plasma free fatty acids under the curve ogtt (mmol/l * min): 16.35,fat mass (%): 24.8,log10 plasma glucose area under the curve (ogtt) (mmol/l * min): 9.801708359,plasma glucose area under the curve above basal (ogtt) (mmol/l * min): 172.5,log10 homair (insulin resistance index based on homa): 0.196820744,log10 homais (insulin secretion index based on homa): 1.673941999,log10 insulin area under the curve (ogtt) (pmol/l * min): 4.434393235,insgenin (insulinogenic index): 1.938019097,log10 insulin area under the curve above basal (ogtt) (pmol/l * min): 4.360612345,log10 matsuda insulin sensitivity index: 0.830887163,muscle mass (%): 42.1,lg10 serum c-reactive protein (mg/l): -0.494850022,lg10 plasma adiponectin (mg/l): 1.28780173,ogtt fasting plasma free fatty acid (mmol/l): 0.37,ogtt 30 min plasma free fatty acid (mmol/l): 0.15,ogtt 120 min plasma free fatty acid (mmol/l): 0.04,ogtt fasting plasma glucose (mmol/l): 6,ogtt 30 min plasma glucose (mmol/l): 10,ogtt 120 min plasma glucose (mmol/l): 4.5,log10 il1 receptor antagonist (pg/ml): 2.230295614,log10 il1 beta (pg/ml): NA,log10 ogtt fasting plasma insulin (mu/l): 0.770852012,ogtt 30 min plasma insulin (mu/l): 1.804139432,ogtt 120 min plasma insulin (mu/l): 1.139879086,log10 ogtt fasting plasma proinsulin (pm/l): 0.77815125,ogtt 30 min plasma proinsulin (pm/l): 1.230448921,ogtt 120 min plasma proinsulin (pm/l): 1.240549248,log10 bioimpedance: Resistance: 2.633468456,log10 bioimpedance (reactance): 1.643452676,waist to hip ratio: 0.972727273,log10 serum bilirubin (umol/l): 1.230448921,log10 serum alanine aminotransfrase (u/l): 1.491361694,log10 creatinine (umol/l): 1.892094603,log10 total cholesterol (mmol/l): 0.704150517,log10 ldl cholesterol (mmol/l): 0.505149978,log10 hdl cholesterol (mmol/l): 0.103803721,log10 total triglycerides (mmol/l): 0.056904851,log10 serum apoa1 (g/l): 0.089905111,log10 serum apob (g/l): -0.045757491,log10 urinary albumin excretion rate (ug/min): 1.121145747
675 Charles E. Young Dr. S. MRL 3220
Los Angeles
USA
University of California Los Angeles
Mete,,Civelek
Illumina Casava1.7 software used for basecalling.,Sequencing files were converted to FASTQ format using a custom Perl script. In order to assign the indexed reads to each METSIM subject, a Python script was used to partition the FASTQ file for each lane into multiple FASTQ files, each of which corresponded to one individual. To be included in the partitioned file, a read had to have an exact match to one of the 48 possible index sequences, unambiguously identifying the individual from whom the read originated. Reads which did not exactly match an index sequence were discarded.,The reads were then aligned to the hg19 version of the genome using the Novoalign tool with the following settings: -l16 -t30 -h90 -rA -R 1 -m -g 200 –k. Novoalign software trims the adapter sequences while aligning.,We used the Bioconductor package GenomicRanges for R (v.2.14.0) to count the number of reads with alignment coordinates that overlap the coordinates of known mature miRNAs. Whenever a read mapped to 'x' genomic loci, the read would contribute a count of 1/x to those regions. The genomic coordinates for known mature miRNAs were downloaded from miRBase version 18.,To enable comparison of counts between samples, we normalized the expression values by dividing the counts for a given mature miRNA by the sum of all the miRNA counts for the corresponding individual. For subsequent analysis, we considered the expression levels of 356 miRNAs that had at least 5 reads in half of the study participants.,Genome_build: hg19,Supplementary_files_format_and_content: tab-delimited text files include unnormalized weighted counts for each miRNA
Abdominal subcutaneous adipose tissue was obtained with needle biopsies. Total RNA was isolated from the adipose tissue using Qiagen miRNeasy kit according to manufacturer’s instructions. RNA Integrity Number (RIN) values were assessed with the Agilent Bioanalyzer 2100 instrument. Samples with RIN values greater than 7.0 were used for transcriptional profiling.,Small RNA libraries were prepared using the Illumina TruSeq Small RNA protocol utilizing up to 48 unique index sequences (Illumina Catalog Number FC-102-1009). For two samples (METSIM490 and METSIM6589) we also prepared small RNA libraries using Illumina Small RNA v1.5 sample preparation protocol (Catalog # FC-930-1501)
GSM1098370
Illumina HiSeq 2000
May 15 2019
size fractionation
transcriptomic
RNA-Seq
total RNA
Homo sapiens
GPL11154
SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX249269,BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN01978197
GSM1098370
GSE45159
0.224733
adipose tissue
Public on Apr 01 2013
Mar 14 2013
9606
METSIM7530
SRA
https://www.ncbi.nlm.nih.gov/sra?term=SRX249269
https://www.ncbi.nlm.nih.gov/biosample/SAMN01978197
1
age: 49,tissue: adipose tissue,log10 body mass index: 1.382269942,log10 basal metabolic rate (kcal): 1731,log2 estimated glomerular filtration rate using modification of diet in renal disease (egfr_mdrd): 6.524492232,log10 estimated creatinine clearance rate using cockfcrot-gault formulaa (egcr): 6.750072755,plasma free fatty acids under the curve ogtt (mmol/l * min): 16.5,fat mass (%): 15.5,log10 plasma glucose area under the curve (ogtt) (mmol/l * min): 9.497851837,plasma glucose area under the curve above basal (ogtt) (mmol/l * min): 15,log10 homair (insulin resistance index based on homa): 0.020729485,log10 homais (insulin secretion index based on homa): 1.522878745,log10 insulin area under the curve (ogtt) (pmol/l * min): 4.168821463,insgenin (insulinogenic index): 2.040898888,log10 insulin area under the curve above basal (ogtt) (pmol/l * min): 4.074487305,log10 matsuda insulin sensitivity index: 1.081552736,muscle mass (%): 48.6,lg10 serum c-reactive protein (mg/l): -0.37675071,lg10 plasma adiponectin (mg/l): 0.602059991,ogtt fasting plasma free fatty acid (mmol/l): 0.27,ogtt 30 min plasma free fatty acid (mmol/l): 0.17,ogtt 120 min plasma free fatty acid (mmol/l): 0.05,ogtt fasting plasma glucose (mmol/l): 5.9,ogtt 30 min plasma glucose (mmol/l): 7.5,ogtt 120 min plasma glucose (mmol/l): 4.1,log10 il1 receptor antagonist (pg/ml): 2.296423849,log10 il1 beta (pg/ml): NA,log10 ogtt fasting plasma insulin (mu/l): 0.602059991,ogtt 30 min plasma insulin (mu/l): 1.522444234,ogtt 120 min plasma insulin (mu/l): 0.949390007,log10 ogtt fasting plasma proinsulin (pm/l): 1.340444115,ogtt 30 min plasma proinsulin (pm/l): 1.418301291,ogtt 120 min plasma proinsulin (pm/l): 1.44870632,log10 bioimpedance: Resistance: 2.640481437,log10 bioimpedance (reactance): 1.653212514,waist to hip ratio: 0.895,log10 serum bilirubin (umol/l): 1.176091259,log10 serum alanine aminotransfrase (u/l): 1.255272505,log10 creatinine (umol/l): 1.913813852,log10 total cholesterol (mmol/l): 0.615950052,log10 ldl cholesterol (mmol/l): 0.418301291,log10 hdl cholesterol (mmol/l): 0.127104798,log10 total triglycerides (mmol/l): -0.161150909,log10 serum apoa1 (g/l): 0.064457989,log10 serum apob (g/l): -0.200659451,log10 urinary albumin excretion rate (ug/min): 0.552574628
675 Charles E. Young Dr. S. MRL 3220
Los Angeles
USA
University of California Los Angeles
Mete,,Civelek
Illumina Casava1.7 software used for basecalling.,Sequencing files were converted to FASTQ format using a custom Perl script. In order to assign the indexed reads to each METSIM subject, a Python script was used to partition the FASTQ file for each lane into multiple FASTQ files, each of which corresponded to one individual. To be included in the partitioned file, a read had to have an exact match to one of the 48 possible index sequences, unambiguously identifying the individual from whom the read originated. Reads which did not exactly match an index sequence were discarded.,The reads were then aligned to the hg19 version of the genome using the Novoalign tool with the following settings: -l16 -t30 -h90 -rA -R 1 -m -g 200 –k. Novoalign software trims the adapter sequences while aligning.,We used the Bioconductor package GenomicRanges for R (v.2.14.0) to count the number of reads with alignment coordinates that overlap the coordinates of known mature miRNAs. Whenever a read mapped to 'x' genomic loci, the read would contribute a count of 1/x to those regions. The genomic coordinates for known mature miRNAs were downloaded from miRBase version 18.,To enable comparison of counts between samples, we normalized the expression values by dividing the counts for a given mature miRNA by the sum of all the miRNA counts for the corresponding individual. For subsequent analysis, we considered the expression levels of 356 miRNAs that had at least 5 reads in half of the study participants.,Genome_build: hg19,Supplementary_files_format_and_content: tab-delimited text files include unnormalized weighted counts for each miRNA
Abdominal subcutaneous adipose tissue was obtained with needle biopsies. Total RNA was isolated from the adipose tissue using Qiagen miRNeasy kit according to manufacturer’s instructions. RNA Integrity Number (RIN) values were assessed with the Agilent Bioanalyzer 2100 instrument. Samples with RIN values greater than 7.0 were used for transcriptional profiling.,Small RNA libraries were prepared using the Illumina TruSeq Small RNA protocol utilizing up to 48 unique index sequences (Illumina Catalog Number FC-102-1009). For two samples (METSIM490 and METSIM6589) we also prepared small RNA libraries using Illumina Small RNA v1.5 sample preparation protocol (Catalog # FC-930-1501)
GSM1098371
Illumina HiSeq 2000
May 15 2019
size fractionation
transcriptomic
RNA-Seq
total RNA
Homo sapiens
GPL11154
SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX249270,BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN01978198
GSM1098371
GSE45159
0.137998
adipose tissue
Public on Apr 01 2013
Mar 14 2013
9606
METSIM7611
SRA
https://www.ncbi.nlm.nih.gov/sra?term=SRX249270
https://www.ncbi.nlm.nih.gov/biosample/SAMN01978198
1
age: 47,tissue: adipose tissue,log10 body mass index: 1.517447814,log10 basal metabolic rate (kcal): 1895,log2 estimated glomerular filtration rate using modification of diet in renal disease (egfr_mdrd): 6.239936646,log10 estimated creatinine clearance rate using cockfcrot-gault formulaa (egcr): 7.059702127,plasma free fatty acids under the curve ogtt (mmol/l * min): 32.1,fat mass (%): 26.8,log10 plasma glucose area under the curve (ogtt) (mmol/l * min): 9.818582177,plasma glucose area under the curve above basal (ogtt) (mmol/l * min): 135,log10 homair (insulin resistance index based on homa): 0.547419141,log10 homais (insulin secretion index based on homa): 1.932053683,log10 insulin area under the curve (ogtt) (pmol/l * min): 4.533225352,insgenin (insulinogenic index): 2.109056724,log10 insulin area under the curve above basal (ogtt) (pmol/l * min): 4.401555618,log10 matsuda insulin sensitivity index: 0.595214804,muscle mass (%): 42.1,lg10 serum c-reactive protein (mg/l): 0.681241237,lg10 plasma adiponectin (mg/l): 0.908485019,ogtt fasting plasma free fatty acid (mmol/l): 0.45,ogtt 30 min plasma free fatty acid (mmol/l): 0.31,ogtt 120 min plasma free fatty acid (mmol/l): 0.15,ogtt fasting plasma glucose (mmol/l): 6.4,ogtt 30 min plasma glucose (mmol/l): 9.7,ogtt 120 min plasma glucose (mmol/l): 5,log10 il1 receptor antagonist (pg/ml): 2.980898323,log10 il1 beta (pg/ml): NA,log10 ogtt fasting plasma insulin (mu/l): 1.093421685,ogtt 30 min plasma insulin (mu/l): 1.919601024,ogtt 120 min plasma insulin (mu/l): 1.06069784,log10 ogtt fasting plasma proinsulin (pm/l): 1.315970345,ogtt 30 min plasma proinsulin (pm/l): 1.603144373,ogtt 120 min plasma proinsulin (pm/l): 1.588831726,log10 bioimpedance: Resistance: 2.630427875,log10 bioimpedance (reactance): 1.681241237,waist to hip ratio: 1.009009009,log10 serum bilirubin (umol/l): 1.342422681,log10 serum alanine aminotransfrase (u/l): 1.662757832,log10 creatinine (umol/l): 1.991226076,log10 total cholesterol (mmol/l): 0.781755375,log10 ldl cholesterol (mmol/l): 0.612783857,log10 hdl cholesterol (mmol/l): -0.026872146,log10 total triglycerides (mmol/l): 0.440909082,log10 serum apoa1 (g/l): 0.004321374,log10 serum apob (g/l): 0.008600172,log10 urinary albumin excretion rate (ug/min): NA
675 Charles E. Young Dr. S. MRL 3220
Los Angeles
USA
University of California Los Angeles
Mete,,Civelek
Illumina Casava1.7 software used for basecalling.,Sequencing files were converted to FASTQ format using a custom Perl script. In order to assign the indexed reads to each METSIM subject, a Python script was used to partition the FASTQ file for each lane into multiple FASTQ files, each of which corresponded to one individual. To be included in the partitioned file, a read had to have an exact match to one of the 48 possible index sequences, unambiguously identifying the individual from whom the read originated. Reads which did not exactly match an index sequence were discarded.,The reads were then aligned to the hg19 version of the genome using the Novoalign tool with the following settings: -l16 -t30 -h90 -rA -R 1 -m -g 200 –k. Novoalign software trims the adapter sequences while aligning.,We used the Bioconductor package GenomicRanges for R (v.2.14.0) to count the number of reads with alignment coordinates that overlap the coordinates of known mature miRNAs. Whenever a read mapped to 'x' genomic loci, the read would contribute a count of 1/x to those regions. The genomic coordinates for known mature miRNAs were downloaded from miRBase version 18.,To enable comparison of counts between samples, we normalized the expression values by dividing the counts for a given mature miRNA by the sum of all the miRNA counts for the corresponding individual. For subsequent analysis, we considered the expression levels of 356 miRNAs that had at least 5 reads in half of the study participants.,Genome_build: hg19,Supplementary_files_format_and_content: tab-delimited text files include unnormalized weighted counts for each miRNA
Abdominal subcutaneous adipose tissue was obtained with needle biopsies. Total RNA was isolated from the adipose tissue using Qiagen miRNeasy kit according to manufacturer’s instructions. RNA Integrity Number (RIN) values were assessed with the Agilent Bioanalyzer 2100 instrument. Samples with RIN values greater than 7.0 were used for transcriptional profiling.,Small RNA libraries were prepared using the Illumina TruSeq Small RNA protocol utilizing up to 48 unique index sequences (Illumina Catalog Number FC-102-1009). For two samples (METSIM490 and METSIM6589) we also prepared small RNA libraries using Illumina Small RNA v1.5 sample preparation protocol (Catalog # FC-930-1501)
GSM1098372
Illumina HiSeq 2000
May 15 2019
size fractionation
transcriptomic
RNA-Seq
total RNA
Homo sapiens
GPL11154
SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX249271,BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN01978199
GSM1098372
GSE45159
0
adipose tissue
Public on Apr 01 2013
Mar 14 2013
9606
METSIM7693
SRA
https://www.ncbi.nlm.nih.gov/sra?term=SRX249271
https://www.ncbi.nlm.nih.gov/biosample/SAMN01978199
1
age: 61,tissue: adipose tissue,log10 body mass index: 1.398532633,log10 basal metabolic rate (kcal): 1581,log2 estimated glomerular filtration rate using modification of diet in renal disease (egfr_mdrd): 6.501448642,log10 estimated creatinine clearance rate using cockfcrot-gault formulaa (egcr): 6.437773362,plasma free fatty acids under the curve ogtt (mmol/l * min): 22.35,fat mass (%): 21.8,log10 plasma glucose area under the curve (ogtt) (mmol/l * min): 10.02375435,plasma glucose area under the curve above basal (ogtt) (mmol/l * min): 321,log10 homair (insulin resistance index based on homa): 0.323595824,log10 homais (insulin secretion index based on homa): 1.800717078,log10 insulin area under the curve (ogtt) (pmol/l * min): 4.489029868,insgenin (insulinogenic index): 1.712055185,log10 insulin area under the curve above basal (ogtt) (pmol/l * min): 4.400468911,log10 matsuda insulin sensitivity index: 0.678959223,muscle mass (%): 55.8,lg10 serum c-reactive protein (mg/l): 0.071882007,lg10 plasma adiponectin (mg/l): 1.029383778,ogtt fasting plasma free fatty acid (mmol/l): 0.34,ogtt 30 min plasma free fatty acid (mmol/l): 0.22,ogtt 120 min plasma free fatty acid (mmol/l): 0.09,ogtt fasting plasma glucose (mmol/l): 6,ogtt 30 min plasma glucose (mmol/l): 9.4,ogtt 120 min plasma glucose (mmol/l): 8.6,log10 il1 receptor antagonist (pg/ml): 2.435716988,log10 il1 beta (pg/ml): NA,log10 ogtt fasting plasma insulin (mu/l): 0.897627091,ogtt 30 min plasma insulin (mu/l): 1.56937391,ogtt 120 min plasma insulin (mu/l): 1.7930916,log10 ogtt fasting plasma proinsulin (pm/l): 1.146128036,ogtt 30 min plasma proinsulin (pm/l): 1.456366033,ogtt 120 min plasma proinsulin (pm/l): 1.910624405,log10 bioimpedance: Resistance: 2.63447727,log10 bioimpedance (reactance): 1.681241237,waist to hip ratio: 0.927835052,log10 serum bilirubin (umol/l): 1.146128036,log10 serum alanine aminotransfrase (u/l): 1.447158031,log10 creatinine (umol/l): 1.903089987,log10 total cholesterol (mmol/l): 0.7355989,log10 ldl cholesterol (mmol/l): 0.509202522,log10 hdl cholesterol (mmol/l): 0.170261715,log10 total triglycerides (mmol/l): 0.113943352,log10 serum apoa1 (g/l): 0.133538908,log10 serum apob (g/l): -0.070581074,log10 urinary albumin excretion rate (ug/min): 0.764787289
675 Charles E. Young Dr. S. MRL 3220
Los Angeles
USA
University of California Los Angeles
Mete,,Civelek
Illumina Casava1.7 software used for basecalling.,Sequencing files were converted to FASTQ format using a custom Perl script. In order to assign the indexed reads to each METSIM subject, a Python script was used to partition the FASTQ file for each lane into multiple FASTQ files, each of which corresponded to one individual. To be included in the partitioned file, a read had to have an exact match to one of the 48 possible index sequences, unambiguously identifying the individual from whom the read originated. Reads which did not exactly match an index sequence were discarded.,The reads were then aligned to the hg19 version of the genome using the Novoalign tool with the following settings: -l16 -t30 -h90 -rA -R 1 -m -g 200 –k. Novoalign software trims the adapter sequences while aligning.,We used the Bioconductor package GenomicRanges for R (v.2.14.0) to count the number of reads with alignment coordinates that overlap the coordinates of known mature miRNAs. Whenever a read mapped to 'x' genomic loci, the read would contribute a count of 1/x to those regions. The genomic coordinates for known mature miRNAs were downloaded from miRBase version 18.,To enable comparison of counts between samples, we normalized the expression values by dividing the counts for a given mature miRNA by the sum of all the miRNA counts for the corresponding individual. For subsequent analysis, we considered the expression levels of 356 miRNAs that had at least 5 reads in half of the study participants.,Genome_build: hg19,Supplementary_files_format_and_content: tab-delimited text files include unnormalized weighted counts for each miRNA
Abdominal subcutaneous adipose tissue was obtained with needle biopsies. Total RNA was isolated from the adipose tissue using Qiagen miRNeasy kit according to manufacturer’s instructions. RNA Integrity Number (RIN) values were assessed with the Agilent Bioanalyzer 2100 instrument. Samples with RIN values greater than 7.0 were used for transcriptional profiling.,Small RNA libraries were prepared using the Illumina TruSeq Small RNA protocol utilizing up to 48 unique index sequences (Illumina Catalog Number FC-102-1009). For two samples (METSIM490 and METSIM6589) we also prepared small RNA libraries using Illumina Small RNA v1.5 sample preparation protocol (Catalog # FC-930-1501)
GSM1098373
Illumina HiSeq 2000
May 15 2019
size fractionation
transcriptomic
RNA-Seq
total RNA
Homo sapiens
GPL11154
SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX249272,BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN01978200
GSM1098373
GSE45159
0.006222
adipose tissue
Public on Apr 01 2013
Mar 14 2013
9606
METSIM7717
SRA
https://www.ncbi.nlm.nih.gov/sra?term=SRX249272
https://www.ncbi.nlm.nih.gov/biosample/SAMN01978200
1
age: 57,tissue: adipose tissue,log10 body mass index: 1.39498930656603,log10 basal metabolic rate (kcal): 1645,log2 estimated glomerular filtration rate using modification of diet in renal disease (egfr_mdrd): 6.50062976688509,log10 estimated creatinine clearance rate using cockfcrot-gault formulaa (egcr): 6.47079015248221,plasma free fatty acids under the curve ogtt (mmol/l * min): 10.2,fat mass (%): 12.2,log10 plasma glucose area under the curve (ogtt) (mmol/l * min): 9.74483383749955,plasma glucose area under the curve above basal (ogtt) (mmol/l * min): 222,log10 homair (insulin resistance index based on homa): -0.500898235252165,log10 homais (insulin secretion index based on homa): 1.52287874523691,log10 insulin area under the curve (ogtt) (pmol/l * min): 4.5520085915843,insgenin (insulinogenic index): 1.8866726285976,log10 insulin area under the curve above basal (ogtt) (pmol/l * min): 4.4160717760782,log10 matsuda insulin sensitivity index: 0.534404469414011,muscle mass (%): 51.4,lg10 serum c-reactive protein (mg/l): NA,lg10 plasma adiponectin (mg/l): 0.944482672150169,ogtt fasting plasma free fatty acid (mmol/l): 0.42,ogtt 30 min plasma free fatty acid (mmol/l): 0.05,ogtt 120 min plasma free fatty acid (mmol/l): 0.02,ogtt fasting plasma glucose (mmol/l): 5.3,ogtt 30 min plasma glucose (mmol/l): 6.1,ogtt 120 min plasma glucose (mmol/l): 8.4,log10 il1 receptor antagonist (pg/ml): NA,log10 il1 beta (pg/ml): NA,log10 ogtt fasting plasma insulin (mu/l): 0.477121254719662,ogtt 30 min plasma insulin (mu/l): 1.63144376901317,ogtt 120 min plasma insulin (mu/l): 1.48995847942483,log10 ogtt fasting plasma proinsulin (pm/l): NA,ogtt 30 min plasma proinsulin (pm/l): NA,ogtt 120 min plasma proinsulin (pm/l): NA,log10 bioimpedance: Resistance: 2.58658730467175,log10 bioimpedance (reactance): 1.63346845557959,waist to hip ratio: 0.885416667,log10 serum bilirubin (umol/l): 1.04139268515822,log10 serum alanine aminotransfrase (u/l): 1.43136376415899,log10 creatinine (umol/l): 1.90848501887865,log10 total cholesterol (mmol/l): 0.751279103983342,log10 ldl cholesterol (mmol/l): 0.301029995663981,log10 hdl cholesterol (mmol/l): 0.444044795918076,log10 total triglycerides (mmol/l): -0.0132282657337552,log10 serum apoa1 (g/l): 0.257678574869184,log10 serum apob (g/l): -0.0604807473813815,log10 urinary albumin excretion rate (ug/min): 0.949742008220188
675 Charles E. Young Dr. S. MRL 3220
Los Angeles
USA
University of California Los Angeles
Mete,,Civelek
Illumina Casava1.7 software used for basecalling.,Sequencing files were converted to FASTQ format using a custom Perl script. In order to assign the indexed reads to each METSIM subject, a Python script was used to partition the FASTQ file for each lane into multiple FASTQ files, each of which corresponded to one individual. To be included in the partitioned file, a read had to have an exact match to one of the 48 possible index sequences, unambiguously identifying the individual from whom the read originated. Reads which did not exactly match an index sequence were discarded.,The reads were then aligned to the hg19 version of the genome using the Novoalign tool with the following settings: -l16 -t30 -h90 -rA -R 1 -m -g 200 –k. Novoalign software trims the adapter sequences while aligning.,We used the Bioconductor package GenomicRanges for R (v.2.14.0) to count the number of reads with alignment coordinates that overlap the coordinates of known mature miRNAs. Whenever a read mapped to 'x' genomic loci, the read would contribute a count of 1/x to those regions. The genomic coordinates for known mature miRNAs were downloaded from miRBase version 18.,To enable comparison of counts between samples, we normalized the expression values by dividing the counts for a given mature miRNA by the sum of all the miRNA counts for the corresponding individual. For subsequent analysis, we considered the expression levels of 356 miRNAs that had at least 5 reads in half of the study participants.,Genome_build: hg19,Supplementary_files_format_and_content: tab-delimited text files include unnormalized weighted counts for each miRNA
Abdominal subcutaneous adipose tissue was obtained with needle biopsies. Total RNA was isolated from the adipose tissue using Qiagen miRNeasy kit according to manufacturer’s instructions. RNA Integrity Number (RIN) values were assessed with the Agilent Bioanalyzer 2100 instrument. Samples with RIN values greater than 7.0 were used for transcriptional profiling.,Small RNA libraries were prepared using the Illumina TruSeq Small RNA protocol utilizing up to 48 unique index sequences (Illumina Catalog Number FC-102-1009). For two samples (METSIM490 and METSIM6589) we also prepared small RNA libraries using Illumina Small RNA v1.5 sample preparation protocol (Catalog # FC-930-1501)
GSM1098374
Illumina HiSeq 2000
May 15 2019
size fractionation
transcriptomic
RNA-Seq
total RNA
Homo sapiens
GPL11154
SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX249273,BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN01978201
GSM1098374
GSE45159
0.3539
adipose tissue
Public on Apr 01 2013
Mar 14 2013
9606
METSIM7897
SRA
https://www.ncbi.nlm.nih.gov/sra?term=SRX249273
https://www.ncbi.nlm.nih.gov/biosample/SAMN01978201
1
age: 66,tissue: adipose tissue,log10 body mass index: 1.305339969,log10 basal metabolic rate (kcal): 1547,log2 estimated glomerular filtration rate using modification of diet in renal disease (egfr_mdrd): 6.263886322,log10 estimated creatinine clearance rate using cockfcrot-gault formulaa (egcr): 5.997708097,plasma free fatty acids under the curve ogtt (mmol/l * min): 13.8,fat mass (%): 21.9,log10 plasma glucose area under the curve (ogtt) (mmol/l * min): 9.582141982,plasma glucose area under the curve above basal (ogtt) (mmol/l * min): 142.5,log10 homair (insulin resistance index based on homa): -0.045114567,log10 homais (insulin secretion index based on homa): 1.661645681,log10 insulin area under the curve (ogtt) (pmol/l * min): 4.232538718,insgenin (insulinogenic index): 1.705696868,log10 insulin area under the curve above basal (ogtt) (pmol/l * min): 4.154545692,log10 matsuda insulin sensitivity index: 1.085902215,muscle mass (%): 46.1,lg10 serum c-reactive protein (mg/l): -0.102372909,lg10 plasma adiponectin (mg/l): 1.037426498,ogtt fasting plasma free fatty acid (mmol/l): 0.28,ogtt 30 min plasma free fatty acid (mmol/l): 0.13,ogtt 120 min plasma free fatty acid (mmol/l): 0.04,ogtt fasting plasma glucose (mmol/l): 5.2,ogtt 30 min plasma glucose (mmol/l): 9.3,ogtt 120 min plasma glucose (mmol/l): 2.9,log10 il1 receptor antagonist (pg/ml): 2.080193419,log10 il1 beta (pg/ml): NA,log10 ogtt fasting plasma insulin (mu/l): 0.591064607,ogtt 30 min plasma insulin (mu/l): 1.586587305,ogtt 120 min plasma insulin (mu/l): 1.021189299,log10 ogtt fasting plasma proinsulin (pm/l): 1.071882007,ogtt 30 min plasma proinsulin (pm/l): 1.503790683,ogtt 120 min plasma proinsulin (pm/l): 1.613841822,log10 bioimpedance: Resistance: 2.73479983,log10 bioimpedance (reactance): 1.740362689,waist to hip ratio: 0.880434783,log10 serum bilirubin (umol/l): 1.113943352,log10 serum alanine aminotransfrase (u/l): 1.278753601,log10 creatinine (umol/l): 1.959041392,log10 total cholesterol (mmol/l): 0.777426822,log10 ldl cholesterol (mmol/l): 0.571708832,log10 hdl cholesterol (mmol/l): 0.222716471,log10 total triglycerides (mmol/l): 0.146128036,log10 serum apoa1 (g/l): 0.170261715,log10 serum apob (g/l): 0.033423755,log10 urinary albumin excretion rate (ug/min): 1.329163104
675 Charles E. Young Dr. S. MRL 3220
Los Angeles
USA
University of California Los Angeles
Mete,,Civelek
Illumina Casava1.7 software used for basecalling.,Sequencing files were converted to FASTQ format using a custom Perl script. In order to assign the indexed reads to each METSIM subject, a Python script was used to partition the FASTQ file for each lane into multiple FASTQ files, each of which corresponded to one individual. To be included in the partitioned file, a read had to have an exact match to one of the 48 possible index sequences, unambiguously identifying the individual from whom the read originated. Reads which did not exactly match an index sequence were discarded.,The reads were then aligned to the hg19 version of the genome using the Novoalign tool with the following settings: -l16 -t30 -h90 -rA -R 1 -m -g 200 –k. Novoalign software trims the adapter sequences while aligning.,We used the Bioconductor package GenomicRanges for R (v.2.14.0) to count the number of reads with alignment coordinates that overlap the coordinates of known mature miRNAs. Whenever a read mapped to 'x' genomic loci, the read would contribute a count of 1/x to those regions. The genomic coordinates for known mature miRNAs were downloaded from miRBase version 18.,To enable comparison of counts between samples, we normalized the expression values by dividing the counts for a given mature miRNA by the sum of all the miRNA counts for the corresponding individual. For subsequent analysis, we considered the expression levels of 356 miRNAs that had at least 5 reads in half of the study participants.,Genome_build: hg19,Supplementary_files_format_and_content: tab-delimited text files include unnormalized weighted counts for each miRNA
Abdominal subcutaneous adipose tissue was obtained with needle biopsies. Total RNA was isolated from the adipose tissue using Qiagen miRNeasy kit according to manufacturer’s instructions. RNA Integrity Number (RIN) values were assessed with the Agilent Bioanalyzer 2100 instrument. Samples with RIN values greater than 7.0 were used for transcriptional profiling.,Small RNA libraries were prepared using the Illumina TruSeq Small RNA protocol utilizing up to 48 unique index sequences (Illumina Catalog Number FC-102-1009). For two samples (METSIM490 and METSIM6589) we also prepared small RNA libraries using Illumina Small RNA v1.5 sample preparation protocol (Catalog # FC-930-1501)
GSM1098375
Illumina HiSeq 2000
May 15 2019
size fractionation
transcriptomic
RNA-Seq
total RNA
Homo sapiens
GPL11154
SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX249274,BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN01978202
GSM1098375
GSE45159
0.22761
adipose tissue
Public on Apr 01 2013
Mar 14 2013
9606
METSIM7927
SRA
https://www.ncbi.nlm.nih.gov/sra?term=SRX249274
https://www.ncbi.nlm.nih.gov/biosample/SAMN01978202
1
age: 55,tissue: adipose tissue,log10 body mass index: 1.39614807,log10 basal metabolic rate (kcal): 1556,log2 estimated glomerular filtration rate using modification of diet in renal disease (egfr_mdrd): 6.661568137,log10 estimated creatinine clearance rate using cockfcrot-gault formulaa (egcr): 6.781389161,plasma free fatty acids under the curve ogtt (mmol/l * min): 7.8,fat mass (%): 18.4,log10 plasma glucose area under the curve (ogtt) (mmol/l * min): 9.784634846,plasma glucose area under the curve above basal (ogtt) (mmol/l * min): 186,log10 homair (insulin resistance index based on homa): 0.127248819,log10 homais (insulin secretion index based on homa): 1.655305503,log10 insulin area under the curve (ogtt) (pmol/l * min): 4.502263204,insgenin (insulinogenic index): 1.95568775,log10 insulin area under the curve above basal (ogtt) (pmol/l * min): 4.447839958,log10 matsuda insulin sensitivity index: 0.830764204,muscle mass (%): 44.9,lg10 serum c-reactive protein (mg/l): 0.133538908,lg10 plasma adiponectin (mg/l): 1.225309282,ogtt fasting plasma free fatty acid (mmol/l): 0.11,ogtt 30 min plasma free fatty acid (mmol/l): 0.08,ogtt 120 min plasma free fatty acid (mmol/l): 0.03,ogtt fasting plasma glucose (mmol/l): 5.8,ogtt 30 min plasma glucose (mmol/l): 9.8,ogtt 120 min plasma glucose (mmol/l): 4.6,log10 il1 receptor antagonist (pg/ml): 2.209515015,log10 il1 beta (pg/ml): NA,log10 ogtt fasting plasma insulin (mu/l): 0.716003344,ogtt 30 min plasma insulin (mu/l): 1.815577748,ogtt 120 min plasma insulin (mu/l): 1.459392488,log10 ogtt fasting plasma proinsulin (pm/l): 0.913813852,ogtt 30 min plasma proinsulin (pm/l): 1.285557309,ogtt 120 min plasma proinsulin (pm/l): 1.457881897,log10 bioimpedance: Resistance: 2.682145076,log10 bioimpedance (reactance): 1.653212514,waist to hip ratio: 1.086956522,log10 serum bilirubin (umol/l): 0.84509804,log10 serum alanine aminotransfrase (u/l): 1.51851394,log10 creatinine (umol/l): 1.86923172,log10 total cholesterol (mmol/l): 0.643452676,log10 ldl cholesterol (mmol/l): 0.372912003,log10 hdl cholesterol (mmol/l): 0.181843588,log10 total triglycerides (mmol/l): -0.026872146,log10 serum apoa1 (g/l): 0.158362492,log10 serum apob (g/l): -0.13076828,log10 urinary albumin excretion rate (ug/min): 0.943331206
675 Charles E. Young Dr. S. MRL 3220
Los Angeles
USA
University of California Los Angeles
Mete,,Civelek
Illumina Casava1.7 software used for basecalling.,Sequencing files were converted to FASTQ format using a custom Perl script. In order to assign the indexed reads to each METSIM subject, a Python script was used to partition the FASTQ file for each lane into multiple FASTQ files, each of which corresponded to one individual. To be included in the partitioned file, a read had to have an exact match to one of the 48 possible index sequences, unambiguously identifying the individual from whom the read originated. Reads which did not exactly match an index sequence were discarded.,The reads were then aligned to the hg19 version of the genome using the Novoalign tool with the following settings: -l16 -t30 -h90 -rA -R 1 -m -g 200 –k. Novoalign software trims the adapter sequences while aligning.,We used the Bioconductor package GenomicRanges for R (v.2.14.0) to count the number of reads with alignment coordinates that overlap the coordinates of known mature miRNAs. Whenever a read mapped to 'x' genomic loci, the read would contribute a count of 1/x to those regions. The genomic coordinates for known mature miRNAs were downloaded from miRBase version 18.,To enable comparison of counts between samples, we normalized the expression values by dividing the counts for a given mature miRNA by the sum of all the miRNA counts for the corresponding individual. For subsequent analysis, we considered the expression levels of 356 miRNAs that had at least 5 reads in half of the study participants.,Genome_build: hg19,Supplementary_files_format_and_content: tab-delimited text files include unnormalized weighted counts for each miRNA
Abdominal subcutaneous adipose tissue was obtained with needle biopsies. Total RNA was isolated from the adipose tissue using Qiagen miRNeasy kit according to manufacturer’s instructions. RNA Integrity Number (RIN) values were assessed with the Agilent Bioanalyzer 2100 instrument. Samples with RIN values greater than 7.0 were used for transcriptional profiling.,Small RNA libraries were prepared using the Illumina TruSeq Small RNA protocol utilizing up to 48 unique index sequences (Illumina Catalog Number FC-102-1009). For two samples (METSIM490 and METSIM6589) we also prepared small RNA libraries using Illumina Small RNA v1.5 sample preparation protocol (Catalog # FC-930-1501)
GSM1098376
Illumina HiSeq 2000
May 15 2019
size fractionation
transcriptomic
RNA-Seq
total RNA
Homo sapiens
GPL11154
SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX249275,BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN01978203
GSM1098376
GSE45159
0.159709
adipose tissue
Public on Apr 01 2013
Mar 14 2013
9606
METSIM7948
SRA
https://www.ncbi.nlm.nih.gov/sra?term=SRX249275
https://www.ncbi.nlm.nih.gov/biosample/SAMN01978203
1
age: 52,tissue: adipose tissue,log10 body mass index: 1.321147221,log10 basal metabolic rate (kcal): 1552,log2 estimated glomerular filtration rate using modification of diet in renal disease (egfr_mdrd): 6.408547286,log10 estimated creatinine clearance rate using cockfcrot-gault formulaa (egcr): 6.356931614,plasma free fatty acids under the curve ogtt (mmol/l * min): 16.5,fat mass (%): 11.8,log10 plasma glucose area under the curve (ogtt) (mmol/l * min): 9.911391988,plasma glucose area under the curve above basal (ogtt) (mmol/l * min): 291,log10 homair (insulin resistance index based on homa): -0.141596493,log10 homais (insulin secretion index based on homa): 1.441208699,log10 insulin area under the curve (ogtt) (pmol/l * min): 4.218115186,insgenin (insulinogenic index): 1.329720249,log10 insulin area under the curve above basal (ogtt) (pmol/l * min): 4.159446873,log10 matsuda insulin sensitivity index: 1.067256369,muscle mass (%): 49.7,lg10 serum c-reactive protein (mg/l): -0.468521083,lg10 plasma adiponectin (mg/l): 0.886490725,ogtt fasting plasma free fatty acid (mmol/l): 0.36,ogtt 30 min plasma free fatty acid (mmol/l): 0.17,ogtt 120 min plasma free fatty acid (mmol/l): 0.02,ogtt fasting plasma glucose (mmol/l): 5.6,ogtt 30 min plasma glucose (mmol/l): 9.7,ogtt 120 min plasma glucose (mmol/l): 6.6,log10 il1 receptor antagonist (pg/ml): 2.112806017,log10 il1 beta (pg/ml): NA,log10 ogtt fasting plasma insulin (mu/l): 0.462397998,ogtt 30 min plasma insulin (mu/l): 1.243038049,ogtt 120 min plasma insulin (mu/l): 1.567026366,log10 ogtt fasting plasma proinsulin (pm/l): 0.944482672,ogtt 30 min plasma proinsulin (pm/l): 1.089905111,ogtt 120 min plasma proinsulin (pm/l): 1.767897616,log10 bioimpedance: Resistance: 2.667452953,log10 bioimpedance (reactance): 1.662757832,waist to hip ratio: 0.873684211,log10 serum bilirubin (umol/l): 1.176091259,log10 serum alanine aminotransfrase (u/l): 1.278753601,log10 creatinine (umol/l): 1.939519253,log10 total cholesterol (mmol/l): 0.79518459,log10 ldl cholesterol (mmol/l): 0.600972896,log10 hdl cholesterol (mmol/l): 0.271841607,log10 total triglycerides (mmol/l): -0.142667504,log10 serum apoa1 (g/l): 0.214843848,log10 serum apob (g/l): 0.025305865,log10 urinary albumin excretion rate (ug/min): 1.000876478
675 Charles E. Young Dr. S. MRL 3220
Los Angeles
USA
University of California Los Angeles
Mete,,Civelek
Illumina Casava1.7 software used for basecalling.,Sequencing files were converted to FASTQ format using a custom Perl script. In order to assign the indexed reads to each METSIM subject, a Python script was used to partition the FASTQ file for each lane into multiple FASTQ files, each of which corresponded to one individual. To be included in the partitioned file, a read had to have an exact match to one of the 48 possible index sequences, unambiguously identifying the individual from whom the read originated. Reads which did not exactly match an index sequence were discarded.,The reads were then aligned to the hg19 version of the genome using the Novoalign tool with the following settings: -l16 -t30 -h90 -rA -R 1 -m -g 200 –k. Novoalign software trims the adapter sequences while aligning.,We used the Bioconductor package GenomicRanges for R (v.2.14.0) to count the number of reads with alignment coordinates that overlap the coordinates of known mature miRNAs. Whenever a read mapped to 'x' genomic loci, the read would contribute a count of 1/x to those regions. The genomic coordinates for known mature miRNAs were downloaded from miRBase version 18.,To enable comparison of counts between samples, we normalized the expression values by dividing the counts for a given mature miRNA by the sum of all the miRNA counts for the corresponding individual. For subsequent analysis, we considered the expression levels of 356 miRNAs that had at least 5 reads in half of the study participants.,Genome_build: hg19,Supplementary_files_format_and_content: tab-delimited text files include unnormalized weighted counts for each miRNA
Abdominal subcutaneous adipose tissue was obtained with needle biopsies. Total RNA was isolated from the adipose tissue using Qiagen miRNeasy kit according to manufacturer’s instructions. RNA Integrity Number (RIN) values were assessed with the Agilent Bioanalyzer 2100 instrument. Samples with RIN values greater than 7.0 were used for transcriptional profiling.,Small RNA libraries were prepared using the Illumina TruSeq Small RNA protocol utilizing up to 48 unique index sequences (Illumina Catalog Number FC-102-1009). For two samples (METSIM490 and METSIM6589) we also prepared small RNA libraries using Illumina Small RNA v1.5 sample preparation protocol (Catalog # FC-930-1501)
GSM1098377
Illumina HiSeq 2000
May 15 2019
size fractionation
transcriptomic
RNA-Seq
total RNA
Homo sapiens
GPL11154
SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX249276,BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN01978204
GSM1098377
GSE45159
0.161784
adipose tissue
Public on Apr 01 2013
Mar 14 2013
9606
METSIM7954
SRA
https://www.ncbi.nlm.nih.gov/sra?term=SRX249276
https://www.ncbi.nlm.nih.gov/biosample/SAMN01978204
1
age: 47,tissue: adipose tissue,log10 body mass index: 1.378849373,log10 basal metabolic rate (kcal): 1910,log2 estimated glomerular filtration rate using modification of diet in renal disease (egfr_mdrd): 6.824074583,log10 estimated creatinine clearance rate using cockfcrot-gault formulaa (egcr): 7.066533729,plasma free fatty acids under the curve ogtt (mmol/l * min): 17.25,fat mass (%): 14.5,log10 plasma glucose area under the curve (ogtt) (mmol/l * min): 9.813781191,plasma glucose area under the curve above basal (ogtt) (mmol/l * min): 192,log10 homair (insulin resistance index based on homa): -0.00154691,log10 homais (insulin secretion index based on homa): 1.500602351,log10 insulin area under the curve (ogtt) (pmol/l * min): 4.125090713,insgenin (insulinogenic index): 1.7307266,log10 insulin area under the curve above basal (ogtt) (pmol/l * min): 4.0253878,log10 matsuda insulin sensitivity index: 1.073796653,muscle mass (%): 51.8,lg10 serum c-reactive protein (mg/l): -0.48148606,lg10 plasma adiponectin (mg/l): 1.136720567,ogtt fasting plasma free fatty acid (mmol/l): 0.38,ogtt 30 min plasma free fatty acid (mmol/l): 0.17,ogtt 120 min plasma free fatty acid (mmol/l): 0.03,ogtt fasting plasma glucose (mmol/l): 5.9,ogtt 30 min plasma glucose (mmol/l): 8.8,ogtt 120 min plasma glucose (mmol/l): 6.3,log10 il1 receptor antagonist (pg/ml): 2.201096565,log10 il1 beta (pg/ml): NA,log10 ogtt fasting plasma insulin (mu/l): 0.579783597,ogtt 30 min plasma insulin (mu/l): 1.474216264,ogtt 120 min plasma insulin (mu/l): 0.924279286,log10 ogtt fasting plasma proinsulin (pm/l): 1.167317335,ogtt 30 min plasma proinsulin (pm/l): 1.605305046,ogtt 120 min plasma proinsulin (pm/l): 1.596597096,log10 bioimpedance: Resistance: 2.620136055,log10 bioimpedance (reactance): 1.698970004,waist to hip ratio: 0.878787879,log10 serum bilirubin (umol/l): 1.301029996,log10 serum alanine aminotransfrase (u/l): 1.322219295,log10 creatinine (umol/l): 1.838849091,log10 total cholesterol (mmol/l): 0.72916479,log10 ldl cholesterol (mmol/l): 0.45331834,log10 hdl cholesterol (mmol/l): 0.326335861,log10 total triglycerides (mmol/l): 0.10720997,log10 serum apoa1 (g/l): 0.290034611,log10 serum apob (g/l): -0.080921908,log10 urinary albumin excretion rate (ug/min): 1.124938736
675 Charles E. Young Dr. S. MRL 3220
Los Angeles
USA
University of California Los Angeles
Mete,,Civelek
Illumina Casava1.7 software used for basecalling.,Sequencing files were converted to FASTQ format using a custom Perl script. In order to assign the indexed reads to each METSIM subject, a Python script was used to partition the FASTQ file for each lane into multiple FASTQ files, each of which corresponded to one individual. To be included in the partitioned file, a read had to have an exact match to one of the 48 possible index sequences, unambiguously identifying the individual from whom the read originated. Reads which did not exactly match an index sequence were discarded.,The reads were then aligned to the hg19 version of the genome using the Novoalign tool with the following settings: -l16 -t30 -h90 -rA -R 1 -m -g 200 –k. Novoalign software trims the adapter sequences while aligning.,We used the Bioconductor package GenomicRanges for R (v.2.14.0) to count the number of reads with alignment coordinates that overlap the coordinates of known mature miRNAs. Whenever a read mapped to 'x' genomic loci, the read would contribute a count of 1/x to those regions. The genomic coordinates for known mature miRNAs were downloaded from miRBase version 18.,To enable comparison of counts between samples, we normalized the expression values by dividing the counts for a given mature miRNA by the sum of all the miRNA counts for the corresponding individual. For subsequent analysis, we considered the expression levels of 356 miRNAs that had at least 5 reads in half of the study participants.,Genome_build: hg19,Supplementary_files_format_and_content: tab-delimited text files include unnormalized weighted counts for each miRNA
Abdominal subcutaneous adipose tissue was obtained with needle biopsies. Total RNA was isolated from the adipose tissue using Qiagen miRNeasy kit according to manufacturer’s instructions. RNA Integrity Number (RIN) values were assessed with the Agilent Bioanalyzer 2100 instrument. Samples with RIN values greater than 7.0 were used for transcriptional profiling.,Small RNA libraries were prepared using the Illumina TruSeq Small RNA protocol utilizing up to 48 unique index sequences (Illumina Catalog Number FC-102-1009). For two samples (METSIM490 and METSIM6589) we also prepared small RNA libraries using Illumina Small RNA v1.5 sample preparation protocol (Catalog # FC-930-1501)
GSM1098378
Illumina HiSeq 2000
May 15 2019
size fractionation
transcriptomic
RNA-Seq
total RNA
Homo sapiens
GPL11154
SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX249277,BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN01978205
GSM1098378
GSE45159
0.304591
adipose tissue
Public on Apr 01 2013
Mar 14 2013
9606
METSIM7988
SRA
https://www.ncbi.nlm.nih.gov/sra?term=SRX249277
https://www.ncbi.nlm.nih.gov/biosample/SAMN01978205
1
age: 61,tissue: adipose tissue,log10 body mass index: 1.458333616,log10 basal metabolic rate (kcal): 1736,log2 estimated glomerular filtration rate using modification of diet in renal disease (egfr_mdrd): 6.361796869,log10 estimated creatinine clearance rate using cockfcrot-gault formulaa (egcr): 6.640702401,plasma free fatty acids under the curve ogtt (mmol/l * min): 16.95,fat mass (%): 27.6,log10 plasma glucose area under the curve (ogtt) (mmol/l * min): 9.747353829,plasma glucose area under the curve above basal (ogtt) (mmol/l * min): 151.5,log10 homair (insulin resistance index based on homa): 0.3680595,log10 homais (insulin secretion index based on homa): 1.870208761,log10 insulin area under the curve (ogtt) (pmol/l * min): 4.603772075,insgenin (insulinogenic index): 2.349106039,log10 insulin area under the curve above basal (ogtt) (pmol/l * min): 4.528273777,log10 matsuda insulin sensitivity index: 0.647879221,muscle mass (%): 46.7,lg10 serum c-reactive protein (mg/l): -0.031517051,lg10 plasma adiponectin (mg/l): 1.173186268,ogtt fasting plasma free fatty acid (mmol/l): 0.3,ogtt 30 min plasma free fatty acid (mmol/l): 0.17,ogtt 120 min plasma free fatty acid (mmol/l): 0.05,ogtt fasting plasma glucose (mmol/l): 5.9,ogtt 30 min plasma glucose (mmol/l): 7.6,ogtt 120 min plasma glucose (mmol/l): 7,log10 il1 receptor antagonist (pg/ml): 2.273695588,log10 il1 beta (pg/ml): NA,log10 ogtt fasting plasma insulin (mu/l): 0.949390007,ogtt 30 min plasma insulin (mu/l): 1.858537198,ogtt 120 min plasma insulin (mu/l): 1.694605199,log10 ogtt fasting plasma proinsulin (pm/l): 1.173186268,ogtt 30 min plasma proinsulin (pm/l): 1.565847819,ogtt 120 min plasma proinsulin (pm/l): 1.745074792,log10 bioimpedance: Resistance: 2.617000341,log10 bioimpedance (reactance): 1.662757832,waist to hip ratio: 0.990196078,log10 serum bilirubin (umol/l): 1.079181246,log10 serum alanine aminotransfrase (u/l): 1.755874856,log10 creatinine (umol/l): 1.939519253,log10 total cholesterol (mmol/l): 0.874481818,log10 ldl cholesterol (mmol/l): 0.716003344,log10 hdl cholesterol (mmol/l): 0.064457989,log10 total triglycerides (mmol/l): 0.387389826,log10 serum apoa1 (g/l): 0.139879086,log10 serum apob (g/l): 0.190331698,log10 urinary albumin excretion rate (ug/min): 1.167136416
675 Charles E. Young Dr. S. MRL 3220
Los Angeles
USA
University of California Los Angeles
Mete,,Civelek
Illumina Casava1.7 software used for basecalling.,Sequencing files were converted to FASTQ format using a custom Perl script. In order to assign the indexed reads to each METSIM subject, a Python script was used to partition the FASTQ file for each lane into multiple FASTQ files, each of which corresponded to one individual. To be included in the partitioned file, a read had to have an exact match to one of the 48 possible index sequences, unambiguously identifying the individual from whom the read originated. Reads which did not exactly match an index sequence were discarded.,The reads were then aligned to the hg19 version of the genome using the Novoalign tool with the following settings: -l16 -t30 -h90 -rA -R 1 -m -g 200 –k. Novoalign software trims the adapter sequences while aligning.,We used the Bioconductor package GenomicRanges for R (v.2.14.0) to count the number of reads with alignment coordinates that overlap the coordinates of known mature miRNAs. Whenever a read mapped to 'x' genomic loci, the read would contribute a count of 1/x to those regions. The genomic coordinates for known mature miRNAs were downloaded from miRBase version 18.,To enable comparison of counts between samples, we normalized the expression values by dividing the counts for a given mature miRNA by the sum of all the miRNA counts for the corresponding individual. For subsequent analysis, we considered the expression levels of 356 miRNAs that had at least 5 reads in half of the study participants.,Genome_build: hg19,Supplementary_files_format_and_content: tab-delimited text files include unnormalized weighted counts for each miRNA
Abdominal subcutaneous adipose tissue was obtained with needle biopsies. Total RNA was isolated from the adipose tissue using Qiagen miRNeasy kit according to manufacturer’s instructions. RNA Integrity Number (RIN) values were assessed with the Agilent Bioanalyzer 2100 instrument. Samples with RIN values greater than 7.0 were used for transcriptional profiling.,Small RNA libraries were prepared using the Illumina TruSeq Small RNA protocol utilizing up to 48 unique index sequences (Illumina Catalog Number FC-102-1009). For two samples (METSIM490 and METSIM6589) we also prepared small RNA libraries using Illumina Small RNA v1.5 sample preparation protocol (Catalog # FC-930-1501)
GSM1098379
Illumina HiSeq 2000
May 15 2019
size fractionation
transcriptomic
RNA-Seq
total RNA
Homo sapiens
GPL11154
SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX249278,BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN01978206
GSM1098379
GSE45159
0.313981
adipose tissue
Public on Apr 01 2013
Mar 14 2013
9606
METSIM8054
SRA
https://www.ncbi.nlm.nih.gov/sra?term=SRX249278
https://www.ncbi.nlm.nih.gov/biosample/SAMN01978206
1
age: 58,tissue: adipose tissue,log10 body mass index: 1.407569229,log10 basal metabolic rate (kcal): 1683,log2 estimated glomerular filtration rate using modification of diet in renal disease (egfr_mdrd): 6.69162975,log10 estimated creatinine clearance rate using cockfcrot-gault formulaa (egcr): 6.741064217,plasma free fatty acids under the curve ogtt (mmol/l * min): 9.15,fat mass (%): 16.5,log10 plasma glucose area under the curve (ogtt) (mmol/l * min): 9.46454575,plasma glucose area under the curve above basal (ogtt) (mmol/l * min): -1.5,log10 homair (insulin resistance index based on homa): 0.117639498,log10 homais (insulin secretion index based on homa): 1.619788758,log10 insulin area under the curve (ogtt) (pmol/l * min): 4.2974541,insgenin (insulinogenic index): 2.171099313,log10 insulin area under the curve above basal (ogtt) (pmol/l * min): 4.210479043,log10 matsuda insulin sensitivity index: 0.96744496,muscle mass (%): 49.1,lg10 serum c-reactive protein (mg/l): -0.124938737,lg10 plasma adiponectin (mg/l): 0.86332286,ogtt fasting plasma free fatty acid (mmol/l): 0.16,ogtt 30 min plasma free fatty acid (mmol/l): 0.09,ogtt 120 min plasma free fatty acid (mmol/l): 0.03,ogtt fasting plasma glucose (mmol/l): 5.9,ogtt 30 min plasma glucose (mmol/l): 7.3,ogtt 120 min plasma glucose (mmol/l): 4,log10 il1 receptor antagonist (pg/ml): 2.145600358,log10 il1 beta (pg/ml): NA,log10 ogtt fasting plasma insulin (mu/l): 0.698970004,ogtt 30 min plasma insulin (mu/l): 1.597695186,ogtt 120 min plasma insulin (mu/l): 1.278753601,log10 ogtt fasting plasma proinsulin (pm/l): 1.021189299,ogtt 30 min plasma proinsulin (pm/l): 1.413299764,ogtt 120 min plasma proinsulin (pm/l): 1.523746467,log10 bioimpedance: Resistance: 2.632457292,log10 bioimpedance (reactance): 1.698970004,waist to hip ratio: 0.940594059,log10 serum bilirubin (umol/l): 1.176091259,log10 serum alanine aminotransfrase (u/l): 1.380211242,log10 creatinine (umol/l): 1.857332496,log10 total cholesterol (mmol/l): 0.769377326,log10 ldl cholesterol (mmol/l): 0.505149978,log10 hdl cholesterol (mmol/l): 0.324282455,log10 total triglycerides (mmol/l): 0.064457989,log10 serum apoa1 (g/l): 0.285557309,log10 serum apob (g/l): -0.026872146,log10 urinary albumin excretion rate (ug/min): 0.920818754
675 Charles E. Young Dr. S. MRL 3220
Los Angeles
USA
University of California Los Angeles
Mete,,Civelek
Illumina Casava1.7 software used for basecalling.,Sequencing files were converted to FASTQ format using a custom Perl script. In order to assign the indexed reads to each METSIM subject, a Python script was used to partition the FASTQ file for each lane into multiple FASTQ files, each of which corresponded to one individual. To be included in the partitioned file, a read had to have an exact match to one of the 48 possible index sequences, unambiguously identifying the individual from whom the read originated. Reads which did not exactly match an index sequence were discarded.,The reads were then aligned to the hg19 version of the genome using the Novoalign tool with the following settings: -l16 -t30 -h90 -rA -R 1 -m -g 200 –k. Novoalign software trims the adapter sequences while aligning.,We used the Bioconductor package GenomicRanges for R (v.2.14.0) to count the number of reads with alignment coordinates that overlap the coordinates of known mature miRNAs. Whenever a read mapped to 'x' genomic loci, the read would contribute a count of 1/x to those regions. The genomic coordinates for known mature miRNAs were downloaded from miRBase version 18.,To enable comparison of counts between samples, we normalized the expression values by dividing the counts for a given mature miRNA by the sum of all the miRNA counts for the corresponding individual. For subsequent analysis, we considered the expression levels of 356 miRNAs that had at least 5 reads in half of the study participants.,Genome_build: hg19,Supplementary_files_format_and_content: tab-delimited text files include unnormalized weighted counts for each miRNA
Abdominal subcutaneous adipose tissue was obtained with needle biopsies. Total RNA was isolated from the adipose tissue using Qiagen miRNeasy kit according to manufacturer’s instructions. RNA Integrity Number (RIN) values were assessed with the Agilent Bioanalyzer 2100 instrument. Samples with RIN values greater than 7.0 were used for transcriptional profiling.,Small RNA libraries were prepared using the Illumina TruSeq Small RNA protocol utilizing up to 48 unique index sequences (Illumina Catalog Number FC-102-1009). For two samples (METSIM490 and METSIM6589) we also prepared small RNA libraries using Illumina Small RNA v1.5 sample preparation protocol (Catalog # FC-930-1501)
GSM1098380
Illumina HiSeq 2000
May 15 2019
size fractionation
transcriptomic
RNA-Seq
total RNA
Homo sapiens
GPL11154
SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX249279,BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN01978207
GSM1098380
GSE45159
0.350909
adipose tissue
Public on Apr 01 2013
Mar 14 2013
9606
METSIM8067
SRA
https://www.ncbi.nlm.nih.gov/sra?term=SRX249279
https://www.ncbi.nlm.nih.gov/biosample/SAMN01978207
1
age: 67,tissue: adipose tissue,log10 body mass index: 1.411121148,log10 basal metabolic rate (kcal): 1667,log2 estimated glomerular filtration rate using modification of diet in renal disease (egfr_mdrd): 6.92540635,log10 estimated creatinine clearance rate using cockfcrot-gault formulaa (egcr): 7.124992201,plasma free fatty acids under the curve ogtt (mmol/l * min): 46.65,fat mass (%): 32.9,log10 plasma glucose area under the curve (ogtt) (mmol/l * min): 10.04644195,plasma glucose area under the curve above basal (ogtt) (mmol/l * min): 421.5,log10 homair (insulin resistance index based on homa): 0.178273325,log10 homais (insulin secretion index based on homa): 1.851937465,log10 insulin area under the curve (ogtt) (pmol/l * min): 4.364344586,insgenin (insulinogenic index): 1.699364638,log10 insulin area under the curve above basal (ogtt) (pmol/l * min): 4.267898856,log10 matsuda insulin sensitivity index: 0.829071452,muscle mass (%): 28.3,lg10 serum c-reactive protein (mg/l): 0.033423755,lg10 plasma adiponectin (mg/l): 1.012837225,ogtt fasting plasma free fatty acid (mmol/l): 0.76,ogtt 30 min plasma free fatty acid (mmol/l): 0.49,ogtt 120 min plasma free fatty acid (mmol/l): 0.13,ogtt fasting plasma glucose (mmol/l): 5.3,ogtt 30 min plasma glucose (mmol/l): 9.7,ogtt 120 min plasma glucose (mmol/l): 8.8,log10 il1 receptor antagonist (pg/ml): 2.465888243,log10 il1 beta (pg/ml): NA,log10 ogtt fasting plasma insulin (mu/l): 0.806179974,ogtt 30 min plasma insulin (mu/l): 1.63447727,ogtt 120 min plasma insulin (mu/l): 1.416640507,log10 ogtt fasting plasma proinsulin (pm/l): 0.903089987,ogtt 30 min plasma proinsulin (pm/l): 1.369215857,ogtt 120 min plasma proinsulin (pm/l): 1.713490543,log10 bioimpedance: Resistance: 2.716003344,log10 bioimpedance (reactance): 1.633468456,waist to hip ratio: 1.018691589,log10 serum bilirubin (umol/l): 1.602059991,log10 serum alanine aminotransfrase (u/l): 1.748188027,log10 creatinine (umol/l): 1.785329835,log10 total cholesterol (mmol/l): 0.804139432,log10 ldl cholesterol (mmol/l): 0.552668216,log10 hdl cholesterol (mmol/l): 0.387389826,log10 total triglycerides (mmol/l): -0.207608311,log10 serum apoa1 (g/l): 0.318063335,log10 serum apob (g/l): -0.022276395,log10 urinary albumin excretion rate (ug/min): 1.412536907
675 Charles E. Young Dr. S. MRL 3220
Los Angeles
USA
University of California Los Angeles
Mete,,Civelek
Illumina Casava1.7 software used for basecalling.,Sequencing files were converted to FASTQ format using a custom Perl script. In order to assign the indexed reads to each METSIM subject, a Python script was used to partition the FASTQ file for each lane into multiple FASTQ files, each of which corresponded to one individual. To be included in the partitioned file, a read had to have an exact match to one of the 48 possible index sequences, unambiguously identifying the individual from whom the read originated. Reads which did not exactly match an index sequence were discarded.,The reads were then aligned to the hg19 version of the genome using the Novoalign tool with the following settings: -l16 -t30 -h90 -rA -R 1 -m -g 200 –k. Novoalign software trims the adapter sequences while aligning.,We used the Bioconductor package GenomicRanges for R (v.2.14.0) to count the number of reads with alignment coordinates that overlap the coordinates of known mature miRNAs. Whenever a read mapped to 'x' genomic loci, the read would contribute a count of 1/x to those regions. The genomic coordinates for known mature miRNAs were downloaded from miRBase version 18.,To enable comparison of counts between samples, we normalized the expression values by dividing the counts for a given mature miRNA by the sum of all the miRNA counts for the corresponding individual. For subsequent analysis, we considered the expression levels of 356 miRNAs that had at least 5 reads in half of the study participants.,Genome_build: hg19,Supplementary_files_format_and_content: tab-delimited text files include unnormalized weighted counts for each miRNA
Abdominal subcutaneous adipose tissue was obtained with needle biopsies. Total RNA was isolated from the adipose tissue using Qiagen miRNeasy kit according to manufacturer’s instructions. RNA Integrity Number (RIN) values were assessed with the Agilent Bioanalyzer 2100 instrument. Samples with RIN values greater than 7.0 were used for transcriptional profiling.,Small RNA libraries were prepared using the Illumina TruSeq Small RNA protocol utilizing up to 48 unique index sequences (Illumina Catalog Number FC-102-1009). For two samples (METSIM490 and METSIM6589) we also prepared small RNA libraries using Illumina Small RNA v1.5 sample preparation protocol (Catalog # FC-930-1501)
GSM1098381
Illumina HiSeq 2000
May 15 2019
size fractionation
transcriptomic
RNA-Seq
total RNA
Homo sapiens
GPL11154
SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX249280,BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN01978208
GSM1098381
GSE45159
0.244681
adipose tissue
Public on Apr 01 2013
Mar 14 2013
9606
METSIM8135
SRA
https://www.ncbi.nlm.nih.gov/sra?term=SRX249280
https://www.ncbi.nlm.nih.gov/biosample/SAMN01978208
1
age: 66,tissue: adipose tissue,log10 body mass index: 1.488375019,log10 basal metabolic rate (kcal): 1607,log2 estimated glomerular filtration rate using modification of diet in renal disease (egfr_mdrd): 6.090305286,log10 estimated creatinine clearance rate using cockfcrot-gault formulaa (egcr): 6.447204097,plasma free fatty acids under the curve ogtt (mmol/l * min): 30.3,fat mass (%): 31.5,log10 plasma glucose area under the curve (ogtt) (mmol/l * min): 9.830515207,plasma glucose area under the curve above basal (ogtt) (mmol/l * min): 178.5,log10 homair (insulin resistance index based on homa): 0.26565623,log10 homais (insulin secretion index based on homa): 1.71856556,log10 insulin area under the curve (ogtt) (pmol/l * min): 4.647177512,insgenin (insulinogenic index): 2.344306825,log10 insulin area under the curve above basal (ogtt) (pmol/l * min): 4.596410144,log10 matsuda insulin sensitivity index: 0.676142101,muscle mass (%): 35.2,lg10 serum c-reactive protein (mg/l): 0.687528961,lg10 plasma adiponectin (mg/l): 0.857332496,ogtt fasting plasma free fatty acid (mmol/l): 0.34,ogtt 30 min plasma free fatty acid (mmol/l): 0.33,ogtt 120 min plasma free fatty acid (mmol/l): 0.12,ogtt fasting plasma glucose (mmol/l): 6.1,ogtt 30 min plasma glucose (mmol/l): 8.4,ogtt 120 min plasma glucose (mmol/l): 7,log10 il1 receptor antagonist (pg/ml): 2.415891078,log10 il1 beta (pg/ml): NA,log10 ogtt fasting plasma insulin (mu/l): 0.832508913,ogtt 30 min plasma insulin (mu/l): 1.961421094,ogtt 120 min plasma insulin (mu/l): 1.603144373,log10 ogtt fasting plasma proinsulin (pm/l): 1.260071388,ogtt 30 min plasma proinsulin (pm/l): 1.640481437,ogtt 120 min plasma proinsulin (pm/l): 1.92992956,log10 bioimpedance: Resistance: 2.62324929,log10 bioimpedance (reactance): 1.568201724,waist to hip ratio: 1,log10 serum bilirubin (umol/l): 1.255272505,log10 serum alanine aminotransfrase (u/l): 1.51851394,log10 creatinine (umol/l): 2.004321374,log10 total cholesterol (mmol/l): 0.687528961,log10 ldl cholesterol (mmol/l): 0.471291711,log10 hdl cholesterol (mmol/l): 0.139879086,log10 total triglycerides (mmol/l): 0.103803721,log10 serum apoa1 (g/l): 0.149219113,log10 serum apob (g/l): -0.017728767,log10 urinary albumin excretion rate (ug/min): 0.913979329
675 Charles E. Young Dr. S. MRL 3220
Los Angeles
USA
University of California Los Angeles
Mete,,Civelek
Illumina Casava1.7 software used for basecalling.,Sequencing files were converted to FASTQ format using a custom Perl script. In order to assign the indexed reads to each METSIM subject, a Python script was used to partition the FASTQ file for each lane into multiple FASTQ files, each of which corresponded to one individual. To be included in the partitioned file, a read had to have an exact match to one of the 48 possible index sequences, unambiguously identifying the individual from whom the read originated. Reads which did not exactly match an index sequence were discarded.,The reads were then aligned to the hg19 version of the genome using the Novoalign tool with the following settings: -l16 -t30 -h90 -rA -R 1 -m -g 200 –k. Novoalign software trims the adapter sequences while aligning.,We used the Bioconductor package GenomicRanges for R (v.2.14.0) to count the number of reads with alignment coordinates that overlap the coordinates of known mature miRNAs. Whenever a read mapped to 'x' genomic loci, the read would contribute a count of 1/x to those regions. The genomic coordinates for known mature miRNAs were downloaded from miRBase version 18.,To enable comparison of counts between samples, we normalized the expression values by dividing the counts for a given mature miRNA by the sum of all the miRNA counts for the corresponding individual. For subsequent analysis, we considered the expression levels of 356 miRNAs that had at least 5 reads in half of the study participants.,Genome_build: hg19,Supplementary_files_format_and_content: tab-delimited text files include unnormalized weighted counts for each miRNA
Abdominal subcutaneous adipose tissue was obtained with needle biopsies. Total RNA was isolated from the adipose tissue using Qiagen miRNeasy kit according to manufacturer’s instructions. RNA Integrity Number (RIN) values were assessed with the Agilent Bioanalyzer 2100 instrument. Samples with RIN values greater than 7.0 were used for transcriptional profiling.,Small RNA libraries were prepared using the Illumina TruSeq Small RNA protocol utilizing up to 48 unique index sequences (Illumina Catalog Number FC-102-1009). For two samples (METSIM490 and METSIM6589) we also prepared small RNA libraries using Illumina Small RNA v1.5 sample preparation protocol (Catalog # FC-930-1501)
GSM1098382
Illumina HiSeq 2000
May 15 2019
size fractionation
transcriptomic
RNA-Seq
total RNA
Homo sapiens
GPL11154
SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX249281,BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN01978209
GSM1098382
GSE45159
0.379856
adipose tissue
Public on Apr 01 2013
Mar 14 2013
9606
METSIM8305
SRA
https://www.ncbi.nlm.nih.gov/sra?term=SRX249281
https://www.ncbi.nlm.nih.gov/biosample/SAMN01978209
1
age: 64,tissue: adipose tissue,log10 body mass index: 1.346110948,log10 basal metabolic rate (kcal): 1511,log2 estimated glomerular filtration rate using modification of diet in renal disease (egfr_mdrd): 6.29129487,log10 estimated creatinine clearance rate using cockfcrot-gault formulaa (egcr): 6.063351044,plasma free fatty acids under the curve ogtt (mmol/l * min): 16.05,fat mass (%): 23,log10 plasma glucose area under the curve (ogtt) (mmol/l * min): 9.47370575,plasma glucose area under the curve above basal (ogtt) (mmol/l * min): -57,log10 homair (insulin resistance index based on homa): 0.087465911,log10 homais (insulin secretion index based on homa): 1.472100453,log10 insulin area under the curve (ogtt) (pmol/l * min): 4.317666442,insgenin (insulinogenic index): 2.698535493,log10 insulin area under the curve above basal (ogtt) (pmol/l * min): 4.247605064,log10 matsuda insulin sensitivity index: 0.962807002,muscle mass (%): 51.8,lg10 serum c-reactive protein (mg/l): -0.468521083,lg10 plasma adiponectin (mg/l): 0.770852012,ogtt fasting plasma free fatty acid (mmol/l): 0.38,ogtt 30 min plasma free fatty acid (mmol/l): 0.15,ogtt 120 min plasma free fatty acid (mmol/l): 0.03,ogtt fasting plasma glucose (mmol/l): 6.4,ogtt 30 min plasma glucose (mmol/l): 6.8,ogtt 120 min plasma glucose (mmol/l): 4.6,log10 il1 receptor antagonist (pg/ml): 1.920018916,log10 il1 beta (pg/ml): -1.045757491,log10 ogtt fasting plasma insulin (mu/l): 0.633468456,ogtt 30 min plasma insulin (mu/l): 1.575187845,ogtt 120 min plasma insulin (mu/l): 1.404833717,log10 ogtt fasting plasma proinsulin (pm/l): 0.919078092,ogtt 30 min plasma proinsulin (pm/l): 1.298853076,ogtt 120 min plasma proinsulin (pm/l): 1.558708571,log10 bioimpedance: Resistance: 2.704150517,log10 bioimpedance (reactance): 1.740362689,waist to hip ratio: 0.835164835,log10 serum bilirubin (umol/l): 1.51851394,log10 serum alanine aminotransfrase (u/l): 1.278753601,log10 creatinine (umol/l): 1.954242509,log10 total cholesterol (mmol/l): 0.673941999,log10 ldl cholesterol (mmol/l): 0.485721426,log10 hdl cholesterol (mmol/l): 0.068185862,log10 total triglycerides (mmol/l): 0.113943352,log10 serum apoa1 (g/l): 0.049218023,log10 serum apob (g/l): -0.060480747,log10 urinary albumin excretion rate (ug/min): 0.717519207
675 Charles E. Young Dr. S. MRL 3220
Los Angeles
USA
University of California Los Angeles
Mete,,Civelek
Illumina Casava1.7 software used for basecalling.,Sequencing files were converted to FASTQ format using a custom Perl script. In order to assign the indexed reads to each METSIM subject, a Python script was used to partition the FASTQ file for each lane into multiple FASTQ files, each of which corresponded to one individual. To be included in the partitioned file, a read had to have an exact match to one of the 48 possible index sequences, unambiguously identifying the individual from whom the read originated. Reads which did not exactly match an index sequence were discarded.,The reads were then aligned to the hg19 version of the genome using the Novoalign tool with the following settings: -l16 -t30 -h90 -rA -R 1 -m -g 200 –k. Novoalign software trims the adapter sequences while aligning.,We used the Bioconductor package GenomicRanges for R (v.2.14.0) to count the number of reads with alignment coordinates that overlap the coordinates of known mature miRNAs. Whenever a read mapped to 'x' genomic loci, the read would contribute a count of 1/x to those regions. The genomic coordinates for known mature miRNAs were downloaded from miRBase version 18.,To enable comparison of counts between samples, we normalized the expression values by dividing the counts for a given mature miRNA by the sum of all the miRNA counts for the corresponding individual. For subsequent analysis, we considered the expression levels of 356 miRNAs that had at least 5 reads in half of the study participants.,Genome_build: hg19,Supplementary_files_format_and_content: tab-delimited text files include unnormalized weighted counts for each miRNA
Abdominal subcutaneous adipose tissue was obtained with needle biopsies. Total RNA was isolated from the adipose tissue using Qiagen miRNeasy kit according to manufacturer’s instructions. RNA Integrity Number (RIN) values were assessed with the Agilent Bioanalyzer 2100 instrument. Samples with RIN values greater than 7.0 were used for transcriptional profiling.,Small RNA libraries were prepared using the Illumina TruSeq Small RNA protocol utilizing up to 48 unique index sequences (Illumina Catalog Number FC-102-1009). For two samples (METSIM490 and METSIM6589) we also prepared small RNA libraries using Illumina Small RNA v1.5 sample preparation protocol (Catalog # FC-930-1501)
GSM1098383
Illumina HiSeq 2000
May 15 2019
size fractionation
transcriptomic
RNA-Seq
total RNA
Homo sapiens
GPL11154
SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX249282,BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN01978210
GSM1098383
GSE45159
0.335999
adipose tissue
Public on Apr 01 2013
Mar 14 2013
9606
METSIM10062
SRA
https://www.ncbi.nlm.nih.gov/sra?term=SRX249282
https://www.ncbi.nlm.nih.gov/biosample/SAMN01978210
1
age: 63,tissue: adipose tissue,log10 body mass index: 1.471049685,log10 basal metabolic rate (kcal): 1575,log2 estimated glomerular filtration rate using modification of diet in renal disease (egfr_mdrd): 6.352348725,log10 estimated creatinine clearance rate using cockfcrot-gault formulaa (egcr): 6.546157171,plasma free fatty acids under the curve ogtt (mmol/l * min): 16.35,fat mass (%): 34.7,log10 plasma glucose area under the curve (ogtt) (mmol/l * min): 9.640244936,plasma glucose area under the curve above basal (ogtt) (mmol/l * min): 126,log10 homair (insulin resistance index based on homa): -0.04769199,log10 homais (insulin secretion index based on homa): 1.535113202,log10 insulin area under the curve (ogtt) (pmol/l * min): 4.459663837,insgenin (insulinogenic index): 2.052651199,log10 insulin area under the curve above basal (ogtt) (pmol/l * min): 4.418732057,log10 matsuda insulin sensitivity index: 0.954161986,muscle mass (%): 43.6,lg10 serum c-reactive protein (mg/l): 1.671635597,lg10 plasma adiponectin (mg/l): 1.037426498,ogtt fasting plasma free fatty acid (mmol/l): 0.31,ogtt 30 min plasma free fatty acid (mmol/l): 0.18,ogtt 120 min plasma free fatty acid (mmol/l): 0.02,ogtt fasting plasma glucose (mmol/l): 5.6,ogtt 30 min plasma glucose (mmol/l): 8.3,ogtt 120 min plasma glucose (mmol/l): 4.8,log10 il1 receptor antagonist (pg/ml): 2.253434935,log10 il1 beta (pg/ml): -1.045757491,log10 ogtt fasting plasma insulin (mu/l): 0.556302501,ogtt 30 min plasma insulin (mu/l): 1.7355989,ogtt 120 min plasma insulin (mu/l): 1.51851394,log10 ogtt fasting plasma proinsulin (pm/l): 0.995635195,ogtt 30 min plasma proinsulin (pm/l): 1.416640507,ogtt 120 min plasma proinsulin (pm/l): 1.81756537,log10 bioimpedance: Resistance: 2.682145076,log10 bioimpedance (reactance): 1.748188027,waist to hip ratio: 0.96713615,log10 serum bilirubin (umol/l): 1.255272505,log10 serum alanine aminotransfrase (u/l): 1.643452676,log10 creatinine (umol/l): 1.939519253,log10 total cholesterol (mmol/l): 0.831229694,log10 ldl cholesterol (mmol/l): 0.668385917,log10 hdl cholesterol (mmol/l): 0.247973266,log10 total triglycerides (mmol/l): -0.031517051,log10 serum apoa1 (g/l): 0.152288344,log10 serum apob (g/l): 0.103803721,log10 urinary albumin excretion rate (ug/min): 0.794598101
675 Charles E. Young Dr. S. MRL 3220
Los Angeles
USA
University of California Los Angeles
Mete,,Civelek
Illumina Casava1.7 software used for basecalling.,Sequencing files were converted to FASTQ format using a custom Perl script. In order to assign the indexed reads to each METSIM subject, a Python script was used to partition the FASTQ file for each lane into multiple FASTQ files, each of which corresponded to one individual. To be included in the partitioned file, a read had to have an exact match to one of the 48 possible index sequences, unambiguously identifying the individual from whom the read originated. Reads which did not exactly match an index sequence were discarded.,The reads were then aligned to the hg19 version of the genome using the Novoalign tool with the following settings: -l16 -t30 -h90 -rA -R 1 -m -g 200 –k. Novoalign software trims the adapter sequences while aligning.,We used the Bioconductor package GenomicRanges for R (v.2.14.0) to count the number of reads with alignment coordinates that overlap the coordinates of known mature miRNAs. Whenever a read mapped to 'x' genomic loci, the read would contribute a count of 1/x to those regions. The genomic coordinates for known mature miRNAs were downloaded from miRBase version 18.,To enable comparison of counts between samples, we normalized the expression values by dividing the counts for a given mature miRNA by the sum of all the miRNA counts for the corresponding individual. For subsequent analysis, we considered the expression levels of 356 miRNAs that had at least 5 reads in half of the study participants.,Genome_build: hg19,Supplementary_files_format_and_content: tab-delimited text files include unnormalized weighted counts for each miRNA
Abdominal subcutaneous adipose tissue was obtained with needle biopsies. Total RNA was isolated from the adipose tissue using Qiagen miRNeasy kit according to manufacturer’s instructions. RNA Integrity Number (RIN) values were assessed with the Agilent Bioanalyzer 2100 instrument. Samples with RIN values greater than 7.0 were used for transcriptional profiling.,Small RNA libraries were prepared using the Illumina TruSeq Small RNA protocol utilizing up to 48 unique index sequences (Illumina Catalog Number FC-102-1009). For two samples (METSIM490 and METSIM6589) we also prepared small RNA libraries using Illumina Small RNA v1.5 sample preparation protocol (Catalog # FC-930-1501)
GSM1098384
Illumina HiSeq 2000
May 15 2019
size fractionation
transcriptomic
RNA-Seq
total RNA
Homo sapiens
GPL11154
SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX249283,BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN01978211
GSM1098384
GSE45159
0.033852
adipose tissue
Public on Apr 01 2013
Mar 14 2013
9606
METSIM10252
SRA
https://www.ncbi.nlm.nih.gov/sra?term=SRX249283
https://www.ncbi.nlm.nih.gov/biosample/SAMN01978211
1
age: 64,tissue: adipose tissue,log10 body mass index: 1.390135575,log10 basal metabolic rate (kcal): 1652,log2 estimated glomerular filtration rate using modification of diet in renal disease (egfr_mdrd): 6.50833036,log10 estimated creatinine clearance rate using cockfcrot-gault formulaa (egcr): 6.562124232,plasma free fatty acids under the curve ogtt (mmol/l * min): 15.75,fat mass (%): 26,log10 plasma glucose area under the curve (ogtt) (mmol/l * min): 9.656424863,plasma glucose area under the curve above basal (ogtt) (mmol/l * min): 159,log10 homair (insulin resistance index based on homa): 0.165541077,log10 homais (insulin secretion index based on homa): 1.80760623,log10 insulin area under the curve (ogtt) (pmol/l * min): 4.452139252,insgenin (insulinogenic index): 2.005291245,log10 insulin area under the curve above basal (ogtt) (pmol/l * min): 4.378960847,log10 matsuda insulin sensitivity index: 0.851154631,muscle mass (%): 41.7,lg10 serum c-reactive protein (mg/l): -0.853871964,lg10 plasma adiponectin (mg/l): 1.184691431,ogtt fasting plasma free fatty acid (mmol/l): 0.26,ogtt 30 min plasma free fatty acid (mmol/l): 0.16,ogtt 120 min plasma free fatty acid (mmol/l): 0.05,ogtt fasting plasma glucose (mmol/l): 5.4,ogtt 30 min plasma glucose (mmol/l): 8.5,ogtt 120 min plasma glucose (mmol/l): 4.8,log10 il1 receptor antagonist (pg/ml): 1.988380565,log10 il1 beta (pg/ml): -1.045757491,log10 ogtt fasting plasma insulin (mu/l): 0.785329835,ogtt 30 min plasma insulin (mu/l): 1.766412847,ogtt 120 min plasma insulin (mu/l): 1.397940009,log10 ogtt fasting plasma proinsulin (pm/l): 0.944482672,ogtt 30 min plasma proinsulin (pm/l): 1.206825876,ogtt 120 min plasma proinsulin (pm/l): 1.401400541,log10 bioimpedance: Resistance: 2.675778342,log10 bioimpedance (reactance): 1.672097858,waist to hip ratio: 0.892156863,log10 serum bilirubin (umol/l): 1.414973348,log10 serum alanine aminotransfrase (u/l): 1.113943352,log10 creatinine (umol/l): 1.897627091,log10 total cholesterol (mmol/l): 0.757396029,log10 ldl cholesterol (mmol/l): 0.456366033,log10 hdl cholesterol (mmol/l): 0.436162647,log10 total triglycerides (mmol/l): -0.096910013,log10 serum apoa1 (g/l): 0.26245109,log10 serum apob (g/l): -0.142667504,log10 urinary albumin excretion rate (ug/min): 0.688658402
675 Charles E. Young Dr. S. MRL 3220
Los Angeles
USA
University of California Los Angeles
Mete,,Civelek
Illumina Casava1.7 software used for basecalling.,Sequencing files were converted to FASTQ format using a custom Perl script. In order to assign the indexed reads to each METSIM subject, a Python script was used to partition the FASTQ file for each lane into multiple FASTQ files, each of which corresponded to one individual. To be included in the partitioned file, a read had to have an exact match to one of the 48 possible index sequences, unambiguously identifying the individual from whom the read originated. Reads which did not exactly match an index sequence were discarded.,The reads were then aligned to the hg19 version of the genome using the Novoalign tool with the following settings: -l16 -t30 -h90 -rA -R 1 -m -g 200 –k. Novoalign software trims the adapter sequences while aligning.,We used the Bioconductor package GenomicRanges for R (v.2.14.0) to count the number of reads with alignment coordinates that overlap the coordinates of known mature miRNAs. Whenever a read mapped to 'x' genomic loci, the read would contribute a count of 1/x to those regions. The genomic coordinates for known mature miRNAs were downloaded from miRBase version 18.,To enable comparison of counts between samples, we normalized the expression values by dividing the counts for a given mature miRNA by the sum of all the miRNA counts for the corresponding individual. For subsequent analysis, we considered the expression levels of 356 miRNAs that had at least 5 reads in half of the study participants.,Genome_build: hg19,Supplementary_files_format_and_content: tab-delimited text files include unnormalized weighted counts for each miRNA
Abdominal subcutaneous adipose tissue was obtained with needle biopsies. Total RNA was isolated from the adipose tissue using Qiagen miRNeasy kit according to manufacturer’s instructions. RNA Integrity Number (RIN) values were assessed with the Agilent Bioanalyzer 2100 instrument. Samples with RIN values greater than 7.0 were used for transcriptional profiling.,Small RNA libraries were prepared using the Illumina TruSeq Small RNA protocol utilizing up to 48 unique index sequences (Illumina Catalog Number FC-102-1009). For two samples (METSIM490 and METSIM6589) we also prepared small RNA libraries using Illumina Small RNA v1.5 sample preparation protocol (Catalog # FC-930-1501)
GSM1098385
Illumina HiSeq 2000
May 15 2019
size fractionation
transcriptomic
RNA-Seq
total RNA
Homo sapiens
GPL11154
SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX249284,BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN01978212
GSM1098385
GSE45159
0.301725
adipose tissue
Public on Apr 01 2013
Mar 14 2013
9606
METSIM10271
SRA
https://www.ncbi.nlm.nih.gov/sra?term=SRX249284
https://www.ncbi.nlm.nih.gov/biosample/SAMN01978212
1
age: 54,tissue: adipose tissue,log10 body mass index: 1.523322968,log10 basal metabolic rate (kcal): 1590,log2 estimated glomerular filtration rate using modification of diet in renal disease (egfr_mdrd): 6.516464277,log10 estimated creatinine clearance rate using cockfcrot-gault formulaa (egcr): 6.982376966,plasma free fatty acids under the curve ogtt (mmol/l * min): 19.2,fat mass (%): 26.2,log10 plasma glucose area under the curve (ogtt) (mmol/l * min): 9.987974524,plasma glucose area under the curve above basal (ogtt) (mmol/l * min): 91.5,log10 homair (insulin resistance index based on homa): 0.965671971,log10 homais (insulin secretion index based on homa): 2.109144469,log10 insulin area under the curve (ogtt) (pmol/l * min): 4.792398694,insgenin (insulinogenic index): 2.221972816,log10 insulin area under the curve above basal (ogtt) (pmol/l * min): 4.629011823,log10 matsuda insulin sensitivity index: 0.207130077,muscle mass (%): 41.3,lg10 serum c-reactive protein (mg/l): 0.305351369,lg10 plasma adiponectin (mg/l): 0.792391689,ogtt fasting plasma free fatty acid (mmol/l): 0.27,ogtt 30 min plasma free fatty acid (mmol/l): 0.2,ogtt 120 min plasma free fatty acid (mmol/l): 0.07,ogtt fasting plasma glucose (mmol/l): 7.7,ogtt 30 min plasma glucose (mmol/l): 10.5,ogtt 120 min plasma glucose (mmol/l): 6,log10 il1 receptor antagonist (pg/ml): 2.514786748,log10 il1 beta (pg/ml): -1.045757491,log10 ogtt fasting plasma insulin (mu/l): 1.431363764,ogtt 30 min plasma insulin (mu/l): 2.020361283,ogtt 120 min plasma insulin (mu/l): 1.907948522,log10 ogtt fasting plasma proinsulin (pm/l): 1.465382851,ogtt 30 min plasma proinsulin (pm/l): 1.671172843,ogtt 120 min plasma proinsulin (pm/l): 1.790285164,log10 bioimpedance: Resistance: 2.643452676,log10 bioimpedance (reactance): 1.681241237,waist to hip ratio: 1.037383178,log10 serum bilirubin (umol/l): 0.903089987,log10 serum alanine aminotransfrase (u/l): 1.792391689,log10 creatinine (umol/l): 1.908485019,log10 total cholesterol (mmol/l): 0.757396029,log10 ldl cholesterol (mmol/l): 0.613841822,log10 hdl cholesterol (mmol/l): -0.013228266,log10 total triglycerides (mmol/l): 0.204119983,log10 serum apoa1 (g/l): 0.049218023,log10 serum apob (g/l): 0.11058971,log10 urinary albumin excretion rate (ug/min): 1.402718583
675 Charles E. Young Dr. S. MRL 3220
Los Angeles
USA
University of California Los Angeles
Mete,,Civelek
Illumina Casava1.7 software used for basecalling.,Sequencing files were converted to FASTQ format using a custom Perl script. In order to assign the indexed reads to each METSIM subject, a Python script was used to partition the FASTQ file for each lane into multiple FASTQ files, each of which corresponded to one individual. To be included in the partitioned file, a read had to have an exact match to one of the 48 possible index sequences, unambiguously identifying the individual from whom the read originated. Reads which did not exactly match an index sequence were discarded.,The reads were then aligned to the hg19 version of the genome using the Novoalign tool with the following settings: -l16 -t30 -h90 -rA -R 1 -m -g 200 –k. Novoalign software trims the adapter sequences while aligning.,We used the Bioconductor package GenomicRanges for R (v.2.14.0) to count the number of reads with alignment coordinates that overlap the coordinates of known mature miRNAs. Whenever a read mapped to 'x' genomic loci, the read would contribute a count of 1/x to those regions. The genomic coordinates for known mature miRNAs were downloaded from miRBase version 18.,To enable comparison of counts between samples, we normalized the expression values by dividing the counts for a given mature miRNA by the sum of all the miRNA counts for the corresponding individual. For subsequent analysis, we considered the expression levels of 356 miRNAs that had at least 5 reads in half of the study participants.,Genome_build: hg19,Supplementary_files_format_and_content: tab-delimited text files include unnormalized weighted counts for each miRNA
Abdominal subcutaneous adipose tissue was obtained with needle biopsies. Total RNA was isolated from the adipose tissue using Qiagen miRNeasy kit according to manufacturer’s instructions. RNA Integrity Number (RIN) values were assessed with the Agilent Bioanalyzer 2100 instrument. Samples with RIN values greater than 7.0 were used for transcriptional profiling.,Small RNA libraries were prepared using the Illumina TruSeq Small RNA protocol utilizing up to 48 unique index sequences (Illumina Catalog Number FC-102-1009). For two samples (METSIM490 and METSIM6589) we also prepared small RNA libraries using Illumina Small RNA v1.5 sample preparation protocol (Catalog # FC-930-1501)
GSM1098386
Illumina HiSeq 2000
May 15 2019
size fractionation
transcriptomic
RNA-Seq
total RNA
Homo sapiens
GPL11154
SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX249285,BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN01978213
GSM1098386
GSE45159
0.224697
adipose tissue
Public on Apr 01 2013
Mar 14 2013
9606
METSIM10277
SRA
https://www.ncbi.nlm.nih.gov/sra?term=SRX249285
https://www.ncbi.nlm.nih.gov/biosample/SAMN01978213
1
age: 65,tissue: adipose tissue,log10 body mass index: 1.35868671,log10 basal metabolic rate (kcal): 1640,log2 estimated glomerular filtration rate using modification of diet in renal disease (egfr_mdrd): 6.729115454,log10 estimated creatinine clearance rate using cockfcrot-gault formulaa (egcr): 6.625796971,plasma free fatty acids under the curve ogtt (mmol/l * min): 22.2,fat mass (%): 31.8,log10 plasma glucose area under the curve (ogtt) (mmol/l * min): 9.811374694,plasma glucose area under the curve above basal (ogtt) (mmol/l * min): 226.5,log10 homair (insulin resistance index based on homa): 0.058763341,log10 homais (insulin secretion index based on homa): 1.641568533,log10 insulin area under the curve (ogtt) (pmol/l * min): 4.406335758,insgenin (insulinogenic index): 2.024560295,log10 insulin area under the curve above basal (ogtt) (pmol/l * min): 4.345883213,log10 matsuda insulin sensitivity index: 0.894695546,muscle mass (%): 43.7,lg10 serum c-reactive protein (mg/l): -0.537602002,lg10 plasma adiponectin (mg/l): 0.785329835,ogtt fasting plasma free fatty acid (mmol/l): 0.28,ogtt 30 min plasma free fatty acid (mmol/l): 0.24,ogtt 120 min plasma free fatty acid (mmol/l): 0.08,ogtt fasting plasma glucose (mmol/l): 5.6,ogtt 30 min plasma glucose (mmol/l): 7.8,ogtt 120 min plasma glucose (mmol/l): 7.7,log10 il1 receptor antagonist (pg/ml): 2.244722323,log10 il1 beta (pg/ml): -1.045757491,log10 ogtt fasting plasma insulin (mu/l): 0.662757832,ogtt 30 min plasma insulin (mu/l): 1.63748973,ogtt 120 min plasma insulin (mu/l): 1.544068044,log10 ogtt fasting plasma proinsulin (pm/l): 1.086359831,ogtt 30 min plasma proinsulin (pm/l): 1.397940009,ogtt 120 min plasma proinsulin (pm/l): 1.743509765,log10 bioimpedance: Resistance: 2.771587481,log10 bioimpedance (reactance): 1.86332286,waist to hip ratio: 0.908163265,log10 serum bilirubin (umol/l): 1.146128036,log10 serum alanine aminotransfrase (u/l): 1.544068044,log10 creatinine (umol/l): 1.838849091,log10 total cholesterol (mmol/l): 0.618048097,log10 ldl cholesterol (mmol/l): 0.460897843,log10 hdl cholesterol (mmol/l): 0.06069784,log10 total triglycerides (mmol/l): 0.008600172,log10 serum apoa1 (g/l): 0.056904851,log10 serum apob (g/l): -0.070581074,log10 urinary albumin excretion rate (ug/min): 1.068715812
675 Charles E. Young Dr. S. MRL 3220
Los Angeles
USA
University of California Los Angeles
Mete,,Civelek
Illumina Casava1.7 software used for basecalling.,Sequencing files were converted to FASTQ format using a custom Perl script. In order to assign the indexed reads to each METSIM subject, a Python script was used to partition the FASTQ file for each lane into multiple FASTQ files, each of which corresponded to one individual. To be included in the partitioned file, a read had to have an exact match to one of the 48 possible index sequences, unambiguously identifying the individual from whom the read originated. Reads which did not exactly match an index sequence were discarded.,The reads were then aligned to the hg19 version of the genome using the Novoalign tool with the following settings: -l16 -t30 -h90 -rA -R 1 -m -g 200 –k. Novoalign software trims the adapter sequences while aligning.,We used the Bioconductor package GenomicRanges for R (v.2.14.0) to count the number of reads with alignment coordinates that overlap the coordinates of known mature miRNAs. Whenever a read mapped to 'x' genomic loci, the read would contribute a count of 1/x to those regions. The genomic coordinates for known mature miRNAs were downloaded from miRBase version 18.,To enable comparison of counts between samples, we normalized the expression values by dividing the counts for a given mature miRNA by the sum of all the miRNA counts for the corresponding individual. For subsequent analysis, we considered the expression levels of 356 miRNAs that had at least 5 reads in half of the study participants.,Genome_build: hg19,Supplementary_files_format_and_content: tab-delimited text files include unnormalized weighted counts for each miRNA
Abdominal subcutaneous adipose tissue was obtained with needle biopsies. Total RNA was isolated from the adipose tissue using Qiagen miRNeasy kit according to manufacturer’s instructions. RNA Integrity Number (RIN) values were assessed with the Agilent Bioanalyzer 2100 instrument. Samples with RIN values greater than 7.0 were used for transcriptional profiling.,Small RNA libraries were prepared using the Illumina TruSeq Small RNA protocol utilizing up to 48 unique index sequences (Illumina Catalog Number FC-102-1009). For two samples (METSIM490 and METSIM6589) we also prepared small RNA libraries using Illumina Small RNA v1.5 sample preparation protocol (Catalog # FC-930-1501)
GSM1098387
Illumina HiSeq 2000
May 15 2019
size fractionation
transcriptomic
RNA-Seq
total RNA
Homo sapiens
GPL11154
SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX249286,BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN01978214
GSM1098387
GSE45159
0.214832
adipose tissue
Public on Apr 01 2013
Mar 14 2013
9606
METSIM10346
SRA
https://www.ncbi.nlm.nih.gov/sra?term=SRX249286
https://www.ncbi.nlm.nih.gov/biosample/SAMN01978214
1
age: 66,tissue: adipose tissue,log10 body mass index: 1.39073176,log10 basal metabolic rate (kcal): 1706,log2 estimated glomerular filtration rate using modification of diet in renal disease (egfr_mdrd): 6.457694434,log10 estimated creatinine clearance rate using cockfcrot-gault formulaa (egcr): 6.505502737,plasma free fatty acids under the curve ogtt (mmol/l * min): 30.45,fat mass (%): 22.1,log10 plasma glucose area under the curve (ogtt) (mmol/l * min): 9.714245518,plasma glucose area under the curve above basal (ogtt) (mmol/l * min): 108,log10 homair (insulin resistance index based on homa): -0.061702705,log10 homais (insulin secretion index based on homa): 1.391206626,log10 insulin area under the curve (ogtt) (pmol/l * min): 4.20588073,insgenin (insulinogenic index): 1.539076099,log10 insulin area under the curve above basal (ogtt) (pmol/l * min): 4.138649995,log10 matsuda insulin sensitivity index: 1.059985451,muscle mass (%): 44,lg10 serum c-reactive protein (mg/l): -0.086186148,lg10 plasma adiponectin (mg/l): 1.089905111,ogtt fasting plasma free fatty acid (mmol/l): 0.46,ogtt 30 min plasma free fatty acid (mmol/l): 0.37,ogtt 120 min plasma free fatty acid (mmol/l): 0.03,ogtt fasting plasma glucose (mmol/l): 6.1,ogtt 30 min plasma glucose (mmol/l): 9.1,ogtt 120 min plasma glucose (mmol/l): 4.5,log10 il1 receptor antagonist (pg/ml): 2.03762567,log10 il1 beta (pg/ml): -0.537602002,log10 ogtt fasting plasma insulin (mu/l): 0.505149978,ogtt 30 min plasma insulin (mu/l): 1.311753861,ogtt 120 min plasma insulin (mu/l): 1.492760389,log10 ogtt fasting plasma proinsulin (pm/l): 1.029383778,ogtt 30 min plasma proinsulin (pm/l): 1.209515015,ogtt 120 min plasma proinsulin (pm/l): 1.725094521,log10 bioimpedance: Resistance: 2.63748973,log10 bioimpedance (reactance): 1.62324929,waist to hip ratio: 0.891089109,log10 serum bilirubin (umol/l): 1.447158031,log10 serum alanine aminotransfrase (u/l): 1.361727836,log10 creatinine (umol/l): 1.908485019,log10 total cholesterol (mmol/l): 0.820201459,log10 ldl cholesterol (mmol/l): 0.558708571,log10 hdl cholesterol (mmol/l): 0.411619706,log10 total triglycerides (mmol/l): -0.050609993,log10 serum apoa1 (g/l): 0.290034611,log10 serum apob (g/l): -0.004364805,log10 urinary albumin excretion rate (ug/min): 0.854484654
675 Charles E. Young Dr. S. MRL 3220
Los Angeles
USA
University of California Los Angeles
Mete,,Civelek
Illumina Casava1.7 software used for basecalling.,Sequencing files were converted to FASTQ format using a custom Perl script. In order to assign the indexed reads to each METSIM subject, a Python script was used to partition the FASTQ file for each lane into multiple FASTQ files, each of which corresponded to one individual. To be included in the partitioned file, a read had to have an exact match to one of the 48 possible index sequences, unambiguously identifying the individual from whom the read originated. Reads which did not exactly match an index sequence were discarded.,The reads were then aligned to the hg19 version of the genome using the Novoalign tool with the following settings: -l16 -t30 -h90 -rA -R 1 -m -g 200 –k. Novoalign software trims the adapter sequences while aligning.,We used the Bioconductor package GenomicRanges for R (v.2.14.0) to count the number of reads with alignment coordinates that overlap the coordinates of known mature miRNAs. Whenever a read mapped to 'x' genomic loci, the read would contribute a count of 1/x to those regions. The genomic coordinates for known mature miRNAs were downloaded from miRBase version 18.,To enable comparison of counts between samples, we normalized the expression values by dividing the counts for a given mature miRNA by the sum of all the miRNA counts for the corresponding individual. For subsequent analysis, we considered the expression levels of 356 miRNAs that had at least 5 reads in half of the study participants.,Genome_build: hg19,Supplementary_files_format_and_content: tab-delimited text files include unnormalized weighted counts for each miRNA
Abdominal subcutaneous adipose tissue was obtained with needle biopsies. Total RNA was isolated from the adipose tissue using Qiagen miRNeasy kit according to manufacturer’s instructions. RNA Integrity Number (RIN) values were assessed with the Agilent Bioanalyzer 2100 instrument. Samples with RIN values greater than 7.0 were used for transcriptional profiling.,Small RNA libraries were prepared using the Illumina TruSeq Small RNA protocol utilizing up to 48 unique index sequences (Illumina Catalog Number FC-102-1009). For two samples (METSIM490 and METSIM6589) we also prepared small RNA libraries using Illumina Small RNA v1.5 sample preparation protocol (Catalog # FC-930-1501)
GSM1098388
Illumina HiSeq 2000
May 15 2019
size fractionation
transcriptomic
RNA-Seq
total RNA
Homo sapiens
GPL11154
SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX249287,BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN01978215
GSM1098388
GSE45159
0.055601
adipose tissue
Public on Apr 01 2013
Mar 14 2013
9606
METSIM10381
SRA
https://www.ncbi.nlm.nih.gov/sra?term=SRX249287
https://www.ncbi.nlm.nih.gov/biosample/SAMN01978215
1
age: 61,tissue: adipose tissue,log10 body mass index: 1.446085957,log10 basal metabolic rate (kcal): 1642,log2 estimated glomerular filtration rate using modification of diet in renal disease (egfr_mdrd): 6.197906938,log10 estimated creatinine clearance rate using cockfcrot-gault formulaa (egcr): 6.474299238,plasma free fatty acids under the curve ogtt (mmol/l * min): 11.4,fat mass (%): 30.6,log10 plasma glucose area under the curve (ogtt) (mmol/l * min): 9.927037169,plasma glucose area under the curve above basal (ogtt) (mmol/l * min): 217.5,log10 homair (insulin resistance index based on homa): 0.260071388,log10 homais (insulin secretion index based on homa): 1.666785321,log10 insulin area under the curve (ogtt) (pmol/l * min): 4.331548761,insgenin (insulinogenic index): 1.635899539,log10 insulin area under the curve above basal (ogtt) (pmol/l * min): 4.224688417,log10 matsuda insulin sensitivity index: 0.831199215,muscle mass (%): 40.2,lg10 serum c-reactive protein (mg/l): 0.376576957,lg10 plasma adiponectin (mg/l): 0.716003344,ogtt fasting plasma free fatty acid (mmol/l): 0.22,ogtt 30 min plasma free fatty acid (mmol/l): 0.12,ogtt 120 min plasma free fatty acid (mmol/l): 0.02,ogtt fasting plasma glucose (mmol/l): 6.3,ogtt 30 min plasma glucose (mmol/l): 12.1,ogtt 120 min plasma glucose (mmol/l): 3.4,log10 il1 receptor antagonist (pg/ml): 2.190835748,log10 il1 beta (pg/ml): -0.744727495,log10 ogtt fasting plasma insulin (mu/l): 0.812913357,ogtt 30 min plasma insulin (mu/l): 1.683947131,ogtt 120 min plasma insulin (mu/l): 1.11058971,log10 ogtt fasting plasma proinsulin (pm/l): 1.243038049,ogtt 30 min plasma proinsulin (pm/l): 1.463892989,ogtt 120 min plasma proinsulin (pm/l): 1.633468456,log10 bioimpedance: Resistance: 2.661812686,log10 bioimpedance (reactance): 1.672097858,waist to hip ratio: 0.979166667,log10 serum bilirubin (umol/l): 0.84509804,log10 serum alanine aminotransfrase (u/l): 1.397940009,log10 creatinine (umol/l): 1.982271233,log10 total cholesterol (mmol/l): 0.733999287,log10 ldl cholesterol (mmol/l): 0.517195898,log10 hdl cholesterol (mmol/l): 0.201397124,log10 total triglycerides (mmol/l): -0.031517051,log10 serum apoa1 (g/l): 0.193124598,log10 serum apob (g/l): -0.036212173,log10 urinary albumin excretion rate (ug/min): 0.707570176
675 Charles E. Young Dr. S. MRL 3220
Los Angeles
USA
University of California Los Angeles
Mete,,Civelek
Illumina Casava1.7 software used for basecalling.,Sequencing files were converted to FASTQ format using a custom Perl script. In order to assign the indexed reads to each METSIM subject, a Python script was used to partition the FASTQ file for each lane into multiple FASTQ files, each of which corresponded to one individual. To be included in the partitioned file, a read had to have an exact match to one of the 48 possible index sequences, unambiguously identifying the individual from whom the read originated. Reads which did not exactly match an index sequence were discarded.,The reads were then aligned to the hg19 version of the genome using the Novoalign tool with the following settings: -l16 -t30 -h90 -rA -R 1 -m -g 200 –k. Novoalign software trims the adapter sequences while aligning.,We used the Bioconductor package GenomicRanges for R (v.2.14.0) to count the number of reads with alignment coordinates that overlap the coordinates of known mature miRNAs. Whenever a read mapped to 'x' genomic loci, the read would contribute a count of 1/x to those regions. The genomic coordinates for known mature miRNAs were downloaded from miRBase version 18.,To enable comparison of counts between samples, we normalized the expression values by dividing the counts for a given mature miRNA by the sum of all the miRNA counts for the corresponding individual. For subsequent analysis, we considered the expression levels of 356 miRNAs that had at least 5 reads in half of the study participants.,Genome_build: hg19,Supplementary_files_format_and_content: tab-delimited text files include unnormalized weighted counts for each miRNA
Abdominal subcutaneous adipose tissue was obtained with needle biopsies. Total RNA was isolated from the adipose tissue using Qiagen miRNeasy kit according to manufacturer’s instructions. RNA Integrity Number (RIN) values were assessed with the Agilent Bioanalyzer 2100 instrument. Samples with RIN values greater than 7.0 were used for transcriptional profiling.,Small RNA libraries were prepared using the Illumina TruSeq Small RNA protocol utilizing up to 48 unique index sequences (Illumina Catalog Number FC-102-1009). For two samples (METSIM490 and METSIM6589) we also prepared small RNA libraries using Illumina Small RNA v1.5 sample preparation protocol (Catalog # FC-930-1501)
GSM1098389
Illumina HiSeq 2000
May 15 2019
size fractionation
transcriptomic
RNA-Seq
total RNA
Homo sapiens
GPL11154
SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX249288,BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN01978216
GSM1098389
GSE45159
0.349677
adipose tissue
Public on Apr 01 2013
Mar 14 2013
9606
METSIM10389
SRA
https://www.ncbi.nlm.nih.gov/sra?term=SRX249288
https://www.ncbi.nlm.nih.gov/biosample/SAMN01978216
1
age: 60,tissue: adipose tissue,log10 body mass index: 1.458797192,log10 basal metabolic rate (kcal): 1612,log2 estimated glomerular filtration rate using modification of diet in renal disease (egfr_mdrd): 6.506289531,log10 estimated creatinine clearance rate using cockfcrot-gault formulaa (egcr): 6.932673993,plasma free fatty acids under the curve ogtt (mmol/l * min): 37.95,fat mass (%): 24.5,log10 plasma glucose area under the curve (ogtt) (mmol/l * min): 10.33315535,plasma glucose area under the curve above basal (ogtt) (mmol/l * min): 534,log10 homair (insulin resistance index based on homa): 0.669874502,log10 homais (insulin secretion index based on homa): 2.076588435,log10 insulin area under the curve (ogtt) (pmol/l * min): 4.854882693,insgenin (insulinogenic index): 1.981810931,log10 insulin area under the curve above basal (ogtt) (pmol/l * min): 4.775034891,log10 matsuda insulin sensitivity index: 0.291652646,muscle mass (%): 40,lg10 serum c-reactive protein (mg/l): 0.77524626,lg10 plasma adiponectin (mg/l): 0.591064607,ogtt fasting plasma free fatty acid (mmol/l): 0.55,ogtt 30 min plasma free fatty acid (mmol/l): 0.42,ogtt 120 min plasma free fatty acid (mmol/l): 0.1,ogtt fasting plasma glucose (mmol/l): 6.3,ogtt 30 min plasma glucose (mmol/l): 12.2,ogtt 120 min plasma glucose (mmol/l): 10.3,log10 il1 receptor antagonist (pg/ml): 2.48248769,log10 il1 beta (pg/ml): -1.045757491,log10 ogtt fasting plasma insulin (mu/l): 1.222716471,ogtt 30 min plasma insulin (mu/l): 2.045322979,ogtt 120 min plasma insulin (mu/l): 2.047664195,log10 ogtt fasting plasma proinsulin (pm/l): 1.571708832,ogtt 30 min plasma proinsulin (pm/l): 1.996949248,ogtt 120 min plasma proinsulin (pm/l): 2.253338005,log10 bioimpedance: Resistance: 2.682145076,log10 bioimpedance (reactance): 1.591064607,waist to hip ratio: 1.018867925,log10 serum bilirubin (umol/l): 0.84509804,log10 serum alanine aminotransfrase (u/l): 1.505149978,log10 creatinine (umol/l): 1.903089987,log10 total cholesterol (mmol/l): 0.852479994,log10 ldl cholesterol (mmol/l): 0.59439255,log10 hdl cholesterol (mmol/l): -0.045757491,log10 total triglycerides (mmol/l): 0.781036939,log10 serum apoa1 (g/l): 0.161368002,log10 serum apob (g/l): 0.255272505,log10 urinary albumin excretion rate (ug/min): NA
675 Charles E. Young Dr. S. MRL 3220
Los Angeles
USA
University of California Los Angeles
Mete,,Civelek
Illumina Casava1.7 software used for basecalling.,Sequencing files were converted to FASTQ format using a custom Perl script. In order to assign the indexed reads to each METSIM subject, a Python script was used to partition the FASTQ file for each lane into multiple FASTQ files, each of which corresponded to one individual. To be included in the partitioned file, a read had to have an exact match to one of the 48 possible index sequences, unambiguously identifying the individual from whom the read originated. Reads which did not exactly match an index sequence were discarded.,The reads were then aligned to the hg19 version of the genome using the Novoalign tool with the following settings: -l16 -t30 -h90 -rA -R 1 -m -g 200 –k. Novoalign software trims the adapter sequences while aligning.,We used the Bioconductor package GenomicRanges for R (v.2.14.0) to count the number of reads with alignment coordinates that overlap the coordinates of known mature miRNAs. Whenever a read mapped to 'x' genomic loci, the read would contribute a count of 1/x to those regions. The genomic coordinates for known mature miRNAs were downloaded from miRBase version 18.,To enable comparison of counts between samples, we normalized the expression values by dividing the counts for a given mature miRNA by the sum of all the miRNA counts for the corresponding individual. For subsequent analysis, we considered the expression levels of 356 miRNAs that had at least 5 reads in half of the study participants.,Genome_build: hg19,Supplementary_files_format_and_content: tab-delimited text files include unnormalized weighted counts for each miRNA
Abdominal subcutaneous adipose tissue was obtained with needle biopsies. Total RNA was isolated from the adipose tissue using Qiagen miRNeasy kit according to manufacturer’s instructions. RNA Integrity Number (RIN) values were assessed with the Agilent Bioanalyzer 2100 instrument. Samples with RIN values greater than 7.0 were used for transcriptional profiling.,Small RNA libraries were prepared using the Illumina TruSeq Small RNA protocol utilizing up to 48 unique index sequences (Illumina Catalog Number FC-102-1009). For two samples (METSIM490 and METSIM6589) we also prepared small RNA libraries using Illumina Small RNA v1.5 sample preparation protocol (Catalog # FC-930-1501)
GSM1098390
Illumina HiSeq 2000
May 15 2019
size fractionation
transcriptomic
RNA-Seq
total RNA
Homo sapiens
GPL11154
SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX249289,BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN01978217
GSM1098390
GSE45159
0.271433
adipose tissue
Public on Apr 01 2013
Mar 14 2013
9606
METSIM10419
SRA
https://www.ncbi.nlm.nih.gov/sra?term=SRX249289
https://www.ncbi.nlm.nih.gov/biosample/SAMN01978217
1
age: 50,tissue: adipose tissue,log10 body mass index: 1.408203206,log10 basal metabolic rate (kcal): 1528,log2 estimated glomerular filtration rate using modification of diet in renal disease (egfr_mdrd): 6.345195522,log10 estimated creatinine clearance rate using cockfcrot-gault formulaa (egcr): 6.556232233,plasma free fatty acids under the curve ogtt (mmol/l * min): 27.3,fat mass (%): 19.8,log10 plasma glucose area under the curve (ogtt) (mmol/l * min): 9.789533645,plasma glucose area under the curve above basal (ogtt) (mmol/l * min): 249,log10 homair (insulin resistance index based on homa): -0.180748617,log10 homais (insulin secretion index based on homa): 1.492915522,log10 insulin area under the curve (ogtt) (pmol/l * min): 4.384640101,insgenin (insulinogenic index): 1.803457116,log10 insulin area under the curve above basal (ogtt) (pmol/l * min): 4.346939463,log10 matsuda insulin sensitivity index: 1.042419386,muscle mass (%): 44.5,lg10 serum c-reactive protein (mg/l): -0.494850022,lg10 plasma adiponectin (mg/l): 0.838849091,ogtt fasting plasma free fatty acid (mmol/l): 0.57,ogtt 30 min plasma free fatty acid (mmol/l): 0.29,ogtt 120 min plasma free fatty acid (mmol/l): 0.03,ogtt fasting plasma glucose (mmol/l): 5.3,ogtt 30 min plasma glucose (mmol/l): 9.3,ogtt 120 min plasma glucose (mmol/l): 5.5,log10 il1 receptor antagonist (pg/ml): 2.29307514,log10 il1 beta (pg/ml): NA,log10 ogtt fasting plasma insulin (mu/l): 0.447158031,ogtt 30 min plasma insulin (mu/l): 1.655138435,ogtt 120 min plasma insulin (mu/l): 1.456366033,log10 ogtt fasting plasma proinsulin (pm/l): 0.897627091,ogtt 30 min plasma proinsulin (pm/l): 1.320146286,ogtt 120 min plasma proinsulin (pm/l): 1.593286067,log10 bioimpedance: Resistance: 2.698100546,log10 bioimpedance (reactance): 1.698970004,waist to hip ratio: 0.979166667,log10 serum bilirubin (umol/l): 1.278753601,log10 serum alanine aminotransfrase (u/l): 1.278753601,log10 creatinine (umol/l): 1.959041392,log10 total cholesterol (mmol/l): 0.791690649,log10 ldl cholesterol (mmol/l): 0.655138435,log10 hdl cholesterol (mmol/l): 0.164352856,log10 total triglycerides (mmol/l): -0.036212173,log10 serum apoa1 (g/l): 0.173186268,log10 serum apob (g/l): 0.079181246,log10 urinary albumin excretion rate (ug/min): 0.745699227
675 Charles E. Young Dr. S. MRL 3220
Los Angeles
USA
University of California Los Angeles
Mete,,Civelek
Illumina Casava1.7 software used for basecalling.,Sequencing files were converted to FASTQ format using a custom Perl script. In order to assign the indexed reads to each METSIM subject, a Python script was used to partition the FASTQ file for each lane into multiple FASTQ files, each of which corresponded to one individual. To be included in the partitioned file, a read had to have an exact match to one of the 48 possible index sequences, unambiguously identifying the individual from whom the read originated. Reads which did not exactly match an index sequence were discarded.,The reads were then aligned to the hg19 version of the genome using the Novoalign tool with the following settings: -l16 -t30 -h90 -rA -R 1 -m -g 200 –k. Novoalign software trims the adapter sequences while aligning.,We used the Bioconductor package GenomicRanges for R (v.2.14.0) to count the number of reads with alignment coordinates that overlap the coordinates of known mature miRNAs. Whenever a read mapped to 'x' genomic loci, the read would contribute a count of 1/x to those regions. The genomic coordinates for known mature miRNAs were downloaded from miRBase version 18.,To enable comparison of counts between samples, we normalized the expression values by dividing the counts for a given mature miRNA by the sum of all the miRNA counts for the corresponding individual. For subsequent analysis, we considered the expression levels of 356 miRNAs that had at least 5 reads in half of the study participants.,Genome_build: hg19,Supplementary_files_format_and_content: tab-delimited text files include unnormalized weighted counts for each miRNA
Abdominal subcutaneous adipose tissue was obtained with needle biopsies. Total RNA was isolated from the adipose tissue using Qiagen miRNeasy kit according to manufacturer’s instructions. RNA Integrity Number (RIN) values were assessed with the Agilent Bioanalyzer 2100 instrument. Samples with RIN values greater than 7.0 were used for transcriptional profiling.,Small RNA libraries were prepared using the Illumina TruSeq Small RNA protocol utilizing up to 48 unique index sequences (Illumina Catalog Number FC-102-1009). For two samples (METSIM490 and METSIM6589) we also prepared small RNA libraries using Illumina Small RNA v1.5 sample preparation protocol (Catalog # FC-930-1501)
GSM1098391
Illumina HiSeq 2000
May 15 2019
size fractionation
transcriptomic
RNA-Seq
total RNA
Homo sapiens
GPL11154
SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX249290,BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN01978218
GSM1098391
GSE45159
0.241196
adipose tissue
Public on Apr 01 2013
Mar 14 2013
9606
METSIM10691
SRA
https://www.ncbi.nlm.nih.gov/sra?term=SRX249290
https://www.ncbi.nlm.nih.gov/biosample/SAMN01978218
1
age: 56,tissue: adipose tissue,log10 body mass index: 1.365955279,log10 basal metabolic rate (kcal): 1618,log2 estimated glomerular filtration rate using modification of diet in renal disease (egfr_mdrd): 6.611891944,log10 estimated creatinine clearance rate using cockfcrot-gault formulaa (egcr): 6.649892647,plasma free fatty acids under the curve ogtt (mmol/l * min): 12,fat mass (%): 13.3,log10 plasma glucose area under the curve (ogtt) (mmol/l * min): 9.938109326,plasma glucose area under the curve above basal (ogtt) (mmol/l * min): 225,log10 homair (insulin resistance index based on homa): 0.179551791,log10 homais (insulin secretion index based on homa): 1.586265724,log10 insulin area under the curve (ogtt) (pmol/l * min): 4.455986239,insgenin (insulinogenic index): 1.943494516,log10 insulin area under the curve above basal (ogtt) (pmol/l * min): 4.392468317,log10 matsuda insulin sensitivity index: 0.79182238,muscle mass (%): 48,lg10 serum c-reactive protein (mg/l): -0.142667504,lg10 plasma adiponectin (mg/l): 0.86923172,ogtt fasting plasma free fatty acid (mmol/l): 0.2,ogtt 30 min plasma free fatty acid (mmol/l): 0.12,ogtt 120 min plasma free fatty acid (mmol/l): 0.04,ogtt fasting plasma glucose (mmol/l): 6.3,ogtt 30 min plasma glucose (mmol/l): 9.3,ogtt 120 min plasma glucose (mmol/l): 7.3,log10 il1 receptor antagonist (pg/ml): 2.272445019,log10 il1 beta (pg/ml): NA,log10 ogtt fasting plasma insulin (mu/l): 0.73239376,ogtt 30 min plasma insulin (mu/l): 1.692846919,ogtt 120 min plasma insulin (mu/l): 1.583198774,log10 ogtt fasting plasma proinsulin (pm/l): 0.73239376,ogtt 30 min plasma proinsulin (pm/l): 1.227886705,ogtt 120 min plasma proinsulin (pm/l): 1.568201724,log10 bioimpedance: Resistance: 2.636487896,log10 bioimpedance (reactance): 1.591064607,waist to hip ratio: 0.87,log10 serum bilirubin (umol/l): 1.041392685,log10 serum alanine aminotransfrase (u/l): 1.146128036,log10 creatinine (umol/l): 1.880813592,log10 total cholesterol (mmol/l): 0.667452953,log10 ldl cholesterol (mmol/l): 0.437750563,log10 hdl cholesterol (mmol/l): 0.184691431,log10 total triglycerides (mmol/l): -0.045757491,log10 serum apoa1 (g/l): 0.1430148,log10 serum apob (g/l): -0.102372909,log10 urinary albumin excretion rate (ug/min): 1.166331422
675 Charles E. Young Dr. S. MRL 3220
Los Angeles
USA
University of California Los Angeles
Mete,,Civelek
Illumina Casava1.7 software used for basecalling.,Sequencing files were converted to FASTQ format using a custom Perl script. In order to assign the indexed reads to each METSIM subject, a Python script was used to partition the FASTQ file for each lane into multiple FASTQ files, each of which corresponded to one individual. To be included in the partitioned file, a read had to have an exact match to one of the 48 possible index sequences, unambiguously identifying the individual from whom the read originated. Reads which did not exactly match an index sequence were discarded.,The reads were then aligned to the hg19 version of the genome using the Novoalign tool with the following settings: -l16 -t30 -h90 -rA -R 1 -m -g 200 –k. Novoalign software trims the adapter sequences while aligning.,We used the Bioconductor package GenomicRanges for R (v.2.14.0) to count the number of reads with alignment coordinates that overlap the coordinates of known mature miRNAs. Whenever a read mapped to 'x' genomic loci, the read would contribute a count of 1/x to those regions. The genomic coordinates for known mature miRNAs were downloaded from miRBase version 18.,To enable comparison of counts between samples, we normalized the expression values by dividing the counts for a given mature miRNA by the sum of all the miRNA counts for the corresponding individual. For subsequent analysis, we considered the expression levels of 356 miRNAs that had at least 5 reads in half of the study participants.,Genome_build: hg19,Supplementary_files_format_and_content: tab-delimited text files include unnormalized weighted counts for each miRNA
Abdominal subcutaneous adipose tissue was obtained with needle biopsies. Total RNA was isolated from the adipose tissue using Qiagen miRNeasy kit according to manufacturer’s instructions. RNA Integrity Number (RIN) values were assessed with the Agilent Bioanalyzer 2100 instrument. Samples with RIN values greater than 7.0 were used for transcriptional profiling.,Small RNA libraries were prepared using the Illumina TruSeq Small RNA protocol utilizing up to 48 unique index sequences (Illumina Catalog Number FC-102-1009). For two samples (METSIM490 and METSIM6589) we also prepared small RNA libraries using Illumina Small RNA v1.5 sample preparation protocol (Catalog # FC-930-1501)
GSM1098392
Illumina HiSeq 2000
May 15 2019
size fractionation
transcriptomic
RNA-Seq
total RNA
Homo sapiens
GPL11154
SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX249291,BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN01978219
GSM1098392
GSE45159
0.105401
adipose tissue
Public on Apr 01 2013
Mar 14 2013
9606
METSIM10830
SRA
https://www.ncbi.nlm.nih.gov/sra?term=SRX249291
https://www.ncbi.nlm.nih.gov/biosample/SAMN01978219
1
age: 52,tissue: adipose tissue,log10 body mass index: 1.41615038,log10 basal metabolic rate (kcal): 1711,log2 estimated glomerular filtration rate using modification of diet in renal disease (egfr_mdrd): 6.466969775,log10 estimated creatinine clearance rate using cockfcrot-gault formulaa (egcr): 6.75548099,plasma free fatty acids under the curve ogtt (mmol/l * min): 18.75,fat mass (%): 20.6,log10 plasma glucose area under the curve (ogtt) (mmol/l * min): 9.82336724,plasma glucose area under the curve above basal (ogtt) (mmol/l * min): 222,log10 homair (insulin resistance index based on homa): -0.005243055,log10 homais (insulin secretion index based on homa): 1.549671922,log10 insulin area under the curve (ogtt) (pmol/l * min): 4.155912689,insgenin (insulinogenic index): 1.562984086,log10 insulin area under the curve above basal (ogtt) (pmol/l * min): 4.061113054,log10 matsuda insulin sensitivity index: 1.061962987,muscle mass (%): 46.2,lg10 serum c-reactive protein (mg/l): -0.522878745,lg10 plasma adiponectin (mg/l): 0.977723605,ogtt fasting plasma free fatty acid (mmol/l): 0.33,ogtt 30 min plasma free fatty acid (mmol/l): 0.2,ogtt 120 min plasma free fatty acid (mmol/l): 0.04,ogtt fasting plasma glucose (mmol/l): 5.7,ogtt 30 min plasma glucose (mmol/l): 10,ogtt 120 min plasma glucose (mmol/l): 4.9,log10 il1 receptor antagonist (pg/ml): 2.124699809,log10 il1 beta (pg/ml): NA,log10 ogtt fasting plasma insulin (mu/l): 0.591064607,ogtt 30 min plasma insulin (mu/l): 1.478566496,ogtt 120 min plasma insulin (mu/l): 1.064457989,log10 ogtt fasting plasma proinsulin (pm/l): 1.212187604,ogtt 30 min plasma proinsulin (pm/l): 1.480006943,ogtt 120 min plasma proinsulin (pm/l): 1.617000341,log10 bioimpedance: Resistance: 2.685741739,log10 bioimpedance (reactance): 1.748188027,waist to hip ratio: 0.94,log10 serum bilirubin (umol/l): 1.531478917,log10 serum alanine aminotransfrase (u/l): 1.255272505,log10 creatinine (umol/l): 1.924279286,log10 total cholesterol (mmol/l): 0.737192643,log10 ldl cholesterol (mmol/l): 0.499687083,log10 hdl cholesterol (mmol/l): 0.330413773,log10 total triglycerides (mmol/l): -0.26760624,log10 serum apoa1 (g/l): 0.222716471,log10 serum apob (g/l): -0.065501549,log10 urinary albumin excretion rate (ug/min): 0.62291013
675 Charles E. Young Dr. S. MRL 3220
Los Angeles
USA
University of California Los Angeles
Mete,,Civelek
Illumina Casava1.7 software used for basecalling.,Sequencing files were converted to FASTQ format using a custom Perl script. In order to assign the indexed reads to each METSIM subject, a Python script was used to partition the FASTQ file for each lane into multiple FASTQ files, each of which corresponded to one individual. To be included in the partitioned file, a read had to have an exact match to one of the 48 possible index sequences, unambiguously identifying the individual from whom the read originated. Reads which did not exactly match an index sequence were discarded.,The reads were then aligned to the hg19 version of the genome using the Novoalign tool with the following settings: -l16 -t30 -h90 -rA -R 1 -m -g 200 –k. Novoalign software trims the adapter sequences while aligning.,We used the Bioconductor package GenomicRanges for R (v.2.14.0) to count the number of reads with alignment coordinates that overlap the coordinates of known mature miRNAs. Whenever a read mapped to 'x' genomic loci, the read would contribute a count of 1/x to those regions. The genomic coordinates for known mature miRNAs were downloaded from miRBase version 18.,To enable comparison of counts between samples, we normalized the expression values by dividing the counts for a given mature miRNA by the sum of all the miRNA counts for the corresponding individual. For subsequent analysis, we considered the expression levels of 356 miRNAs that had at least 5 reads in half of the study participants.,Genome_build: hg19,Supplementary_files_format_and_content: tab-delimited text files include unnormalized weighted counts for each miRNA
Abdominal subcutaneous adipose tissue was obtained with needle biopsies. Total RNA was isolated from the adipose tissue using Qiagen miRNeasy kit according to manufacturer’s instructions. RNA Integrity Number (RIN) values were assessed with the Agilent Bioanalyzer 2100 instrument. Samples with RIN values greater than 7.0 were used for transcriptional profiling.,Small RNA libraries were prepared using the Illumina TruSeq Small RNA protocol utilizing up to 48 unique index sequences (Illumina Catalog Number FC-102-1009). For two samples (METSIM490 and METSIM6589) we also prepared small RNA libraries using Illumina Small RNA v1.5 sample preparation protocol (Catalog # FC-930-1501)
GSM1098393
Illumina HiSeq 2000
May 15 2019
size fractionation
transcriptomic
RNA-Seq
total RNA
Homo sapiens
GPL11154
SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX249292,BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN01978220
GSM1098393
GSE45159
0.218228
adipose tissue
Public on Apr 01 2013
Mar 14 2013
9606
METSIM11138
SRA
https://www.ncbi.nlm.nih.gov/sra?term=SRX249292
https://www.ncbi.nlm.nih.gov/biosample/SAMN01978220
1
age: 53,tissue: adipose tissue,log10 body mass index: 1.367376327,log10 basal metabolic rate (kcal): 1589,log2 estimated glomerular filtration rate using modification of diet in renal disease (egfr_mdrd): 6.187847951,log10 estimated creatinine clearance rate using cockfcrot-gault formulaa (egcr): 6.299460806,plasma free fatty acids under the curve ogtt (mmol/l * min): 30,fat mass (%): 16.2,log10 plasma glucose area under the curve (ogtt) (mmol/l * min): 9.73470962,plasma glucose area under the curve above basal (ogtt) (mmol/l * min): 216,log10 homair (insulin resistance index based on homa): -0.305687354,log10 homais (insulin secretion index based on homa): 1.367976785,log10 insulin area under the curve (ogtt) (pmol/l * min): 4.352529815,insgenin (insulinogenic index): 1.783546282,log10 insulin area under the curve above basal (ogtt) (pmol/l * min): 4.322343361,log10 matsuda insulin sensitivity index: 1.108767833,muscle mass (%): 47.3,lg10 serum c-reactive protein (mg/l): 0.045322979,lg10 plasma adiponectin (mg/l): 0.929418926,ogtt fasting plasma free fatty acid (mmol/l): 0.52,ogtt 30 min plasma free fatty acid (mmol/l): 0.34,ogtt 120 min plasma free fatty acid (mmol/l): 0.04,ogtt fasting plasma glucose (mmol/l): 5.3,ogtt 30 min plasma glucose (mmol/l): 7.7,ogtt 120 min plasma glucose (mmol/l): 6.9,log10 il1 receptor antagonist (pg/ml): 2.402089351,log10 il1 beta (pg/ml): NA,log10 ogtt fasting plasma insulin (mu/l): 0.322219295,ogtt 30 min plasma insulin (mu/l): 1.421603927,ogtt 120 min plasma insulin (mu/l): 1.67669361,log10 ogtt fasting plasma proinsulin (pm/l): 0.949390007,ogtt 30 min plasma proinsulin (pm/l): 1.316180099,ogtt 120 min plasma proinsulin (pm/l): 1.981818607,log10 bioimpedance: Resistance: 2.691965103,log10 bioimpedance (reactance): 1.698970004,waist to hip ratio: 0.989130435,log10 serum bilirubin (umol/l): 1.041392685,log10 serum alanine aminotransfrase (u/l): 1.230448921,log10 creatinine (umol/l): 1.995635195,log10 total cholesterol (mmol/l): 0.86569606,log10 ldl cholesterol (mmol/l): 0.689308859,log10 hdl cholesterol (mmol/l): 0.26245109,log10 total triglycerides (mmol/l): 0.071882007,log10 serum apoa1 (g/l): 0.257678575,log10 serum apob (g/l): 0.127104798,log10 urinary albumin excretion rate (ug/min): 0.749187554
675 Charles E. Young Dr. S. MRL 3220
Los Angeles
USA
University of California Los Angeles
Mete,,Civelek
Illumina Casava1.7 software used for basecalling.,Sequencing files were converted to FASTQ format using a custom Perl script. In order to assign the indexed reads to each METSIM subject, a Python script was used to partition the FASTQ file for each lane into multiple FASTQ files, each of which corresponded to one individual. To be included in the partitioned file, a read had to have an exact match to one of the 48 possible index sequences, unambiguously identifying the individual from whom the read originated. Reads which did not exactly match an index sequence were discarded.,The reads were then aligned to the hg19 version of the genome using the Novoalign tool with the following settings: -l16 -t30 -h90 -rA -R 1 -m -g 200 –k. Novoalign software trims the adapter sequences while aligning.,We used the Bioconductor package GenomicRanges for R (v.2.14.0) to count the number of reads with alignment coordinates that overlap the coordinates of known mature miRNAs. Whenever a read mapped to 'x' genomic loci, the read would contribute a count of 1/x to those regions. The genomic coordinates for known mature miRNAs were downloaded from miRBase version 18.,To enable comparison of counts between samples, we normalized the expression values by dividing the counts for a given mature miRNA by the sum of all the miRNA counts for the corresponding individual. For subsequent analysis, we considered the expression levels of 356 miRNAs that had at least 5 reads in half of the study participants.,Genome_build: hg19,Supplementary_files_format_and_content: tab-delimited text files include unnormalized weighted counts for each miRNA
Abdominal subcutaneous adipose tissue was obtained with needle biopsies. Total RNA was isolated from the adipose tissue using Qiagen miRNeasy kit according to manufacturer’s instructions. RNA Integrity Number (RIN) values were assessed with the Agilent Bioanalyzer 2100 instrument. Samples with RIN values greater than 7.0 were used for transcriptional profiling.,Small RNA libraries were prepared using the Illumina TruSeq Small RNA protocol utilizing up to 48 unique index sequences (Illumina Catalog Number FC-102-1009). For two samples (METSIM490 and METSIM6589) we also prepared small RNA libraries using Illumina Small RNA v1.5 sample preparation protocol (Catalog # FC-930-1501)
GSM1098394
Illumina HiSeq 2000
May 15 2019
size fractionation
transcriptomic
RNA-Seq
total RNA
Homo sapiens
GPL11154
SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX249293,BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN01978221
GSM1098394
GSE45159
0.161388
adipose tissue
Public on Apr 01 2013
Mar 14 2013
9606
METSIM11295
SRA
https://www.ncbi.nlm.nih.gov/sra?term=SRX249293
https://www.ncbi.nlm.nih.gov/biosample/SAMN01978221
1
age: 47,tissue: adipose tissue,log10 body mass index: 1.37285687,log10 basal metabolic rate (kcal): 1498,log2 estimated glomerular filtration rate using modification of diet in renal disease (egfr_mdrd): 6.239936646,log10 estimated creatinine clearance rate using cockfcrot-gault formulaa (egcr): 6.329022795,plasma free fatty acids under the curve ogtt (mmol/l * min): 28.5,fat mass (%): 20.4,log10 plasma glucose area under the curve (ogtt) (mmol/l * min): 9.787086325,plasma glucose area under the curve above basal (ogtt) (mmol/l * min): 235.5,log10 homair (insulin resistance index based on homa): 0.165541077,log10 homais (insulin secretion index based on homa): 1.80760623,log10 insulin area under the curve (ogtt) (pmol/l * min): 4.882330969,insgenin (insulinogenic index): 2.319528073,log10 insulin area under the curve above basal (ogtt) (pmol/l * min): 4.856571815,log10 matsuda insulin sensitivity index: 0.618762803,muscle mass (%): 46.4,lg10 serum c-reactive protein (mg/l): 0.049218023,lg10 plasma adiponectin (mg/l): 1,ogtt fasting plasma free fatty acid (mmol/l): 0.53,ogtt 30 min plasma free fatty acid (mmol/l): 0.29,ogtt 120 min plasma free fatty acid (mmol/l): 0.07,ogtt fasting plasma glucose (mmol/l): 5.4,ogtt 30 min plasma glucose (mmol/l): 9.1,ogtt 120 min plasma glucose (mmol/l): 5.7,log10 il1 receptor antagonist (pg/ml): 2.297235102,log10 il1 beta (pg/ml): NA,log10 ogtt fasting plasma insulin (mu/l): 0.785329835,ogtt 30 min plasma insulin (mu/l): 2.129689892,ogtt 120 min plasma insulin (mu/l): 2.003029471,log10 ogtt fasting plasma proinsulin (pm/l): 1.224014811,ogtt 30 min plasma proinsulin (pm/l): 1.83305782,ogtt 120 min plasma proinsulin (pm/l): 1.923244019,log10 bioimpedance: Resistance: 2.781755375,log10 bioimpedance (reactance): 1.880813592,waist to hip ratio: 0.956989247,log10 serum bilirubin (umol/l): 0.954242509,log10 serum alanine aminotransfrase (u/l): 1.653212514,log10 creatinine (umol/l): 1.991226076,log10 total cholesterol (mmol/l): 0.784617293,log10 ldl cholesterol (mmol/l): 0.541579244,log10 hdl cholesterol (mmol/l): 0.26245109,log10 total triglycerides (mmol/l): 0.255272505,log10 serum apoa1 (g/l): 0.276461804,log10 serum apob (g/l): 0.041392685,log10 urinary albumin excretion rate (ug/min): 1.021189299
675 Charles E. Young Dr. S. MRL 3220
Los Angeles
USA
University of California Los Angeles
Mete,,Civelek
Illumina Casava1.7 software used for basecalling.,Sequencing files were converted to FASTQ format using a custom Perl script. In order to assign the indexed reads to each METSIM subject, a Python script was used to partition the FASTQ file for each lane into multiple FASTQ files, each of which corresponded to one individual. To be included in the partitioned file, a read had to have an exact match to one of the 48 possible index sequences, unambiguously identifying the individual from whom the read originated. Reads which did not exactly match an index sequence were discarded.,The reads were then aligned to the hg19 version of the genome using the Novoalign tool with the following settings: -l16 -t30 -h90 -rA -R 1 -m -g 200 –k. Novoalign software trims the adapter sequences while aligning.,We used the Bioconductor package GenomicRanges for R (v.2.14.0) to count the number of reads with alignment coordinates that overlap the coordinates of known mature miRNAs. Whenever a read mapped to 'x' genomic loci, the read would contribute a count of 1/x to those regions. The genomic coordinates for known mature miRNAs were downloaded from miRBase version 18.,To enable comparison of counts between samples, we normalized the expression values by dividing the counts for a given mature miRNA by the sum of all the miRNA counts for the corresponding individual. For subsequent analysis, we considered the expression levels of 356 miRNAs that had at least 5 reads in half of the study participants.,Genome_build: hg19,Supplementary_files_format_and_content: tab-delimited text files include unnormalized weighted counts for each miRNA
Abdominal subcutaneous adipose tissue was obtained with needle biopsies. Total RNA was isolated from the adipose tissue using Qiagen miRNeasy kit according to manufacturer’s instructions. RNA Integrity Number (RIN) values were assessed with the Agilent Bioanalyzer 2100 instrument. Samples with RIN values greater than 7.0 were used for transcriptional profiling.,Small RNA libraries were prepared using the Illumina TruSeq Small RNA protocol utilizing up to 48 unique index sequences (Illumina Catalog Number FC-102-1009). For two samples (METSIM490 and METSIM6589) we also prepared small RNA libraries using Illumina Small RNA v1.5 sample preparation protocol (Catalog # FC-930-1501)
GSM1098395
Illumina HiSeq 2000
May 15 2019
size fractionation
transcriptomic
RNA-Seq
total RNA
Homo sapiens
GPL11154
SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX249294,BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN01978222
GSM1098395
GSE45159
0.142514
adipose tissue
Public on Apr 01 2013
Mar 14 2013
9606
METSIM11401
SRA
https://www.ncbi.nlm.nih.gov/sra?term=SRX249294
https://www.ncbi.nlm.nih.gov/biosample/SAMN01978222
1
cell type: Induced endothelial cells from cultured foreskin fibroblast cells (Stegment)
3333 Burnet Ave
Cincinnati
USA
Cincinnati Children's Hospital Medical Center
Rebekah,,Karns
Trimmed sequences were generated as fastq outputs and analyzed based on the TopHat/Cufflinks pipeline based on reference annotations produced by the Ensembl Gencode project. Differential and significant gene expression analysis was carried out using gene-level FPKM (fragments per kilobase of gene locus summarized mRNA per million reads) expression levels.,Gene-level expression was normalized and baselined to the 80th percentile of that sample's overall expression in GeneSpring v7.,Genome_build: GRCh37/hg19,Supplementary_files_format_and_content: Each sample has a corresponding .txt file with normalized FPKM
Using RNeasy Mini Kit (Qiagen), total RNA was extracted and quantitative polymerase chain reaction was performed using Taqman gene expression assays (Applied Biosystems),RNA-Seq–based expression analysis was carried out using RNA samples converted into individual cDNA libraries using Illumina (San Diego, CA). TruSeq methods employed single reads of 50 base-lengths sequenced at 20-30 million read depths using the Illumina HiSeq 2500 instrument.
GSM1098572
Illumina HiSeq 2500
May 15 2019
cDNA
transcriptomic
RNA-Seq
total RNA
Homo sapiens
GPL16791
SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX249507,BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN01978505
GSM1098572
GSE45176
0.008376
Induced endothelial cell
Public on Apr 14 2013
Mar 14 2013
9606
iEC: Rep1
SRA
https://www.ncbi.nlm.nih.gov/sra?term=SRX249507
https://www.ncbi.nlm.nih.gov/biosample/SAMN01978505
1
cell type: Induced endothelial cells from cultured foreskin fibroblast cells (Stegment)
3333 Burnet Ave
Cincinnati
USA
Cincinnati Children's Hospital Medical Center
Rebekah,,Karns
Trimmed sequences were generated as fastq outputs and analyzed based on the TopHat/Cufflinks pipeline based on reference annotations produced by the Ensembl Gencode project. Differential and significant gene expression analysis was carried out using gene-level FPKM (fragments per kilobase of gene locus summarized mRNA per million reads) expression levels.,Gene-level expression was normalized and baselined to the 80th percentile of that sample's overall expression in GeneSpring v7.,Genome_build: GRCh37/hg19,Supplementary_files_format_and_content: Each sample has a corresponding .txt file with normalized FPKM
Using RNeasy Mini Kit (Qiagen), total RNA was extracted and quantitative polymerase chain reaction was performed using Taqman gene expression assays (Applied Biosystems),RNA-Seq–based expression analysis was carried out using RNA samples converted into individual cDNA libraries using Illumina (San Diego, CA). TruSeq methods employed single reads of 50 base-lengths sequenced at 20-30 million read depths using the Illumina HiSeq 2500 instrument.
GSM1098573
Illumina HiSeq 2500
May 15 2019
cDNA
transcriptomic
RNA-Seq
total RNA
Homo sapiens
GPL16791
SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX249508,BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN01978506
GSM1098573
GSE45176
0.032723
Induced endothelial cell
Public on Apr 14 2013
Mar 14 2013
9606
iEC: Rep2
SRA
https://www.ncbi.nlm.nih.gov/sra?term=SRX249508
https://www.ncbi.nlm.nih.gov/biosample/SAMN01978506
1
cell type: Human Dermal Microvascular Endothelial Cells (Lonza)
3333 Burnet Ave
Cincinnati
USA
Cincinnati Children's Hospital Medical Center
Rebekah,,Karns
Trimmed sequences were generated as fastq outputs and analyzed based on the TopHat/Cufflinks pipeline based on reference annotations produced by the Ensembl Gencode project. Differential and significant gene expression analysis was carried out using gene-level FPKM (fragments per kilobase of gene locus summarized mRNA per million reads) expression levels.,Gene-level expression was normalized and baselined to the 80th percentile of that sample's overall expression in GeneSpring v7.,Genome_build: GRCh37/hg19,Supplementary_files_format_and_content: Each sample has a corresponding .txt file with normalized FPKM
Using RNeasy Mini Kit (Qiagen), total RNA was extracted and quantitative polymerase chain reaction was performed using Taqman gene expression assays (Applied Biosystems),RNA-Seq–based expression analysis was carried out using RNA samples converted into individual cDNA libraries using Illumina (San Diego, CA). TruSeq methods employed single reads of 50 base-lengths sequenced at 20-30 million read depths using the Illumina HiSeq 2500 instrument.
GSM1098574
Illumina HiSeq 2500
May 15 2019
cDNA
transcriptomic
RNA-Seq
total RNA
Homo sapiens
GPL16791
SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX249509,BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN01978507
GSM1098574
GSE45176
0.001947
Human microvascular endothilial cell
Public on Apr 14 2013
Mar 14 2013
9606
Human microvascular endothelial cell
SRA
https://www.ncbi.nlm.nih.gov/sra?term=SRX249509
https://www.ncbi.nlm.nih.gov/biosample/SAMN01978507
1
cell type: Cultured foreskin fibroblast cells (Stegment)
3333 Burnet Ave
Cincinnati
USA
Cincinnati Children's Hospital Medical Center
Rebekah,,Karns
Trimmed sequences were generated as fastq outputs and analyzed based on the TopHat/Cufflinks pipeline based on reference annotations produced by the Ensembl Gencode project. Differential and significant gene expression analysis was carried out using gene-level FPKM (fragments per kilobase of gene locus summarized mRNA per million reads) expression levels.,Gene-level expression was normalized and baselined to the 80th percentile of that sample's overall expression in GeneSpring v7.,Genome_build: GRCh37/hg19,Supplementary_files_format_and_content: Each sample has a corresponding .txt file with normalized FPKM
Using RNeasy Mini Kit (Qiagen), total RNA was extracted and quantitative polymerase chain reaction was performed using Taqman gene expression assays (Applied Biosystems),RNA-Seq–based expression analysis was carried out using RNA samples converted into individual cDNA libraries using Illumina (San Diego, CA). TruSeq methods employed single reads of 50 base-lengths sequenced at 20-30 million read depths using the Illumina HiSeq 2500 instrument.
GSM1098575
Illumina HiSeq 2500
May 15 2019
cDNA
transcriptomic
RNA-Seq
total RNA
Homo sapiens
GPL16791
SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX249510,BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN01978508
GSM1098575
GSE45176
0.006019
Fibroblast
Public on Apr 14 2013
Mar 14 2013
9606
Fibroblast
SRA
https://www.ncbi.nlm.nih.gov/sra?term=SRX249510
https://www.ncbi.nlm.nih.gov/biosample/SAMN01978508
1
cell line: MDA-MB-453,cell type: breast cancer
1400 Pressler Street
Houston
USA
University of Texas MD Anderson Cancer Center
Yiwen,,Chen
Basecalls performed using CASAVA version 1.9,RNA-seq reads were aligned to hg19 using TopHat v2.0.4,Differential expression was characterized using Cuffdiff (version 0.0.5).,Genome_build: hg19,Supplementary_files_format_and_content: tab-delimited text files include FPKM values for each condition
Total RNA was prepared using RNeasy Mini Kit (Qiagen) according to the manufacturer's instruction. The polyadenylated mRNA was purified using oligo d(T)25 beads (NEB).,1 ng of mRNA was used for library preparation using Encore Complete RNA-seq kit (NuGEN) according to the manufacturer's instruction.
GSM1099035
Illumina HiSeq 2000
May 15 2019
cDNA
transcriptomic
RNA-Seq
polyA RNA
Homo sapiens
GPL11154
SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX250097,BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN01978926
GSM1099035
GSE45202,GSE45203
0.189933
MDA-MB-453 cells transfected with control siRNA followed by vehicle treatment
Public on Mar 16 2013
Mar 15 2013
9606
MDA-MB-453 siCtrl-veh
SRA
https://www.ncbi.nlm.nih.gov/sra?term=SRX250097
https://www.ncbi.nlm.nih.gov/biosample/SAMN01978926
1
cell line: MDA-MB-453,cell type: breast cancer
1400 Pressler Street
Houston
USA
University of Texas MD Anderson Cancer Center
Yiwen,,Chen
Basecalls performed using CASAVA version 1.9,RNA-seq reads were aligned to hg19 using TopHat v2.0.4,Differential expression was characterized using Cuffdiff (version 0.0.5).,Genome_build: hg19,Supplementary_files_format_and_content: tab-delimited text files include FPKM values for each condition
Total RNA was prepared using RNeasy Mini Kit (Qiagen) according to the manufacturer's instruction. The polyadenylated mRNA was purified using oligo d(T)25 beads (NEB).,1 ng of mRNA was used for library preparation using Encore Complete RNA-seq kit (NuGEN) according to the manufacturer's instruction.
GSM1099036
Illumina HiSeq 2000
May 15 2019
cDNA
transcriptomic
RNA-Seq
polyA RNA
Homo sapiens
GPL11154
SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX250098,BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN01978927
GSM1099036
GSE45202,GSE45203
0.027956
MDA-MB-453 cells transfected with control siRNA followed by DHT treatment
Public on Mar 16 2013
Mar 15 2013
9606
MDA-MB-453 siCtrl-DHT
SRA
https://www.ncbi.nlm.nih.gov/sra?term=SRX250098
https://www.ncbi.nlm.nih.gov/biosample/SAMN01978927
1
cell line: MDA-MB-453,cell type: breast cancer
1400 Pressler Street
Houston
USA
University of Texas MD Anderson Cancer Center
Yiwen,,Chen
Basecalls performed using CASAVA version 1.9,RNA-seq reads were aligned to hg19 using TopHat v2.0.4,Differential expression was characterized using Cuffdiff (version 0.0.5).,Genome_build: hg19,Supplementary_files_format_and_content: tab-delimited text files include FPKM values for each condition
Total RNA was prepared using RNeasy Mini Kit (Qiagen) according to the manufacturer's instruction. The polyadenylated mRNA was purified using oligo d(T)25 beads (NEB).,1 ng of mRNA was used for library preparation using Encore Complete RNA-seq kit (NuGEN) according to the manufacturer's instruction.
GSM1099037
Illumina HiSeq 2000
May 15 2019
cDNA
transcriptomic
RNA-Seq
polyA RNA
Homo sapiens
GPL11154
SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX250099,BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN01978928
GSM1099037
GSE45202,GSE45203
0.16577
MDA-MB-453 cells transfected with MYC siRNA followed by DHT treatment
Public on Mar 16 2013
Mar 15 2013
9606
MDA-MB-453 siMYC-DHT
SRA
https://www.ncbi.nlm.nih.gov/sra?term=SRX250099
https://www.ncbi.nlm.nih.gov/biosample/SAMN01978928
1
origen of cultured cells: RPE isolated from 16 weeks gestation human fetus,transepithelial electrical resistance: 730 ± 10 ohm*cm^2,peak transepitheilal electrical resistance (ksr only): N/A
10 Amistad Street
New Haven
USA
Yale University
Mei,,Zhong
Basecalls performed using CASAVA version 1.7.0 and 1.8.1,Sequenced reads from the sequencing run were imported into the public Galaxy platform, a free online bioinformatics interface available at http://main.g2.bx.psu.edu. The sequences were aligned against the hg19 reference genome using the Tophat for Illumina (version 1.5.0) with default parameters.,Transcripts were assembled using Cufflinks (version 0.0.5) with quartile normalization and bias correction.,Fold change in transcript expression were analyzed using Cuffdiff (version 0.0.5) with false discovery rate of 0.05, minimum alignment count of 100, quartile normalization, and bias correction.,Genome_build: hg19,Supplementary_files_format_and_content: tab-delimited text files for RPKM values of each sample and tab-delimited text files for fold changes between two compared cell types
Libraries were prepared according to Illumina’s mRNA Sequencing Sample Preparation Guide for mRNA-Seq 8 Sample Prep Kit (Cat# RS-100-0801) for illumina Genome Analyzer II and TruSeq RNA Sample Preparation Guide for TruSeq RNA Sample Prep Kit v2 (Cat RS-122-2001) for HiSeq 2000. Briefly, poly-A containing mRNA molecules were purified from 10ug of total RNA using poly-T oligo-attached magnetic beads then fragmented into small pieces using divalent cations under elevated temperature. The cleaved RNA fragments are copied into first strand cDNA using reverse transcriptase and random primers followed by second strand cDNA synthesis using DNA Polymerase I and RNaseH. These cDNA fragments then go through an end repair process using a combination of T4 DNA polymerase, E. coli DNA Pol I large fragment (Klenow polymerase) and T4 polynucleotide kinase. The blunt, phosphorylated ends were treated with Klenow fragment (3’ to 5’ exo minus) and dATP to yield a protruding 3- 'A' base for ligation of Illumina's adapters which have a single 'T' base overhang at the 3’ end. These products are then purified and enriched with 15 cycles of PCR to create the final cDNA library. Library fragments of 150 to 350 bp (insert plus adaptor and PCR primer sequences) were isolated from 2% E-Gel EX Gel (Invirotgen #G4020-02). The purified DNA was captured on an Illumina flow cell for cluster generation. Libraries were sequenced on the Genome Analyzer following the manufacturer's protocols.
GSM1099813
Illumina HiSeq 2000
May 15 2019
cDNA
transcriptomic
RNA-Seq
total RNA
Homo sapiens
GPL11154
SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX251952,BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN01983922
GSM1099813
GSE36695
0
Retinal Pigment Epithelium
Public on Mar 20 2013
Mar 18 2013
9606
hfRPESeq072611
SRA
https://www.ncbi.nlm.nih.gov/sra?term=SRX251952
https://www.ncbi.nlm.nih.gov/biosample/SAMN01983922
1
origen of cultured cells: hESC H1 line - derived RPE,transepithelial electrical resistance: 41±1 ohm*cm^2,peak transepitheilal electrical resistance (ksr only): 150±10 ohm*cm^2
10 Amistad Street
New Haven
USA
Yale University
Mei,,Zhong
Basecalls performed using CASAVA version 1.7.0 and 1.8.1,Sequenced reads from the sequencing run were imported into the public Galaxy platform, a free online bioinformatics interface available at http://main.g2.bx.psu.edu. The sequences were aligned against the hg19 reference genome using the Tophat for Illumina (version 1.5.0) with default parameters.,Transcripts were assembled using Cufflinks (version 0.0.5) with quartile normalization and bias correction.,Fold change in transcript expression were analyzed using Cuffdiff (version 0.0.5) with false discovery rate of 0.05, minimum alignment count of 100, quartile normalization, and bias correction.,Genome_build: hg19,Supplementary_files_format_and_content: tab-delimited text files for RPKM values of each sample and tab-delimited text files for fold changes between two compared cell types
Libraries were prepared according to Illumina’s mRNA Sequencing Sample Preparation Guide for mRNA-Seq 8 Sample Prep Kit (Cat# RS-100-0801) for illumina Genome Analyzer II and TruSeq RNA Sample Preparation Guide for TruSeq RNA Sample Prep Kit v2 (Cat RS-122-2001) for HiSeq 2000. Briefly, poly-A containing mRNA molecules were purified from 10ug of total RNA using poly-T oligo-attached magnetic beads then fragmented into small pieces using divalent cations under elevated temperature. The cleaved RNA fragments are copied into first strand cDNA using reverse transcriptase and random primers followed by second strand cDNA synthesis using DNA Polymerase I and RNaseH. These cDNA fragments then go through an end repair process using a combination of T4 DNA polymerase, E. coli DNA Pol I large fragment (Klenow polymerase) and T4 polynucleotide kinase. The blunt, phosphorylated ends were treated with Klenow fragment (3’ to 5’ exo minus) and dATP to yield a protruding 3- 'A' base for ligation of Illumina's adapters which have a single 'T' base overhang at the 3’ end. These products are then purified and enriched with 15 cycles of PCR to create the final cDNA library. Library fragments of 150 to 350 bp (insert plus adaptor and PCR primer sequences) were isolated from 2% E-Gel EX Gel (Invirotgen #G4020-02). The purified DNA was captured on an Illumina flow cell for cluster generation. Libraries were sequenced on the Genome Analyzer following the manufacturer's protocols.
GSM1099814
Illumina HiSeq 2000
May 15 2019
cDNA
transcriptomic
RNA-Seq
total RNA
Homo sapiens
GPL11154
SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX251953,BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN01983923
GSM1099814
GSE36695
0.000823
Retinal Pigment Epithelium
Public on Mar 20 2013
Mar 18 2013
9606
H1RPE.ksr.061511
SRA
https://www.ncbi.nlm.nih.gov/sra?term=SRX251953
https://www.ncbi.nlm.nih.gov/biosample/SAMN01983923
1
origen of cultured cells: hESC H9 line - derived RPE,transepithelial electrical resistance: 37± 4 ohm*cm^2,peak transepitheilal electrical resistance (ksr only): 110±10 ohm*cm^2
10 Amistad Street
New Haven
USA
Yale University
Mei,,Zhong
Basecalls performed using CASAVA version 1.7.0 and 1.8.1,Sequenced reads from the sequencing run were imported into the public Galaxy platform, a free online bioinformatics interface available at http://main.g2.bx.psu.edu. The sequences were aligned against the hg19 reference genome using the Tophat for Illumina (version 1.5.0) with default parameters.,Transcripts were assembled using Cufflinks (version 0.0.5) with quartile normalization and bias correction.,Fold change in transcript expression were analyzed using Cuffdiff (version 0.0.5) with false discovery rate of 0.05, minimum alignment count of 100, quartile normalization, and bias correction.,Genome_build: hg19,Supplementary_files_format_and_content: tab-delimited text files for RPKM values of each sample and tab-delimited text files for fold changes between two compared cell types
Libraries were prepared according to Illumina’s mRNA Sequencing Sample Preparation Guide for mRNA-Seq 8 Sample Prep Kit (Cat# RS-100-0801) for illumina Genome Analyzer II and TruSeq RNA Sample Preparation Guide for TruSeq RNA Sample Prep Kit v2 (Cat RS-122-2001) for HiSeq 2000. Briefly, poly-A containing mRNA molecules were purified from 10ug of total RNA using poly-T oligo-attached magnetic beads then fragmented into small pieces using divalent cations under elevated temperature. The cleaved RNA fragments are copied into first strand cDNA using reverse transcriptase and random primers followed by second strand cDNA synthesis using DNA Polymerase I and RNaseH. These cDNA fragments then go through an end repair process using a combination of T4 DNA polymerase, E. coli DNA Pol I large fragment (Klenow polymerase) and T4 polynucleotide kinase. The blunt, phosphorylated ends were treated with Klenow fragment (3’ to 5’ exo minus) and dATP to yield a protruding 3- 'A' base for ligation of Illumina's adapters which have a single 'T' base overhang at the 3’ end. These products are then purified and enriched with 15 cycles of PCR to create the final cDNA library. Library fragments of 150 to 350 bp (insert plus adaptor and PCR primer sequences) were isolated from 2% E-Gel EX Gel (Invirotgen #G4020-02). The purified DNA was captured on an Illumina flow cell for cluster generation. Libraries were sequenced on the Genome Analyzer following the manufacturer's protocols.
GSM1099815
Illumina HiSeq 2000
May 15 2019
cDNA
transcriptomic
RNA-Seq
total RNA
Homo sapiens
GPL11154
SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX251954,BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN01983924
GSM1099815
GSE36695
0
Retinal Pigment Epithelium
Public on Mar 20 2013
Mar 18 2013
9606
H9RPE.ksr.041511
SRA
https://www.ncbi.nlm.nih.gov/sra?term=SRX251954
https://www.ncbi.nlm.nih.gov/biosample/SAMN01983924
1
origen of cultured cells: hESC H9 line - derived RPE,transepithelial electrical resistance: 49± 4 ohm*cm^2,peak transepitheilal electrical resistance (ksr only): 55±4 ohm*cm^2
10 Amistad Street
New Haven
USA
Yale University
Mei,,Zhong
Basecalls performed using CASAVA version 1.7.0 and 1.8.1,Sequenced reads from the sequencing run were imported into the public Galaxy platform, a free online bioinformatics interface available at http://main.g2.bx.psu.edu. The sequences were aligned against the hg19 reference genome using the Tophat for Illumina (version 1.5.0) with default parameters.,Transcripts were assembled using Cufflinks (version 0.0.5) with quartile normalization and bias correction.,Fold change in transcript expression were analyzed using Cuffdiff (version 0.0.5) with false discovery rate of 0.05, minimum alignment count of 100, quartile normalization, and bias correction.,Genome_build: hg19,Supplementary_files_format_and_content: tab-delimited text files for RPKM values of each sample and tab-delimited text files for fold changes between two compared cell types
Libraries were prepared according to Illumina’s mRNA Sequencing Sample Preparation Guide for mRNA-Seq 8 Sample Prep Kit (Cat# RS-100-0801) for illumina Genome Analyzer II and TruSeq RNA Sample Preparation Guide for TruSeq RNA Sample Prep Kit v2 (Cat RS-122-2001) for HiSeq 2000. Briefly, poly-A containing mRNA molecules were purified from 10ug of total RNA using poly-T oligo-attached magnetic beads then fragmented into small pieces using divalent cations under elevated temperature. The cleaved RNA fragments are copied into first strand cDNA using reverse transcriptase and random primers followed by second strand cDNA synthesis using DNA Polymerase I and RNaseH. These cDNA fragments then go through an end repair process using a combination of T4 DNA polymerase, E. coli DNA Pol I large fragment (Klenow polymerase) and T4 polynucleotide kinase. The blunt, phosphorylated ends were treated with Klenow fragment (3’ to 5’ exo minus) and dATP to yield a protruding 3- 'A' base for ligation of Illumina's adapters which have a single 'T' base overhang at the 3’ end. These products are then purified and enriched with 15 cycles of PCR to create the final cDNA library. Library fragments of 150 to 350 bp (insert plus adaptor and PCR primer sequences) were isolated from 2% E-Gel EX Gel (Invirotgen #G4020-02). The purified DNA was captured on an Illumina flow cell for cluster generation. Libraries were sequenced on the Genome Analyzer following the manufacturer's protocols.
GSM1099816
Illumina HiSeq 2000
May 15 2019
cDNA
transcriptomic
RNA-Seq
total RNA
Homo sapiens
GPL11154
SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX251955,BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN01983925
GSM1099816
GSE36695
0
Retinal Pigment Epithelium
Public on Mar 20 2013
Mar 18 2013
9606
H9RPE.ksr.060311
SRA
https://www.ncbi.nlm.nih.gov/sra?term=SRX251955
https://www.ncbi.nlm.nih.gov/biosample/SAMN01983925
1
cell type: mammary epithelial,cell line: MCF10A,sample type: 25 M reads
415 Lane Road, MR5-Rm. 2225
Charlottesville
USA
University of Virginia
Byong,Ha,Kang
RNA-seq reads were chastity filtered and assessed for overall quality with FastQC (http://www.bioinformatics.babraham.ac.uk/projects/fastqc/).,Sequenced reads were mapped using STAR 2.2.0 against the human genome build hg19.,Reads that map to each gene were counted with HTSeq (http://www-huber.embl.de/users/anders/HTSeq/) under the union set, whereby reads that do not completely overlap a gene are still counted. The counts were normalized by the library size (read depth).,RPKM calculations were performed by normalizing to the median transcript length for each gene and the total library size of each sample.,Genome_build: hg19,Supplementary_files_format_and_content: tab-delimited text files include normalized count in the first column and RPKM value in the second column for each sample
Total RNA was isolated with the RNeasy Mini Kit (Qiagen) according to the manufacturer's protocols.,Each cDNA library was prepared with the NEBNext first-strand synthesis, second-strand synthesis, end repair, dA tailing, and quick ligation modules (New England Biolabs). Libraries were indexed with standard Illumina-type adapters and sequenced on an Illumina HiSeq 2000 using version 3 reagents that generate 180–200M reads per lane. Samples were 50-bp paired-end sequenced in duplicate at 25M and 50M or 100M reads per sample.
GSM1100205
Illumina HiSeq 2000
May 15 2019
cDNA
transcriptomic
RNA-Seq
total RNA
Homo sapiens
GPL11154
SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX251969,BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN01983939
GSM1100205
GSE45258
0.002925
breast
Public on Aug 06 2013
Mar 18 2013
9606
MCF10A cells run at 25M reads
SRA
https://www.ncbi.nlm.nih.gov/sra?term=SRX251969
https://www.ncbi.nlm.nih.gov/biosample/SAMN01983939
1
cell type: mammary epithelial,cell line: MCF10A,sample type: 50 M reads
415 Lane Road, MR5-Rm. 2225
Charlottesville
USA
University of Virginia
Byong,Ha,Kang
RNA-seq reads were chastity filtered and assessed for overall quality with FastQC (http://www.bioinformatics.babraham.ac.uk/projects/fastqc/).,Sequenced reads were mapped using STAR 2.2.0 against the human genome build hg19.,Reads that map to each gene were counted with HTSeq (http://www-huber.embl.de/users/anders/HTSeq/) under the union set, whereby reads that do not completely overlap a gene are still counted. The counts were normalized by the library size (read depth).,RPKM calculations were performed by normalizing to the median transcript length for each gene and the total library size of each sample.,Genome_build: hg19,Supplementary_files_format_and_content: tab-delimited text files include normalized count in the first column and RPKM value in the second column for each sample
Total RNA was isolated with the RNeasy Mini Kit (Qiagen) according to the manufacturer's protocols.,Each cDNA library was prepared with the NEBNext first-strand synthesis, second-strand synthesis, end repair, dA tailing, and quick ligation modules (New England Biolabs). Libraries were indexed with standard Illumina-type adapters and sequenced on an Illumina HiSeq 2000 using version 3 reagents that generate 180–200M reads per lane. Samples were 50-bp paired-end sequenced in duplicate at 25M and 50M or 100M reads per sample.
GSM1100206
Illumina HiSeq 2000
May 15 2019
cDNA
transcriptomic
RNA-Seq
total RNA
Homo sapiens
GPL11154
SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX251970,BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN01983940
GSM1100206
GSE45258
0.001486
breast
Public on Aug 06 2013
Mar 18 2013
9606
MCF10A cells run at 100M reads
SRA
https://www.ncbi.nlm.nih.gov/sra?term=SRX251970
https://www.ncbi.nlm.nih.gov/biosample/SAMN01983940
1
cell type: colon adenocarcinoma,cell line: HT-29,treatment: IFN-g,sample type: 25 M reads
415 Lane Road, MR5-Rm. 2225
Charlottesville
USA
University of Virginia
Byong,Ha,Kang
RNA-seq reads were chastity filtered and assessed for overall quality with FastQC (http://www.bioinformatics.babraham.ac.uk/projects/fastqc/).,Sequenced reads were mapped using STAR 2.2.0 against the human genome build hg19.,Reads that map to each gene were counted with HTSeq (http://www-huber.embl.de/users/anders/HTSeq/) under the union set, whereby reads that do not completely overlap a gene are still counted. The counts were normalized by the library size (read depth).,RPKM calculations were performed by normalizing to the median transcript length for each gene and the total library size of each sample.,Genome_build: hg19,Supplementary_files_format_and_content: tab-delimited text files include normalized count in the first column and RPKM value in the second column for each sample
Total RNA was isolated with the RNeasy Mini Kit (Qiagen) according to the manufacturer's protocols.,Each cDNA library was prepared with the NEBNext first-strand synthesis, second-strand synthesis, end repair, dA tailing, and quick ligation modules (New England Biolabs). Libraries were indexed with standard Illumina-type adapters and sequenced on an Illumina HiSeq 2000 using version 3 reagents that generate 180–200M reads per lane. Samples were 50-bp paired-end sequenced in duplicate at 25M and 50M or 100M reads per sample.
GSM1100207
Illumina HiSeq 2000
May 15 2019
cDNA
transcriptomic
RNA-Seq
total RNA
Homo sapiens
GPL11154
SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX251971,BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN01983941
GSM1100207
GSE45258
0.006352
colon
Public on Aug 06 2013
Mar 18 2013
9606
IFN-g stimulated HT-29 cells run at 25M reads
SRA
https://www.ncbi.nlm.nih.gov/sra?term=SRX251971
https://www.ncbi.nlm.nih.gov/biosample/SAMN01983941
1
cell type: colon adenocarcinoma,cell line: HT-29,treatment: IFN-g,sample type: 50 M reads
415 Lane Road, MR5-Rm. 2225
Charlottesville
USA
University of Virginia
Byong,Ha,Kang
RNA-seq reads were chastity filtered and assessed for overall quality with FastQC (http://www.bioinformatics.babraham.ac.uk/projects/fastqc/).,Sequenced reads were mapped using STAR 2.2.0 against the human genome build hg19.,Reads that map to each gene were counted with HTSeq (http://www-huber.embl.de/users/anders/HTSeq/) under the union set, whereby reads that do not completely overlap a gene are still counted. The counts were normalized by the library size (read depth).,RPKM calculations were performed by normalizing to the median transcript length for each gene and the total library size of each sample.,Genome_build: hg19,Supplementary_files_format_and_content: tab-delimited text files include normalized count in the first column and RPKM value in the second column for each sample
Total RNA was isolated with the RNeasy Mini Kit (Qiagen) according to the manufacturer's protocols.,Each cDNA library was prepared with the NEBNext first-strand synthesis, second-strand synthesis, end repair, dA tailing, and quick ligation modules (New England Biolabs). Libraries were indexed with standard Illumina-type adapters and sequenced on an Illumina HiSeq 2000 using version 3 reagents that generate 180–200M reads per lane. Samples were 50-bp paired-end sequenced in duplicate at 25M and 50M or 100M reads per sample.
GSM1100208
Illumina HiSeq 2000
May 15 2019
cDNA
transcriptomic
RNA-Seq
total RNA
Homo sapiens
GPL11154
SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX251972,BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN01983942
GSM1100208
GSE45258
0
colon
Public on Aug 06 2013
Mar 18 2013
9606
IFN-g stimulated HT-29 cells run at 50M reads
SRA
https://www.ncbi.nlm.nih.gov/sra?term=SRX251972
https://www.ncbi.nlm.nih.gov/biosample/SAMN01983942
1
cell type: breast adenocarcinoma,cell line: MDA-MB-436,sample type: 25 M reads
415 Lane Road, MR5-Rm. 2225
Charlottesville
USA
University of Virginia
Byong,Ha,Kang
RNA-seq reads were chastity filtered and assessed for overall quality with FastQC (http://www.bioinformatics.babraham.ac.uk/projects/fastqc/).,Sequenced reads were mapped using STAR 2.2.0 against the human genome build hg19.,Reads that map to each gene were counted with HTSeq (http://www-huber.embl.de/users/anders/HTSeq/) under the union set, whereby reads that do not completely overlap a gene are still counted. The counts were normalized by the library size (read depth).,RPKM calculations were performed by normalizing to the median transcript length for each gene and the total library size of each sample.,Genome_build: hg19,Supplementary_files_format_and_content: tab-delimited text files include normalized count in the first column and RPKM value in the second column for each sample
Total RNA was isolated with the RNeasy Mini Kit (Qiagen) according to the manufacturer's protocols.,Each cDNA library was prepared with the NEBNext first-strand synthesis, second-strand synthesis, end repair, dA tailing, and quick ligation modules (New England Biolabs). Libraries were indexed with standard Illumina-type adapters and sequenced on an Illumina HiSeq 2000 using version 3 reagents that generate 180–200M reads per lane. Samples were 50-bp paired-end sequenced in duplicate at 25M and 50M or 100M reads per sample.
GSM1100209
Illumina HiSeq 2000
May 15 2019
cDNA
transcriptomic
RNA-Seq
total RNA
Homo sapiens
GPL11154
SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX251973,BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN01983943
GSM1100209
GSE45258
0.000271
breast
Public on Aug 06 2013
Mar 18 2013
9606
MDA-MB-436 cells run at 25M reads
SRA
https://www.ncbi.nlm.nih.gov/sra?term=SRX251973
https://www.ncbi.nlm.nih.gov/biosample/SAMN01983943
1
cell type: breast adenocarcinoma,cell line: MDA-MB-436,sample type: 50 M reads
415 Lane Road, MR5-Rm. 2225
Charlottesville
USA
University of Virginia
Byong,Ha,Kang
RNA-seq reads were chastity filtered and assessed for overall quality with FastQC (http://www.bioinformatics.babraham.ac.uk/projects/fastqc/).,Sequenced reads were mapped using STAR 2.2.0 against the human genome build hg19.,Reads that map to each gene were counted with HTSeq (http://www-huber.embl.de/users/anders/HTSeq/) under the union set, whereby reads that do not completely overlap a gene are still counted. The counts were normalized by the library size (read depth).,RPKM calculations were performed by normalizing to the median transcript length for each gene and the total library size of each sample.,Genome_build: hg19,Supplementary_files_format_and_content: tab-delimited text files include normalized count in the first column and RPKM value in the second column for each sample
Total RNA was isolated with the RNeasy Mini Kit (Qiagen) according to the manufacturer's protocols.,Each cDNA library was prepared with the NEBNext first-strand synthesis, second-strand synthesis, end repair, dA tailing, and quick ligation modules (New England Biolabs). Libraries were indexed with standard Illumina-type adapters and sequenced on an Illumina HiSeq 2000 using version 3 reagents that generate 180–200M reads per lane. Samples were 50-bp paired-end sequenced in duplicate at 25M and 50M or 100M reads per sample.
GSM1100210
Illumina HiSeq 2000
May 15 2019
cDNA
transcriptomic
RNA-Seq
total RNA
Homo sapiens
GPL11154
SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX251974,BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN01983944
GSM1100210
GSE45258
0
breast
Public on Aug 06 2013
Mar 18 2013
9606
MDA-MB-436 cells run at 50M reads
SRA
https://www.ncbi.nlm.nih.gov/sra?term=SRX251974
https://www.ncbi.nlm.nih.gov/biosample/SAMN01983944
1
tissue: Prefrontal Cortex,organism: human
320 Yue Yang Road
Shanghai
China
PICB
Liu,,He
Illumina Casava1.7 software used for basecalling, and only the ones passing illumina quality controls were retained.,Reads were mapped onto correponding reference genomes (hg19, panTro3) by Tophat-1.4.1, with parameters: -a 8 -m 2 no-coverage-search microexon-search segment-mismatches 3 segment-length 25.,We made a reciprocal lift-over between chimpanzee and human (Ensembl annotation v. 69, coding exons only), and used only exons that could be lift-overed to calculate RPKMs for each gene.,Then quantile normalization was applied, and each gene was z-transformed.,Genome_build: hg19, panTro3,Supplementary_files_format_and_content: tab-delimited text files including expression measurements for each gene from each sample.
Total RNA was isolated using Trizol reagent (Cat. No. 15596-026, Invitrogen). The libraries were constructed from the isolated total RNA according to the "TruSeq RNA Sample Preparation Kit" protocol (www.illumina.com) without modification. As the protocol includes the procedure of enrichment for the mRNA, an additional polyA selection was not necessary.,RNA libraries were prepared for sequencing using Illumina TruSeq protocols
GSM1100295
Illumina HiSeq 2000
May 15 2019
cDNA
transcriptomic
RNA-Seq
total RNA
Homo sapiens
GPL11154
SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX252083,BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN01983956
GSM1100295
GSE45263
0.002116
Prefrontal Cortex
Public on Mar 31 2014
Mar 18 2013
9606
Human_EU_1
SRA
https://www.ncbi.nlm.nih.gov/sra?term=SRX252083
https://www.ncbi.nlm.nih.gov/biosample/SAMN01983956
1
tissue: Prefrontal Cortex,organism: human
320 Yue Yang Road
Shanghai
China
PICB
Liu,,He
Illumina Casava1.7 software used for basecalling, and only the ones passing illumina quality controls were retained.,Reads were mapped onto correponding reference genomes (hg19, panTro3) by Tophat-1.4.1, with parameters: -a 8 -m 2 no-coverage-search microexon-search segment-mismatches 3 segment-length 25.,We made a reciprocal lift-over between chimpanzee and human (Ensembl annotation v. 69, coding exons only), and used only exons that could be lift-overed to calculate RPKMs for each gene.,Then quantile normalization was applied, and each gene was z-transformed.,Genome_build: hg19, panTro3,Supplementary_files_format_and_content: tab-delimited text files including expression measurements for each gene from each sample.
Total RNA was isolated using Trizol reagent (Cat. No. 15596-026, Invitrogen). The libraries were constructed from the isolated total RNA according to the "TruSeq RNA Sample Preparation Kit" protocol (www.illumina.com) without modification. As the protocol includes the procedure of enrichment for the mRNA, an additional polyA selection was not necessary.,RNA libraries were prepared for sequencing using Illumina TruSeq protocols
GSM1100296
Illumina HiSeq 2000
May 15 2019
cDNA
transcriptomic
RNA-Seq
total RNA
Homo sapiens
GPL11154
SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX252084,BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN01983957
GSM1100296
GSE45263
0.001403
Prefrontal Cortex
Public on Mar 31 2014
Mar 18 2013
9606
Human_AF_2
SRA
https://www.ncbi.nlm.nih.gov/sra?term=SRX252084
https://www.ncbi.nlm.nih.gov/biosample/SAMN01983957
1
tissue: Prefrontal Cortex,organism: human
320 Yue Yang Road
Shanghai
China
PICB
Liu,,He
Illumina Casava1.7 software used for basecalling, and only the ones passing illumina quality controls were retained.,Reads were mapped onto correponding reference genomes (hg19, panTro3) by Tophat-1.4.1, with parameters: -a 8 -m 2 no-coverage-search microexon-search segment-mismatches 3 segment-length 25.,We made a reciprocal lift-over between chimpanzee and human (Ensembl annotation v. 69, coding exons only), and used only exons that could be lift-overed to calculate RPKMs for each gene.,Then quantile normalization was applied, and each gene was z-transformed.,Genome_build: hg19, panTro3,Supplementary_files_format_and_content: tab-delimited text files including expression measurements for each gene from each sample.
Total RNA was isolated using Trizol reagent (Cat. No. 15596-026, Invitrogen). The libraries were constructed from the isolated total RNA according to the "TruSeq RNA Sample Preparation Kit" protocol (www.illumina.com) without modification. As the protocol includes the procedure of enrichment for the mRNA, an additional polyA selection was not necessary.,RNA libraries were prepared for sequencing using Illumina TruSeq protocols
GSM1100297
Illumina HiSeq 2000
May 15 2019
cDNA
transcriptomic
RNA-Seq
total RNA
Homo sapiens
GPL11154
SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX252085,BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN01983958
GSM1100297
GSE45263
0
Prefrontal Cortex
Public on Mar 31 2014
Mar 18 2013
9606
Human_EU_3
SRA
https://www.ncbi.nlm.nih.gov/sra?term=SRX252085
https://www.ncbi.nlm.nih.gov/biosample/SAMN01983958
1
tissue: Prefrontal Cortex,organism: human
320 Yue Yang Road
Shanghai
China
PICB
Liu,,He
Illumina Casava1.7 software used for basecalling, and only the ones passing illumina quality controls were retained.,Reads were mapped onto correponding reference genomes (hg19, panTro3) by Tophat-1.4.1, with parameters: -a 8 -m 2 no-coverage-search microexon-search segment-mismatches 3 segment-length 25.,We made a reciprocal lift-over between chimpanzee and human (Ensembl annotation v. 69, coding exons only), and used only exons that could be lift-overed to calculate RPKMs for each gene.,Then quantile normalization was applied, and each gene was z-transformed.,Genome_build: hg19, panTro3,Supplementary_files_format_and_content: tab-delimited text files including expression measurements for each gene from each sample.
Total RNA was isolated using Trizol reagent (Cat. No. 15596-026, Invitrogen). The libraries were constructed from the isolated total RNA according to the "TruSeq RNA Sample Preparation Kit" protocol (www.illumina.com) without modification. As the protocol includes the procedure of enrichment for the mRNA, an additional polyA selection was not necessary.,RNA libraries were prepared for sequencing using Illumina TruSeq protocols
GSM1100298
Illumina HiSeq 2000
May 15 2019
cDNA
transcriptomic
RNA-Seq
total RNA
Homo sapiens
GPL11154
SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX252086,BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN01983959
GSM1100298
GSE45263
0.000652
Prefrontal Cortex
Public on Mar 31 2014
Mar 18 2013
9606
Human_EU_4
SRA
https://www.ncbi.nlm.nih.gov/sra?term=SRX252086
https://www.ncbi.nlm.nih.gov/biosample/SAMN01983959
1
tissue: Prefrontal Cortex,organism: human
320 Yue Yang Road
Shanghai
China
PICB
Liu,,He
Illumina Casava1.7 software used for basecalling, and only the ones passing illumina quality controls were retained.,Reads were mapped onto correponding reference genomes (hg19, panTro3) by Tophat-1.4.1, with parameters: -a 8 -m 2 no-coverage-search microexon-search segment-mismatches 3 segment-length 25.,We made a reciprocal lift-over between chimpanzee and human (Ensembl annotation v. 69, coding exons only), and used only exons that could be lift-overed to calculate RPKMs for each gene.,Then quantile normalization was applied, and each gene was z-transformed.,Genome_build: hg19, panTro3,Supplementary_files_format_and_content: tab-delimited text files including expression measurements for each gene from each sample.
Total RNA was isolated using Trizol reagent (Cat. No. 15596-026, Invitrogen). The libraries were constructed from the isolated total RNA according to the "TruSeq RNA Sample Preparation Kit" protocol (www.illumina.com) without modification. As the protocol includes the procedure of enrichment for the mRNA, an additional polyA selection was not necessary.,RNA libraries were prepared for sequencing using Illumina TruSeq protocols
GSM1100299
Illumina HiSeq 2000
May 15 2019
cDNA
transcriptomic
RNA-Seq
total RNA
Homo sapiens
GPL11154
SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX252087,BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN01983960
GSM1100299
GSE45263
0.001587
Prefrontal Cortex
Public on Mar 31 2014
Mar 18 2013
9606
Human_AS_5
SRA
https://www.ncbi.nlm.nih.gov/sra?term=SRX252087
https://www.ncbi.nlm.nih.gov/biosample/SAMN01983960
1
tissue: Prefrontal Cortex,organism: human
320 Yue Yang Road
Shanghai
China
PICB
Liu,,He
Illumina Casava1.7 software used for basecalling, and only the ones passing illumina quality controls were retained.,Reads were mapped onto correponding reference genomes (hg19, panTro3) by Tophat-1.4.1, with parameters: -a 8 -m 2 no-coverage-search microexon-search segment-mismatches 3 segment-length 25.,We made a reciprocal lift-over between chimpanzee and human (Ensembl annotation v. 69, coding exons only), and used only exons that could be lift-overed to calculate RPKMs for each gene.,Then quantile normalization was applied, and each gene was z-transformed.,Genome_build: hg19, panTro3,Supplementary_files_format_and_content: tab-delimited text files including expression measurements for each gene from each sample.
Total RNA was isolated using Trizol reagent (Cat. No. 15596-026, Invitrogen). The libraries were constructed from the isolated total RNA according to the "TruSeq RNA Sample Preparation Kit" protocol (www.illumina.com) without modification. As the protocol includes the procedure of enrichment for the mRNA, an additional polyA selection was not necessary.,RNA libraries were prepared for sequencing using Illumina TruSeq protocols
GSM1100300
Illumina HiSeq 2000
May 15 2019
cDNA
transcriptomic
RNA-Seq
total RNA
Homo sapiens
GPL11154
SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX252088,BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN01983961
GSM1100300
GSE45263
0.001369
Prefrontal Cortex
Public on Mar 31 2014
Mar 18 2013
9606
Human_AF_6
SRA
https://www.ncbi.nlm.nih.gov/sra?term=SRX252088
https://www.ncbi.nlm.nih.gov/biosample/SAMN01983961
1
tissue: Prefrontal Cortex,organism: human
320 Yue Yang Road
Shanghai
China
PICB
Liu,,He
Illumina Casava1.7 software used for basecalling, and only the ones passing illumina quality controls were retained.,Reads were mapped onto correponding reference genomes (hg19, panTro3) by Tophat-1.4.1, with parameters: -a 8 -m 2 no-coverage-search microexon-search segment-mismatches 3 segment-length 25.,We made a reciprocal lift-over between chimpanzee and human (Ensembl annotation v. 69, coding exons only), and used only exons that could be lift-overed to calculate RPKMs for each gene.,Then quantile normalization was applied, and each gene was z-transformed.,Genome_build: hg19, panTro3,Supplementary_files_format_and_content: tab-delimited text files including expression measurements for each gene from each sample.
Total RNA was isolated using Trizol reagent (Cat. No. 15596-026, Invitrogen). The libraries were constructed from the isolated total RNA according to the "TruSeq RNA Sample Preparation Kit" protocol (www.illumina.com) without modification. As the protocol includes the procedure of enrichment for the mRNA, an additional polyA selection was not necessary.,RNA libraries were prepared for sequencing using Illumina TruSeq protocols
GSM1100301
Illumina HiSeq 2000
May 15 2019
cDNA
transcriptomic
RNA-Seq
total RNA
Homo sapiens
GPL11154
SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX252089,BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN01983962
GSM1100301
GSE45263
0.027837
Prefrontal Cortex
Public on Mar 31 2014
Mar 18 2013
9606
Human_AS_7
SRA
https://www.ncbi.nlm.nih.gov/sra?term=SRX252089
https://www.ncbi.nlm.nih.gov/biosample/SAMN01983962
1
tissue: Prefrontal Cortex,organism: human
320 Yue Yang Road
Shanghai
China
PICB
Liu,,He
Illumina Casava1.7 software used for basecalling, and only the ones passing illumina quality controls were retained.,Reads were mapped onto correponding reference genomes (hg19, panTro3) by Tophat-1.4.1, with parameters: -a 8 -m 2 no-coverage-search microexon-search segment-mismatches 3 segment-length 25.,We made a reciprocal lift-over between chimpanzee and human (Ensembl annotation v. 69, coding exons only), and used only exons that could be lift-overed to calculate RPKMs for each gene.,Then quantile normalization was applied, and each gene was z-transformed.,Genome_build: hg19, panTro3,Supplementary_files_format_and_content: tab-delimited text files including expression measurements for each gene from each sample.
Total RNA was isolated using Trizol reagent (Cat. No. 15596-026, Invitrogen). The libraries were constructed from the isolated total RNA according to the "TruSeq RNA Sample Preparation Kit" protocol (www.illumina.com) without modification. As the protocol includes the procedure of enrichment for the mRNA, an additional polyA selection was not necessary.,RNA libraries were prepared for sequencing using Illumina TruSeq protocols
GSM1100302
Illumina HiSeq 2000
May 15 2019
cDNA
transcriptomic
RNA-Seq
total RNA
Homo sapiens
GPL11154
SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX252090,BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN01983963
GSM1100302
GSE45263
0.002247
Prefrontal Cortex
Public on Mar 31 2014
Mar 18 2013
9606
Human_AF_8
SRA
https://www.ncbi.nlm.nih.gov/sra?term=SRX252090
https://www.ncbi.nlm.nih.gov/biosample/SAMN01983963
1
tissue: Prefrontal Cortex,organism: human
320 Yue Yang Road
Shanghai
China
PICB
Liu,,He
Illumina Casava1.7 software used for basecalling, and only the ones passing illumina quality controls were retained.,Reads were mapped onto correponding reference genomes (hg19, panTro3) by Tophat-1.4.1, with parameters: -a 8 -m 2 no-coverage-search microexon-search segment-mismatches 3 segment-length 25.,We made a reciprocal lift-over between chimpanzee and human (Ensembl annotation v. 69, coding exons only), and used only exons that could be lift-overed to calculate RPKMs for each gene.,Then quantile normalization was applied, and each gene was z-transformed.,Genome_build: hg19, panTro3,Supplementary_files_format_and_content: tab-delimited text files including expression measurements for each gene from each sample.
Total RNA was isolated using Trizol reagent (Cat. No. 15596-026, Invitrogen). The libraries were constructed from the isolated total RNA according to the "TruSeq RNA Sample Preparation Kit" protocol (www.illumina.com) without modification. As the protocol includes the procedure of enrichment for the mRNA, an additional polyA selection was not necessary.,RNA libraries were prepared for sequencing using Illumina TruSeq protocols
GSM1100303
Illumina HiSeq 2000
May 15 2019
cDNA
transcriptomic
RNA-Seq
total RNA
Homo sapiens
GPL11154
SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX252091,BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN01983964
GSM1100303
GSE45263
0.000497
Prefrontal Cortex
Public on Mar 31 2014
Mar 18 2013
9606
Human_AS_9
SRA
https://www.ncbi.nlm.nih.gov/sra?term=SRX252091
https://www.ncbi.nlm.nih.gov/biosample/SAMN01983964
1
tissue: Prefrontal Cortex,organism: human
320 Yue Yang Road
Shanghai
China
PICB
Liu,,He
Illumina Casava1.7 software used for basecalling, and only the ones passing illumina quality controls were retained.,Reads were mapped onto correponding reference genomes (hg19, panTro3) by Tophat-1.4.1, with parameters: -a 8 -m 2 no-coverage-search microexon-search segment-mismatches 3 segment-length 25.,We made a reciprocal lift-over between chimpanzee and human (Ensembl annotation v. 69, coding exons only), and used only exons that could be lift-overed to calculate RPKMs for each gene.,Then quantile normalization was applied, and each gene was z-transformed.,Genome_build: hg19, panTro3,Supplementary_files_format_and_content: tab-delimited text files including expression measurements for each gene from each sample.
Total RNA was isolated using Trizol reagent (Cat. No. 15596-026, Invitrogen). The libraries were constructed from the isolated total RNA according to the "TruSeq RNA Sample Preparation Kit" protocol (www.illumina.com) without modification. As the protocol includes the procedure of enrichment for the mRNA, an additional polyA selection was not necessary.,RNA libraries were prepared for sequencing using Illumina TruSeq protocols
GSM1100304
Illumina HiSeq 2000
May 15 2019
cDNA
transcriptomic
RNA-Seq
total RNA
Homo sapiens
GPL11154
SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX252092,BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN01983965
GSM1100304
GSE45263
0.025625
Prefrontal Cortex
Public on Mar 31 2014
Mar 18 2013
9606
Human_AS_10
SRA
https://www.ncbi.nlm.nih.gov/sra?term=SRX252092
https://www.ncbi.nlm.nih.gov/biosample/SAMN01983965
1
tissue: Prefrontal Cortex,organism: human
320 Yue Yang Road
Shanghai
China
PICB
Liu,,He
Illumina Casava1.7 software used for basecalling, and only the ones passing illumina quality controls were retained.,Reads were mapped onto correponding reference genomes (hg19, panTro3) by Tophat-1.4.1, with parameters: -a 8 -m 2 no-coverage-search microexon-search segment-mismatches 3 segment-length 25.,We made a reciprocal lift-over between chimpanzee and human (Ensembl annotation v. 69, coding exons only), and used only exons that could be lift-overed to calculate RPKMs for each gene.,Then quantile normalization was applied, and each gene was z-transformed.,Genome_build: hg19, panTro3,Supplementary_files_format_and_content: tab-delimited text files including expression measurements for each gene from each sample.
Total RNA was isolated using Trizol reagent (Cat. No. 15596-026, Invitrogen). The libraries were constructed from the isolated total RNA according to the "TruSeq RNA Sample Preparation Kit" protocol (www.illumina.com) without modification. As the protocol includes the procedure of enrichment for the mRNA, an additional polyA selection was not necessary.,RNA libraries were prepared for sequencing using Illumina TruSeq protocols
GSM1100305
Illumina HiSeq 2000
May 15 2019
cDNA
transcriptomic
RNA-Seq
total RNA
Homo sapiens
GPL11154
SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX252093,BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN01983966
GSM1100305
GSE45263
0.009388
Prefrontal Cortex
Public on Mar 31 2014
Mar 18 2013
9606
Human_EU_11
SRA
https://www.ncbi.nlm.nih.gov/sra?term=SRX252093
https://www.ncbi.nlm.nih.gov/biosample/SAMN01983966
1
tissue: Prefrontal Cortex,organism: human
320 Yue Yang Road
Shanghai
China
PICB
Liu,,He
Illumina Casava1.7 software used for basecalling, and only the ones passing illumina quality controls were retained.,Reads were mapped onto correponding reference genomes (hg19, panTro3) by Tophat-1.4.1, with parameters: -a 8 -m 2 no-coverage-search microexon-search segment-mismatches 3 segment-length 25.,We made a reciprocal lift-over between chimpanzee and human (Ensembl annotation v. 69, coding exons only), and used only exons that could be lift-overed to calculate RPKMs for each gene.,Then quantile normalization was applied, and each gene was z-transformed.,Genome_build: hg19, panTro3,Supplementary_files_format_and_content: tab-delimited text files including expression measurements for each gene from each sample.
Total RNA was isolated using Trizol reagent (Cat. No. 15596-026, Invitrogen). The libraries were constructed from the isolated total RNA according to the "TruSeq RNA Sample Preparation Kit" protocol (www.illumina.com) without modification. As the protocol includes the procedure of enrichment for the mRNA, an additional polyA selection was not necessary.,RNA libraries were prepared for sequencing using Illumina TruSeq protocols
GSM1100306
Illumina HiSeq 2000
May 15 2019
cDNA
transcriptomic
RNA-Seq
total RNA
Homo sapiens
GPL11154
SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX252094,BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN01983967
GSM1100306
GSE45263
0.002902
Prefrontal Cortex
Public on Mar 31 2014
Mar 18 2013
9606
Human_AF_12
SRA
https://www.ncbi.nlm.nih.gov/sra?term=SRX252094
https://www.ncbi.nlm.nih.gov/biosample/SAMN01983967
1
tissue: Prefrontal Cortex,organism: human
320 Yue Yang Road
Shanghai
China
PICB
Liu,,He
Illumina Casava1.7 software used for basecalling, and only the ones passing illumina quality controls were retained.,Reads were mapped onto correponding reference genomes (hg19, panTro3) by Tophat-1.4.1, with parameters: -a 8 -m 2 no-coverage-search microexon-search segment-mismatches 3 segment-length 25.,We made a reciprocal lift-over between chimpanzee and human (Ensembl annotation v. 69, coding exons only), and used only exons that could be lift-overed to calculate RPKMs for each gene.,Then quantile normalization was applied, and each gene was z-transformed.,Genome_build: hg19, panTro3,Supplementary_files_format_and_content: tab-delimited text files including expression measurements for each gene from each sample.
Total RNA was isolated using Trizol reagent (Cat. No. 15596-026, Invitrogen). The libraries were constructed from the isolated total RNA according to the "TruSeq RNA Sample Preparation Kit" protocol (www.illumina.com) without modification. As the protocol includes the procedure of enrichment for the mRNA, an additional polyA selection was not necessary.,RNA libraries were prepared for sequencing using Illumina TruSeq protocols
GSM1100307
Illumina HiSeq 2000
May 15 2019
cDNA
transcriptomic
RNA-Seq
total RNA
Homo sapiens
GPL11154
SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX252095,BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN01983968
GSM1100307
GSE45263
0.000497
Prefrontal Cortex
Public on Mar 31 2014
Mar 18 2013
9606
Human_AS_13
SRA
https://www.ncbi.nlm.nih.gov/sra?term=SRX252095
https://www.ncbi.nlm.nih.gov/biosample/SAMN01983968
1
tissue: Prefrontal Cortex,organism: human
320 Yue Yang Road
Shanghai
China
PICB
Liu,,He
Illumina Casava1.7 software used for basecalling, and only the ones passing illumina quality controls were retained.,Reads were mapped onto correponding reference genomes (hg19, panTro3) by Tophat-1.4.1, with parameters: -a 8 -m 2 no-coverage-search microexon-search segment-mismatches 3 segment-length 25.,We made a reciprocal lift-over between chimpanzee and human (Ensembl annotation v. 69, coding exons only), and used only exons that could be lift-overed to calculate RPKMs for each gene.,Then quantile normalization was applied, and each gene was z-transformed.,Genome_build: hg19, panTro3,Supplementary_files_format_and_content: tab-delimited text files including expression measurements for each gene from each sample.
Total RNA was isolated using Trizol reagent (Cat. No. 15596-026, Invitrogen). The libraries were constructed from the isolated total RNA according to the "TruSeq RNA Sample Preparation Kit" protocol (www.illumina.com) without modification. As the protocol includes the procedure of enrichment for the mRNA, an additional polyA selection was not necessary.,RNA libraries were prepared for sequencing using Illumina TruSeq protocols
GSM1100308
Illumina HiSeq 2000
May 15 2019
cDNA
transcriptomic
RNA-Seq
total RNA
Homo sapiens
GPL11154
SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX252096,BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN01983969
GSM1100308
GSE45263
0.00199
Prefrontal Cortex
Public on Mar 31 2014
Mar 18 2013
9606
Human_EU_14
SRA
https://www.ncbi.nlm.nih.gov/sra?term=SRX252096
https://www.ncbi.nlm.nih.gov/biosample/SAMN01983969
1
tissue: bladder
Palle Juul-Jensens Bouleward 99
Aarhus
Denmark
Aarhus University
Morten,Muhlig,Nielsen
Illumina Casava software used for basecalling, and Tophat and Cufflinks used for transcript FPKM estiamtes.,Genome_build: hg18,Supplementary_files_format_and_content: Total transcript FPKM values in the GTF file format
Normal tissue provided by Biochain. Total RNA was isolated by a modified guanidine thiocyanate technique according to BioCahin certificate of analysis F-753-1-6 revA.,Using 500 ng of total-RNA from each of the samples, RNA-Seq libraries were constructed by depletion of rRNA followed by synthesis of directional, paired-end and indexed RNA-Seq libraries. The rRNA depleted RNA was purified using the RNA Clean & Concentrator™-5 columns (Zymo Research). Speed-vac was used to reduce the remaining sample volume to 9.5μL followed by synthesis of directional, paired-end and indexed RNA-Seq libraries using the ScriptSeq kit (Epicentre). Briefly, rRNA depleted RNA was chemically fragmented and cDNA was synthesized from a tagged random hexamer. The cDNA was terminal tagged using a 3’-end blocked and tagged oligo followed by MiniElute (Qiagen) purification. The di-tagged cDNA was then used as template in a 10 cycle PCR reaction. Libraries were purified by agarose gel electrophoresis selecting elements of 200-600 bp in size. The RNA-Seq libraries were denaturated and diluted to 10 pM with pre-chilled Hybridization buffer (Illumina) and loaded into TruSeq PE v3 flowcells (Illumina) on an Illumina cBot followed by indexed paired-end sequencing (101+7+101 bp) on a Illumina HiSeq 2000 using TruSeq SBS Kit v3 chemistry.
GSM1101966
Illumina HiSeq 2000
May 15 2019
cDNA
transcriptomic
RNA-Seq
total RNA
Homo sapiens
GPL11154
SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX252502,BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN01984805
GSM1101966
GSE45326
0.020581
Biochain:R-1234010-P
Public on Sep 01 2013
Mar 19 2013
9606
Bladder
SRA
https://www.ncbi.nlm.nih.gov/sra?term=SRX252502
https://www.ncbi.nlm.nih.gov/biosample/SAMN01984805
1
tissue: brain
Palle Juul-Jensens Bouleward 99
Aarhus
Denmark
Aarhus University
Morten,Muhlig,Nielsen
Illumina Casava software used for basecalling, and Tophat and Cufflinks used for transcript FPKM estiamtes.,Genome_build: hg18,Supplementary_files_format_and_content: Total transcript FPKM values in the GTF file format
Normal tissue provided by Biochain. Total RNA was isolated by a modified guanidine thiocyanate technique according to BioCahin certificate of analysis F-753-1-6 revA.,Using 500 ng of total-RNA from each of the samples, RNA-Seq libraries were constructed by depletion of rRNA followed by synthesis of directional, paired-end and indexed RNA-Seq libraries. The rRNA depleted RNA was purified using the RNA Clean & Concentrator™-5 columns (Zymo Research). Speed-vac was used to reduce the remaining sample volume to 9.5μL followed by synthesis of directional, paired-end and indexed RNA-Seq libraries using the ScriptSeq kit (Epicentre). Briefly, rRNA depleted RNA was chemically fragmented and cDNA was synthesized from a tagged random hexamer. The cDNA was terminal tagged using a 3’-end blocked and tagged oligo followed by MiniElute (Qiagen) purification. The di-tagged cDNA was then used as template in a 10 cycle PCR reaction. Libraries were purified by agarose gel electrophoresis selecting elements of 200-600 bp in size. The RNA-Seq libraries were denaturated and diluted to 10 pM with pre-chilled Hybridization buffer (Illumina) and loaded into TruSeq PE v3 flowcells (Illumina) on an Illumina cBot followed by indexed paired-end sequencing (101+7+101 bp) on a Illumina HiSeq 2000 using TruSeq SBS Kit v3 chemistry.
GSM1101967
Illumina HiSeq 2000
May 15 2019
cDNA
transcriptomic
RNA-Seq
total RNA
Homo sapiens
GPL11154
SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX252503,BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN01984806
GSM1101967
GSE45326
0.010386
Biochain:R-1234035-P
Public on Sep 01 2013
Mar 19 2013
9606
Brain
SRA
https://www.ncbi.nlm.nih.gov/sra?term=SRX252503
https://www.ncbi.nlm.nih.gov/biosample/SAMN01984806
1
tissue: breast
Palle Juul-Jensens Bouleward 99
Aarhus
Denmark
Aarhus University
Morten,Muhlig,Nielsen
Illumina Casava software used for basecalling, and Tophat and Cufflinks used for transcript FPKM estiamtes.,Genome_build: hg18,Supplementary_files_format_and_content: Total transcript FPKM values in the GTF file format
Normal tissue provided by Biochain. Total RNA was isolated by a modified guanidine thiocyanate technique according to BioCahin certificate of analysis F-753-1-6 revA.,Using 500 ng of total-RNA from each of the samples, RNA-Seq libraries were constructed by depletion of rRNA followed by synthesis of directional, paired-end and indexed RNA-Seq libraries. The rRNA depleted RNA was purified using the RNA Clean & Concentrator™-5 columns (Zymo Research). Speed-vac was used to reduce the remaining sample volume to 9.5μL followed by synthesis of directional, paired-end and indexed RNA-Seq libraries using the ScriptSeq kit (Epicentre). Briefly, rRNA depleted RNA was chemically fragmented and cDNA was synthesized from a tagged random hexamer. The cDNA was terminal tagged using a 3’-end blocked and tagged oligo followed by MiniElute (Qiagen) purification. The di-tagged cDNA was then used as template in a 10 cycle PCR reaction. Libraries were purified by agarose gel electrophoresis selecting elements of 200-600 bp in size. The RNA-Seq libraries were denaturated and diluted to 10 pM with pre-chilled Hybridization buffer (Illumina) and loaded into TruSeq PE v3 flowcells (Illumina) on an Illumina cBot followed by indexed paired-end sequencing (101+7+101 bp) on a Illumina HiSeq 2000 using TruSeq SBS Kit v3 chemistry.
GSM1101968
Illumina HiSeq 2000
May 15 2019
cDNA
transcriptomic
RNA-Seq
total RNA
Homo sapiens
GPL11154
SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX252504,BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN01984807
GSM1101968
GSE45326
0.006547
Biochain:R-1234086-P
Public on Sep 01 2013
Mar 19 2013
9606
Breast
SRA
https://www.ncbi.nlm.nih.gov/sra?term=SRX252504
https://www.ncbi.nlm.nih.gov/biosample/SAMN01984807
1
tissue: colon
Palle Juul-Jensens Bouleward 99
Aarhus
Denmark
Aarhus University
Morten,Muhlig,Nielsen
Illumina Casava software used for basecalling, and Tophat and Cufflinks used for transcript FPKM estiamtes.,Genome_build: hg18,Supplementary_files_format_and_content: Total transcript FPKM values in the GTF file format
Normal tissue provided by Biochain. Total RNA was isolated by a modified guanidine thiocyanate technique according to BioCahin certificate of analysis F-753-1-6 revA.,Using 500 ng of total-RNA from each of the samples, RNA-Seq libraries were constructed by depletion of rRNA followed by synthesis of directional, paired-end and indexed RNA-Seq libraries. The rRNA depleted RNA was purified using the RNA Clean & Concentrator™-5 columns (Zymo Research). Speed-vac was used to reduce the remaining sample volume to 9.5μL followed by synthesis of directional, paired-end and indexed RNA-Seq libraries using the ScriptSeq kit (Epicentre). Briefly, rRNA depleted RNA was chemically fragmented and cDNA was synthesized from a tagged random hexamer. The cDNA was terminal tagged using a 3’-end blocked and tagged oligo followed by MiniElute (Qiagen) purification. The di-tagged cDNA was then used as template in a 10 cycle PCR reaction. Libraries were purified by agarose gel electrophoresis selecting elements of 200-600 bp in size. The RNA-Seq libraries were denaturated and diluted to 10 pM with pre-chilled Hybridization buffer (Illumina) and loaded into TruSeq PE v3 flowcells (Illumina) on an Illumina cBot followed by indexed paired-end sequencing (101+7+101 bp) on a Illumina HiSeq 2000 using TruSeq SBS Kit v3 chemistry.
GSM1101969
Illumina HiSeq 2000
May 15 2019
cDNA
transcriptomic
RNA-Seq
total RNA
Homo sapiens
GPL11154
SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX252505,BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN01984808
GSM1101969
GSE45326
0.008579
Biochain:R-1234090-P
Public on Sep 01 2013
Mar 19 2013
9606
Colon
SRA
https://www.ncbi.nlm.nih.gov/sra?term=SRX252505
https://www.ncbi.nlm.nih.gov/biosample/SAMN01984808
1
tissue: heart
Palle Juul-Jensens Bouleward 99
Aarhus
Denmark
Aarhus University
Morten,Muhlig,Nielsen
Illumina Casava software used for basecalling, and Tophat and Cufflinks used for transcript FPKM estiamtes.,Genome_build: hg18,Supplementary_files_format_and_content: Total transcript FPKM values in the GTF file format
Normal tissue provided by Biochain. Total RNA was isolated by a modified guanidine thiocyanate technique according to BioCahin certificate of analysis F-753-1-6 revA.,Using 500 ng of total-RNA from each of the samples, RNA-Seq libraries were constructed by depletion of rRNA followed by synthesis of directional, paired-end and indexed RNA-Seq libraries. The rRNA depleted RNA was purified using the RNA Clean & Concentrator™-5 columns (Zymo Research). Speed-vac was used to reduce the remaining sample volume to 9.5μL followed by synthesis of directional, paired-end and indexed RNA-Seq libraries using the ScriptSeq kit (Epicentre). Briefly, rRNA depleted RNA was chemically fragmented and cDNA was synthesized from a tagged random hexamer. The cDNA was terminal tagged using a 3’-end blocked and tagged oligo followed by MiniElute (Qiagen) purification. The di-tagged cDNA was then used as template in a 10 cycle PCR reaction. Libraries were purified by agarose gel electrophoresis selecting elements of 200-600 bp in size. The RNA-Seq libraries were denaturated and diluted to 10 pM with pre-chilled Hybridization buffer (Illumina) and loaded into TruSeq PE v3 flowcells (Illumina) on an Illumina cBot followed by indexed paired-end sequencing (101+7+101 bp) on a Illumina HiSeq 2000 using TruSeq SBS Kit v3 chemistry.
GSM1101970
Illumina HiSeq 2000
May 15 2019
cDNA
transcriptomic
RNA-Seq
total RNA
Homo sapiens
GPL11154
SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX252506,BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN01984809
GSM1101970
GSE45326
0.014112
Biochain:R-1234122-P
Public on Sep 01 2013
Mar 19 2013
9606
Heart
SRA
https://www.ncbi.nlm.nih.gov/sra?term=SRX252506
https://www.ncbi.nlm.nih.gov/biosample/SAMN01984809
1
tissue: kidney
Palle Juul-Jensens Bouleward 99
Aarhus
Denmark
Aarhus University
Morten,Muhlig,Nielsen
Illumina Casava software used for basecalling, and Tophat and Cufflinks used for transcript FPKM estiamtes.,Genome_build: hg18,Supplementary_files_format_and_content: Total transcript FPKM values in the GTF file format
Normal tissue provided by Biochain. Total RNA was isolated by a modified guanidine thiocyanate technique according to BioCahin certificate of analysis F-753-1-6 revA.,Using 500 ng of total-RNA from each of the samples, RNA-Seq libraries were constructed by depletion of rRNA followed by synthesis of directional, paired-end and indexed RNA-Seq libraries. The rRNA depleted RNA was purified using the RNA Clean & Concentrator™-5 columns (Zymo Research). Speed-vac was used to reduce the remaining sample volume to 9.5μL followed by synthesis of directional, paired-end and indexed RNA-Seq libraries using the ScriptSeq kit (Epicentre). Briefly, rRNA depleted RNA was chemically fragmented and cDNA was synthesized from a tagged random hexamer. The cDNA was terminal tagged using a 3’-end blocked and tagged oligo followed by MiniElute (Qiagen) purification. The di-tagged cDNA was then used as template in a 10 cycle PCR reaction. Libraries were purified by agarose gel electrophoresis selecting elements of 200-600 bp in size. The RNA-Seq libraries were denaturated and diluted to 10 pM with pre-chilled Hybridization buffer (Illumina) and loaded into TruSeq PE v3 flowcells (Illumina) on an Illumina cBot followed by indexed paired-end sequencing (101+7+101 bp) on a Illumina HiSeq 2000 using TruSeq SBS Kit v3 chemistry.
GSM1101971
Illumina HiSeq 2000
May 15 2019
cDNA
transcriptomic
RNA-Seq
total RNA
Homo sapiens
GPL11154
SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX252507,BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN01984810
GSM1101971
GSE45326
0.007266
Biochain:R-1234142-P
Public on Sep 01 2013
Mar 19 2013
9606
Kidney
SRA
https://www.ncbi.nlm.nih.gov/sra?term=SRX252507
https://www.ncbi.nlm.nih.gov/biosample/SAMN01984810
1
tissue: liver
Palle Juul-Jensens Bouleward 99
Aarhus
Denmark
Aarhus University
Morten,Muhlig,Nielsen
Illumina Casava software used for basecalling, and Tophat and Cufflinks used for transcript FPKM estiamtes.,Genome_build: hg18,Supplementary_files_format_and_content: Total transcript FPKM values in the GTF file format
Normal tissue provided by Biochain. Total RNA was isolated by a modified guanidine thiocyanate technique according to BioCahin certificate of analysis F-753-1-6 revA.,Using 500 ng of total-RNA from each of the samples, RNA-Seq libraries were constructed by depletion of rRNA followed by synthesis of directional, paired-end and indexed RNA-Seq libraries. The rRNA depleted RNA was purified using the RNA Clean & Concentrator™-5 columns (Zymo Research). Speed-vac was used to reduce the remaining sample volume to 9.5μL followed by synthesis of directional, paired-end and indexed RNA-Seq libraries using the ScriptSeq kit (Epicentre). Briefly, rRNA depleted RNA was chemically fragmented and cDNA was synthesized from a tagged random hexamer. The cDNA was terminal tagged using a 3’-end blocked and tagged oligo followed by MiniElute (Qiagen) purification. The di-tagged cDNA was then used as template in a 10 cycle PCR reaction. Libraries were purified by agarose gel electrophoresis selecting elements of 200-600 bp in size. The RNA-Seq libraries were denaturated and diluted to 10 pM with pre-chilled Hybridization buffer (Illumina) and loaded into TruSeq PE v3 flowcells (Illumina) on an Illumina cBot followed by indexed paired-end sequencing (101+7+101 bp) on a Illumina HiSeq 2000 using TruSeq SBS Kit v3 chemistry.
GSM1101972
Illumina HiSeq 2000
May 15 2019
cDNA
transcriptomic
RNA-Seq
total RNA
Homo sapiens
GPL11154
SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX252508,BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN01984811
GSM1101972
GSE45326
0.008176
Biochain:R-1234149-P
Public on Sep 01 2013
Mar 19 2013
9606
Liver
SRA
https://www.ncbi.nlm.nih.gov/sra?term=SRX252508
https://www.ncbi.nlm.nih.gov/biosample/SAMN01984811
1
tissue: lung
Palle Juul-Jensens Bouleward 99
Aarhus
Denmark
Aarhus University
Morten,Muhlig,Nielsen
Illumina Casava software used for basecalling, and Tophat and Cufflinks used for transcript FPKM estiamtes.,Genome_build: hg18,Supplementary_files_format_and_content: Total transcript FPKM values in the GTF file format
Normal tissue provided by Biochain. Total RNA was isolated by a modified guanidine thiocyanate technique according to BioCahin certificate of analysis F-753-1-6 revA.,Using 500 ng of total-RNA from each of the samples, RNA-Seq libraries were constructed by depletion of rRNA followed by synthesis of directional, paired-end and indexed RNA-Seq libraries. The rRNA depleted RNA was purified using the RNA Clean & Concentrator™-5 columns (Zymo Research). Speed-vac was used to reduce the remaining sample volume to 9.5μL followed by synthesis of directional, paired-end and indexed RNA-Seq libraries using the ScriptSeq kit (Epicentre). Briefly, rRNA depleted RNA was chemically fragmented and cDNA was synthesized from a tagged random hexamer. The cDNA was terminal tagged using a 3’-end blocked and tagged oligo followed by MiniElute (Qiagen) purification. The di-tagged cDNA was then used as template in a 10 cycle PCR reaction. Libraries were purified by agarose gel electrophoresis selecting elements of 200-600 bp in size. The RNA-Seq libraries were denaturated and diluted to 10 pM with pre-chilled Hybridization buffer (Illumina) and loaded into TruSeq PE v3 flowcells (Illumina) on an Illumina cBot followed by indexed paired-end sequencing (101+7+101 bp) on a Illumina HiSeq 2000 using TruSeq SBS Kit v3 chemistry.
GSM1101973
Illumina HiSeq 2000
May 15 2019
cDNA
transcriptomic
RNA-Seq
total RNA
Homo sapiens
GPL11154
SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX252509,BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN01984812
GSM1101973
GSE45326
0.003979
Biochain:R-1234152-P
Public on Sep 01 2013
Mar 19 2013
9606
Lung
SRA
https://www.ncbi.nlm.nih.gov/sra?term=SRX252509
https://www.ncbi.nlm.nih.gov/biosample/SAMN01984812
1
tissue: muscle
Palle Juul-Jensens Bouleward 99
Aarhus
Denmark
Aarhus University
Morten,Muhlig,Nielsen
Illumina Casava software used for basecalling, and Tophat and Cufflinks used for transcript FPKM estiamtes.,Genome_build: hg18,Supplementary_files_format_and_content: Total transcript FPKM values in the GTF file format
Normal tissue provided by Biochain. Total RNA was isolated by a modified guanidine thiocyanate technique according to BioCahin certificate of analysis F-753-1-6 revA.,Using 500 ng of total-RNA from each of the samples, RNA-Seq libraries were constructed by depletion of rRNA followed by synthesis of directional, paired-end and indexed RNA-Seq libraries. The rRNA depleted RNA was purified using the RNA Clean & Concentrator™-5 columns (Zymo Research). Speed-vac was used to reduce the remaining sample volume to 9.5μL followed by synthesis of directional, paired-end and indexed RNA-Seq libraries using the ScriptSeq kit (Epicentre). Briefly, rRNA depleted RNA was chemically fragmented and cDNA was synthesized from a tagged random hexamer. The cDNA was terminal tagged using a 3’-end blocked and tagged oligo followed by MiniElute (Qiagen) purification. The di-tagged cDNA was then used as template in a 10 cycle PCR reaction. Libraries were purified by agarose gel electrophoresis selecting elements of 200-600 bp in size. The RNA-Seq libraries were denaturated and diluted to 10 pM with pre-chilled Hybridization buffer (Illumina) and loaded into TruSeq PE v3 flowcells (Illumina) on an Illumina cBot followed by indexed paired-end sequencing (101+7+101 bp) on a Illumina HiSeq 2000 using TruSeq SBS Kit v3 chemistry.
GSM1101974
Illumina HiSeq 2000
May 15 2019
cDNA
transcriptomic
RNA-Seq
total RNA
Homo sapiens
GPL11154
SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX252510,BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN01984813
GSM1101974
GSE45326
0.091524
Biochain:R-1234171-P
Public on Sep 01 2013
Mar 19 2013
9606
Muscle
SRA
https://www.ncbi.nlm.nih.gov/sra?term=SRX252510
https://www.ncbi.nlm.nih.gov/biosample/SAMN01984813
1
tissue: ovary
Palle Juul-Jensens Bouleward 99
Aarhus
Denmark
Aarhus University
Morten,Muhlig,Nielsen
Illumina Casava software used for basecalling, and Tophat and Cufflinks used for transcript FPKM estiamtes.,Genome_build: hg18,Supplementary_files_format_and_content: Total transcript FPKM values in the GTF file format
Normal tissue provided by Biochain. Total RNA was isolated by a modified guanidine thiocyanate technique according to BioCahin certificate of analysis F-753-1-6 revA.,Using 500 ng of total-RNA from each of the samples, RNA-Seq libraries were constructed by depletion of rRNA followed by synthesis of directional, paired-end and indexed RNA-Seq libraries. The rRNA depleted RNA was purified using the RNA Clean & Concentrator™-5 columns (Zymo Research). Speed-vac was used to reduce the remaining sample volume to 9.5μL followed by synthesis of directional, paired-end and indexed RNA-Seq libraries using the ScriptSeq kit (Epicentre). Briefly, rRNA depleted RNA was chemically fragmented and cDNA was synthesized from a tagged random hexamer. The cDNA was terminal tagged using a 3’-end blocked and tagged oligo followed by MiniElute (Qiagen) purification. The di-tagged cDNA was then used as template in a 10 cycle PCR reaction. Libraries were purified by agarose gel electrophoresis selecting elements of 200-600 bp in size. The RNA-Seq libraries were denaturated and diluted to 10 pM with pre-chilled Hybridization buffer (Illumina) and loaded into TruSeq PE v3 flowcells (Illumina) on an Illumina cBot followed by indexed paired-end sequencing (101+7+101 bp) on a Illumina HiSeq 2000 using TruSeq SBS Kit v3 chemistry.
GSM1101975
Illumina HiSeq 2000
May 15 2019
cDNA
transcriptomic
RNA-Seq
total RNA
Homo sapiens
GPL11154
SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX252511,BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN01984814
GSM1101975
GSE45326
0.011156
Biochain:R-1234183-P
Public on Sep 01 2013
Mar 19 2013
9606
Ovary
SRA
https://www.ncbi.nlm.nih.gov/sra?term=SRX252511
https://www.ncbi.nlm.nih.gov/biosample/SAMN01984814
1
tissue: prostate
Palle Juul-Jensens Bouleward 99
Aarhus
Denmark
Aarhus University
Morten,Muhlig,Nielsen
Illumina Casava software used for basecalling, and Tophat and Cufflinks used for transcript FPKM estiamtes.,Genome_build: hg18,Supplementary_files_format_and_content: Total transcript FPKM values in the GTF file format
Normal tissue provided by Biochain. Total RNA was isolated by a modified guanidine thiocyanate technique according to BioCahin certificate of analysis F-753-1-6 revA.,Using 500 ng of total-RNA from each of the samples, RNA-Seq libraries were constructed by depletion of rRNA followed by synthesis of directional, paired-end and indexed RNA-Seq libraries. The rRNA depleted RNA was purified using the RNA Clean & Concentrator™-5 columns (Zymo Research). Speed-vac was used to reduce the remaining sample volume to 9.5μL followed by synthesis of directional, paired-end and indexed RNA-Seq libraries using the ScriptSeq kit (Epicentre). Briefly, rRNA depleted RNA was chemically fragmented and cDNA was synthesized from a tagged random hexamer. The cDNA was terminal tagged using a 3’-end blocked and tagged oligo followed by MiniElute (Qiagen) purification. The di-tagged cDNA was then used as template in a 10 cycle PCR reaction. Libraries were purified by agarose gel electrophoresis selecting elements of 200-600 bp in size. The RNA-Seq libraries were denaturated and diluted to 10 pM with pre-chilled Hybridization buffer (Illumina) and loaded into TruSeq PE v3 flowcells (Illumina) on an Illumina cBot followed by indexed paired-end sequencing (101+7+101 bp) on a Illumina HiSeq 2000 using TruSeq SBS Kit v3 chemistry.
GSM1101976
Illumina HiSeq 2000
May 15 2019
cDNA
transcriptomic
RNA-Seq
total RNA
Homo sapiens
GPL11154
SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX252513,BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN01984815
GSM1101976
GSE45326
0.027888
Biochain:R-1234201-P
Public on Sep 01 2013
Mar 19 2013
9606
Prostate
SRA
https://www.ncbi.nlm.nih.gov/sra?term=SRX252513
https://www.ncbi.nlm.nih.gov/biosample/SAMN01984815
1
tissue: skin
Palle Juul-Jensens Bouleward 99
Aarhus
Denmark
Aarhus University
Morten,Muhlig,Nielsen
Illumina Casava software used for basecalling, and Tophat and Cufflinks used for transcript FPKM estiamtes.,Genome_build: hg18,Supplementary_files_format_and_content: Total transcript FPKM values in the GTF file format
Normal tissue provided by Biochain. Total RNA was isolated by a modified guanidine thiocyanate technique according to BioCahin certificate of analysis F-753-1-6 revA.,Using 500 ng of total-RNA from each of the samples, RNA-Seq libraries were constructed by depletion of rRNA followed by synthesis of directional, paired-end and indexed RNA-Seq libraries. The rRNA depleted RNA was purified using the RNA Clean & Concentrator™-5 columns (Zymo Research). Speed-vac was used to reduce the remaining sample volume to 9.5μL followed by synthesis of directional, paired-end and indexed RNA-Seq libraries using the ScriptSeq kit (Epicentre). Briefly, rRNA depleted RNA was chemically fragmented and cDNA was synthesized from a tagged random hexamer. The cDNA was terminal tagged using a 3’-end blocked and tagged oligo followed by MiniElute (Qiagen) purification. The di-tagged cDNA was then used as template in a 10 cycle PCR reaction. Libraries were purified by agarose gel electrophoresis selecting elements of 200-600 bp in size. The RNA-Seq libraries were denaturated and diluted to 10 pM with pre-chilled Hybridization buffer (Illumina) and loaded into TruSeq PE v3 flowcells (Illumina) on an Illumina cBot followed by indexed paired-end sequencing (101+7+101 bp) on a Illumina HiSeq 2000 using TruSeq SBS Kit v3 chemistry.
GSM1101977
Illumina HiSeq 2000
May 15 2019
cDNA
transcriptomic
RNA-Seq
total RNA
Homo sapiens
GPL11154
SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX252512,BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN01984816
GSM1101977
GSE45326
0.014822
Biochain:R-1234218-P
Public on Sep 01 2013
Mar 19 2013
9606
Skin
SRA
https://www.ncbi.nlm.nih.gov/sra?term=SRX252512
https://www.ncbi.nlm.nih.gov/biosample/SAMN01984816
1
cell line: TIB-152
1101 University Ave.
Madison
USA
UW-Madison
Gloria,,Sheynkman
Basecalls performed using CASAVA version 1.8.,Annotated and unannotated junctions were detected using the Bowtie (v0.12.7) and Tophat (v1.4.0) splice-junction discovery programs (49, 50). All default Bowtie parameters were used. In Tophat, the mate inner distance was set to 150. Two rounds of Bowtie-Tophat processing were conducted with a supplied set of RefSeq gene model annotations in GTF format (7): the first round detected junctions only matching the gene annotation file (option --no-novel-junctions) and the second round detected all junctions, both aligning to the GTF file and novel (option -G).,RNA-Seq reads were processed by RSEM v1.1.20 (RNA-Seq by Expectation-Maximization) to estimate transcript abundances. All default parameters used for both Bowtie (v0.12.7) and RSEM.,Genome_build: hg19
~2e6 cells were pelleted, washed twice with cold PBS, and total RNA was extracted using the Trizol protocol.,RNA-Seq paired end libraries were prepared using the Illumina TruSeq RNA Sample Prep Rev. A (kit lot #6849988, Illumina, San Diego, CA).
GSM1104129
Illumina HiSeq 2000
May 15 2019
cDNA
transcriptomic
RNA-Seq
total RNA
Homo sapiens
GPL11154
SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX254396,BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN01985824
GSM1104129
GSE45428
0
immortalized T-cell line
Public on May 17 2013
Mar 22 2013
9606
Jurkat Cells 216
SRA
https://www.ncbi.nlm.nih.gov/sra?term=SRX254396
https://www.ncbi.nlm.nih.gov/biosample/SAMN01985824
1
cell line: TIB-152
1101 University Ave.
Madison
USA
UW-Madison
Gloria,,Sheynkman
Basecalls performed using CASAVA version 1.8.,Annotated and unannotated junctions were detected using the Bowtie (v0.12.7) and Tophat (v1.4.0) splice-junction discovery programs (49, 50). All default Bowtie parameters were used. In Tophat, the mate inner distance was set to 150. Two rounds of Bowtie-Tophat processing were conducted with a supplied set of RefSeq gene model annotations in GTF format (7): the first round detected junctions only matching the gene annotation file (option --no-novel-junctions) and the second round detected all junctions, both aligning to the GTF file and novel (option -G).,RNA-Seq reads were processed by RSEM v1.1.20 (RNA-Seq by Expectation-Maximization) to estimate transcript abundances. All default parameters used for both Bowtie (v0.12.7) and RSEM.,Genome_build: hg19
~2e6 cells were pelleted, washed twice with cold PBS, and total RNA was extracted using the Trizol protocol.,RNA-Seq paired end libraries were prepared using the Illumina TruSeq RNA Sample Prep Rev. A (kit lot #6849988, Illumina, San Diego, CA).
GSM1104130
Illumina HiSeq 2000
May 15 2019
cDNA
transcriptomic
RNA-Seq
total RNA
Homo sapiens
GPL11154
SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX254397,BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN01985825
GSM1104130
GSE45428
0.006955
immortalized T-cell line
Public on May 17 2013
Mar 22 2013
9606
Jurkat Cells 245
SRA
https://www.ncbi.nlm.nih.gov/sra?term=SRX254397
https://www.ncbi.nlm.nih.gov/biosample/SAMN01985825
1
cell line: TIB-152
1101 University Ave.
Madison
USA
UW-Madison
Gloria,,Sheynkman
Basecalls performed using CASAVA version 1.8.,Annotated and unannotated junctions were detected using the Bowtie (v0.12.7) and Tophat (v1.4.0) splice-junction discovery programs (49, 50). All default Bowtie parameters were used. In Tophat, the mate inner distance was set to 150. Two rounds of Bowtie-Tophat processing were conducted with a supplied set of RefSeq gene model annotations in GTF format (7): the first round detected junctions only matching the gene annotation file (option --no-novel-junctions) and the second round detected all junctions, both aligning to the GTF file and novel (option -G).,RNA-Seq reads were processed by RSEM v1.1.20 (RNA-Seq by Expectation-Maximization) to estimate transcript abundances. All default parameters used for both Bowtie (v0.12.7) and RSEM.,Genome_build: hg19
~2e6 cells were pelleted, washed twice with cold PBS, and total RNA was extracted using the Trizol protocol.,RNA-Seq paired end libraries were prepared using the Illumina TruSeq RNA Sample Prep Rev. A (kit lot #6849988, Illumina, San Diego, CA).
GSM1104131
Illumina HiSeq 2000
May 15 2019
cDNA
transcriptomic
RNA-Seq
total RNA
Homo sapiens
GPL11154
SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX254398,BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN01985826
GSM1104131
GSE45428
0.00928
immortalized T-cell line
Public on May 17 2013
Mar 22 2013
9606
Jurkat Cells 236
SRA
https://www.ncbi.nlm.nih.gov/sra?term=SRX254398
https://www.ncbi.nlm.nih.gov/biosample/SAMN01985826
1
cell line: HeLa S3,treatment: siRNA control,internal reference: 120123_lane7_VLB1
3400 Civic Center Blvd - SCTR 9-111
Philadelphia
USA
University of Pennsylvania
Roberto,,Bonasio
Trimmed sequences in 3' to 36 nts,mapped to hg19 with BOWTIE -m40 -v2,assigned counts to gene models in ENS65 with DEGseq,Genome_build: hg19 (HeLaS3) or mm9 (germ cells),Supplementary_files_format_and_content: RPKM and count table for ENS65
RNA was isolated with TRIzol, depleted of polyA+ transcripts with oligo-dT beads, and depleted of rRNA with the Ribominus kit,libraries were prepared with the dUTP strand-specific protocol. After RT and second-strand synthesis, cDNA was end-repaired using End-It Repair Kit (Epicenter), tailed with an A using Klenow exo minus (NEB M0212), and ligated to custom adapters with T4 ligase (Enzymatics). Fragments of 200±50 bp were size-selected and subjected to ligation-mediated PCR amplification (LM-PCR), using Phusion DNA polymerase (NEB M0530) after removal of the 2nd strand with heat-labile UDG (Roche).
GSM1104373
Illumina HiSeq 2000
Feb 04 2022
cDNA
transcriptomic
RNA-Seq
total RNA
Homo sapiens
GPL11154
SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX254634,BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN01986103
GSM1104373
GSE45442,GSE45489
0.002883
HeLa S3
Public on Mar 26 2013
Mar 22 2013
9606
HeLaS3.siCtrl.R
SRA
https://www.ncbi.nlm.nih.gov/sra?term=SRX254634
https://www.ncbi.nlm.nih.gov/biosample/SAMN01986103
1
cell line: HeLa S3,treatment: siRNA against SFMBT1 (#1) + LSD1 (#2) + CoREST (#1),internal reference: 120123_lane7_VLB4
3400 Civic Center Blvd - SCTR 9-111
Philadelphia
USA
University of Pennsylvania
Roberto,,Bonasio
Trimmed sequences in 3' to 36 nts,mapped to hg19 with BOWTIE -m40 -v2,assigned counts to gene models in ENS65 with DEGseq,Genome_build: hg19 (HeLaS3) or mm9 (germ cells),Supplementary_files_format_and_content: RPKM and count table for ENS65
RNA was isolated with TRIzol, depleted of polyA+ transcripts with oligo-dT beads, and depleted of rRNA with the Ribominus kit,libraries were prepared with the dUTP strand-specific protocol. After RT and second-strand synthesis, cDNA was end-repaired using End-It Repair Kit (Epicenter), tailed with an A using Klenow exo minus (NEB M0212), and ligated to custom adapters with T4 ligase (Enzymatics). Fragments of 200±50 bp were size-selected and subjected to ligation-mediated PCR amplification (LM-PCR), using Phusion DNA polymerase (NEB M0530) after removal of the 2nd strand with heat-labile UDG (Roche).
GSM1104374
Illumina HiSeq 2000
Feb 04 2022
cDNA
transcriptomic
RNA-Seq
total RNA
Homo sapiens
GPL11154
SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX254635,BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN01986104
GSM1104374
GSE45442,GSE45489
0.002366
HeLa S3
Public on Mar 26 2013
Mar 22 2013
9606
HeLaS3.siSFMBT1-1_siLSD1-2_siCoREST-1.R
SRA
https://www.ncbi.nlm.nih.gov/sra?term=SRX254635
https://www.ncbi.nlm.nih.gov/biosample/SAMN01986104
1
cell line: gastric carcinoma cell line SNU-719,passage: 3-5,infection: EBV
1430 Tulane Ave., SL79
New Orleans
USA
Tulane Health Sciences Center
Erik,K,Flemington
alignments to hg19 (UCSC) using novoalign (v.2.08.02) using default settings,read counts were calculated using HT-seq count using the interesection-strict option and the GRCh37.70 annotation file.,Genome_build: hg19,Supplementary_files_format_and_content: tab-delimited text files include read counts for each sample
RNA was extracted using the Trizol protocol.,Two separate cDNA libraries were prepared from polyA selected and from Ribo-Zero selected RNAs using the Illumina Truseq Stranded Total RNA Sample Prep Kit (RS-122-2101).
GSM1104509
Illumina HiSeq 2000
May 15 2019
cDNA
transcriptomic
RNA-Seq
total RNA
Homo sapiens
GPL11154
SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX254850,BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN01990909
GSM1104509
GSE45453
0
Gastric carcinoma cell line
Public on Jun 23 2013
Mar 24 2013
9606
poly-A-SNU-719
SRA
https://www.ncbi.nlm.nih.gov/sra?term=SRX254850
https://www.ncbi.nlm.nih.gov/biosample/SAMN01990909
1
cell line: gastric carcinoma cell line SNU-719,passage: 3-5,infection: EBV
1430 Tulane Ave., SL79
New Orleans
USA
Tulane Health Sciences Center
Erik,K,Flemington
alignments to hg19 (UCSC) using novoalign (v.2.08.02) using default settings,read counts were calculated using HT-seq count using the interesection-strict option and the GRCh37.70 annotation file.,Genome_build: hg19,Supplementary_files_format_and_content: tab-delimited text files include read counts for each sample
RNA was extracted using the Trizol protocol.,Two separate cDNA libraries were prepared from polyA selected and from Ribo-Zero selected RNAs using the Illumina Truseq Stranded Total RNA Sample Prep Kit (RS-122-2101).
GSM1104510
Illumina HiSeq 2000
May 15 2019
cDNA
transcriptomic
RNA-Seq
total RNA
Homo sapiens
GPL11154
SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX254851,BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN01990910
GSM1104510
GSE45453
0
Gastric carcinoma cell line
Public on Jun 23 2013
Mar 24 2013
9606
ribo-zero-SNU-719
SRA
https://www.ncbi.nlm.nih.gov/sra?term=SRX254851
https://www.ncbi.nlm.nih.gov/biosample/SAMN01990910
1
treatment: non-targeting siRNA pool,cell line: 293T
88 Dr. Aiguader
Barcelona
Spain
Centre for Genomic Regulation
Manuel,,Irimia
Full genomic sequences for the analyzed species were downloaded from the Ensembl database. Full transcriptomic sequences for all species were downloaded from Ensembl. For each gene, the canonical transcript was selected for gene expression analysis based on BioMart.,For each species, we assembled all canonical transcript (as defined above) sequences. In order to calculate the effective number of unique mappable positions in each transcript (i.e. the effective length) we performed the following steps. For each read length k, we extracted the L-k+1 (L being the transcript length) k-mer sequences from each canonical transcript and then aligned the full set of k-mers against the respective genome using Bowtie, allowing for a maximum of two mismatches. k-mers with no or one unique genomic alignment were then likewise aligned back to the canonical transcriptome. For each transcript, the number of such k-mers having a unique transcriptomic alignment was determined. This corresponds to the transcript’s effective number of unique mappable positions for k-mer mRNA-Seq reads. For each sample, the corresponding mRNA-Seq data were aligned against the respective genome using Bowtie, allowing for a maximum of two mismatches. Reads with one unique genomic alignment were then aligned against the canonical transcriptome and, for each transcript, the number of reads with one unique transcriptomic alignment were counted. Gene expression levels were determined as reads per thousand mappable positions of target transcript sequence per million of reads, where the reads uniquely align to the analyzed transcriptome. This procedure for estimating gene expression levels is a corrected version of the widely used RPKM (reads per kilobase of target transcript sequence per million of total reads) metric, and is referred to as “cRPKM” [Labbe RM et al. Stem Cells (2012)].,Genome_build: hg19, mm9,Supplementary_files_format_and_content: Tab-delimited text files include cRPKM values (as defined above), as well as the total read count for each gene's canonical transcript
Total RNA was extracted using Tri Reagent (Sigma) or RNeasy columns (Qiagen),Standard Illumina library preparation according to manufacturer
GSM1105743
Illumina HiSeq 2000
May 15 2019
cDNA
transcriptomic
RNA-Seq
polyA RNA
Homo sapiens
GPL11154
SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX255055,BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN01992326
GSM1105743
GSE45504,GSE45505
0.010696
293T cell line
Public on Jun 26 2013
Mar 26 2013
9606
293T nt_control
SRA
https://www.ncbi.nlm.nih.gov/sra?term=SRX255055
https://www.ncbi.nlm.nih.gov/biosample/SAMN01992326
1
treatment: MBNL1 and MBNL2 SMART-pool siRNAs,cell line: 293T
88 Dr. Aiguader
Barcelona
Spain
Centre for Genomic Regulation
Manuel,,Irimia
Full genomic sequences for the analyzed species were downloaded from the Ensembl database. Full transcriptomic sequences for all species were downloaded from Ensembl. For each gene, the canonical transcript was selected for gene expression analysis based on BioMart.,For each species, we assembled all canonical transcript (as defined above) sequences. In order to calculate the effective number of unique mappable positions in each transcript (i.e. the effective length) we performed the following steps. For each read length k, we extracted the L-k+1 (L being the transcript length) k-mer sequences from each canonical transcript and then aligned the full set of k-mers against the respective genome using Bowtie, allowing for a maximum of two mismatches. k-mers with no or one unique genomic alignment were then likewise aligned back to the canonical transcriptome. For each transcript, the number of such k-mers having a unique transcriptomic alignment was determined. This corresponds to the transcript’s effective number of unique mappable positions for k-mer mRNA-Seq reads. For each sample, the corresponding mRNA-Seq data were aligned against the respective genome using Bowtie, allowing for a maximum of two mismatches. Reads with one unique genomic alignment were then aligned against the canonical transcriptome and, for each transcript, the number of reads with one unique transcriptomic alignment were counted. Gene expression levels were determined as reads per thousand mappable positions of target transcript sequence per million of reads, where the reads uniquely align to the analyzed transcriptome. This procedure for estimating gene expression levels is a corrected version of the widely used RPKM (reads per kilobase of target transcript sequence per million of total reads) metric, and is referred to as “cRPKM” [Labbe RM et al. Stem Cells (2012)].,Genome_build: hg19, mm9,Supplementary_files_format_and_content: Tab-delimited text files include cRPKM values (as defined above), as well as the total read count for each gene's canonical transcript
Total RNA was extracted using Tri Reagent (Sigma) or RNeasy columns (Qiagen),Standard Illumina library preparation according to manufacturer
GSM1105744
Illumina HiSeq 2000
May 15 2019
cDNA
transcriptomic
RNA-Seq
polyA RNA
Homo sapiens
GPL11154
SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX255056,BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN01992327
GSM1105744
GSE45504,GSE45505
0.005734
293T cell line
Public on Jun 26 2013
Mar 26 2013
9606
293T siMBNL1+2
SRA
https://www.ncbi.nlm.nih.gov/sra?term=SRX255056
https://www.ncbi.nlm.nih.gov/biosample/SAMN01992327
1
treatment: non-targeting siRNA pool,cell line: HeLa
88 Dr. Aiguader
Barcelona
Spain
Centre for Genomic Regulation
Manuel,,Irimia
Full genomic sequences for the analyzed species were downloaded from the Ensembl database. Full transcriptomic sequences for all species were downloaded from Ensembl. For each gene, the canonical transcript was selected for gene expression analysis based on BioMart.,For each species, we assembled all canonical transcript (as defined above) sequences. In order to calculate the effective number of unique mappable positions in each transcript (i.e. the effective length) we performed the following steps. For each read length k, we extracted the L-k+1 (L being the transcript length) k-mer sequences from each canonical transcript and then aligned the full set of k-mers against the respective genome using Bowtie, allowing for a maximum of two mismatches. k-mers with no or one unique genomic alignment were then likewise aligned back to the canonical transcriptome. For each transcript, the number of such k-mers having a unique transcriptomic alignment was determined. This corresponds to the transcript’s effective number of unique mappable positions for k-mer mRNA-Seq reads. For each sample, the corresponding mRNA-Seq data were aligned against the respective genome using Bowtie, allowing for a maximum of two mismatches. Reads with one unique genomic alignment were then aligned against the canonical transcriptome and, for each transcript, the number of reads with one unique transcriptomic alignment were counted. Gene expression levels were determined as reads per thousand mappable positions of target transcript sequence per million of reads, where the reads uniquely align to the analyzed transcriptome. This procedure for estimating gene expression levels is a corrected version of the widely used RPKM (reads per kilobase of target transcript sequence per million of total reads) metric, and is referred to as “cRPKM” [Labbe RM et al. Stem Cells (2012)].,Genome_build: hg19, mm9,Supplementary_files_format_and_content: Tab-delimited text files include cRPKM values (as defined above), as well as the total read count for each gene's canonical transcript
Total RNA was extracted using Tri Reagent (Sigma) or RNeasy columns (Qiagen),Standard Illumina library preparation according to manufacturer
GSM1105745
Illumina HiSeq 2000
May 15 2019
cDNA
transcriptomic
RNA-Seq
polyA RNA
Homo sapiens
GPL11154
SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX255057,BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN01992328
GSM1105745
GSE45504,GSE45505
0.004763
HeLa cell line
Public on Jun 26 2013
Mar 26 2013
9606
HeLa nt_control
SRA
https://www.ncbi.nlm.nih.gov/sra?term=SRX255057
https://www.ncbi.nlm.nih.gov/biosample/SAMN01992328
1
treatment: MBNL1 and MBNL2 SMART-pool siRNAs,cell line: HeLa
88 Dr. Aiguader
Barcelona
Spain
Centre for Genomic Regulation
Manuel,,Irimia
Full genomic sequences for the analyzed species were downloaded from the Ensembl database. Full transcriptomic sequences for all species were downloaded from Ensembl. For each gene, the canonical transcript was selected for gene expression analysis based on BioMart.,For each species, we assembled all canonical transcript (as defined above) sequences. In order to calculate the effective number of unique mappable positions in each transcript (i.e. the effective length) we performed the following steps. For each read length k, we extracted the L-k+1 (L being the transcript length) k-mer sequences from each canonical transcript and then aligned the full set of k-mers against the respective genome using Bowtie, allowing for a maximum of two mismatches. k-mers with no or one unique genomic alignment were then likewise aligned back to the canonical transcriptome. For each transcript, the number of such k-mers having a unique transcriptomic alignment was determined. This corresponds to the transcript’s effective number of unique mappable positions for k-mer mRNA-Seq reads. For each sample, the corresponding mRNA-Seq data were aligned against the respective genome using Bowtie, allowing for a maximum of two mismatches. Reads with one unique genomic alignment were then aligned against the canonical transcriptome and, for each transcript, the number of reads with one unique transcriptomic alignment were counted. Gene expression levels were determined as reads per thousand mappable positions of target transcript sequence per million of reads, where the reads uniquely align to the analyzed transcriptome. This procedure for estimating gene expression levels is a corrected version of the widely used RPKM (reads per kilobase of target transcript sequence per million of total reads) metric, and is referred to as “cRPKM” [Labbe RM et al. Stem Cells (2012)].,Genome_build: hg19, mm9,Supplementary_files_format_and_content: Tab-delimited text files include cRPKM values (as defined above), as well as the total read count for each gene's canonical transcript
Total RNA was extracted using Tri Reagent (Sigma) or RNeasy columns (Qiagen),Standard Illumina library preparation according to manufacturer
GSM1105746
Illumina HiSeq 2000
May 15 2019
cDNA
transcriptomic
RNA-Seq
polyA RNA
Homo sapiens
GPL11154
SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX255058,BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN01992329
GSM1105746
GSE45504,GSE45505
0.005762
HeLa cell line
Public on Jun 26 2013
Mar 26 2013
9606
HeLa siMBNL1+2
SRA
https://www.ncbi.nlm.nih.gov/sra?term=SRX255058
https://www.ncbi.nlm.nih.gov/biosample/SAMN01992329
1
subject id: 154,lactation stage: Transitional,extraction protocol: Soft spin, Unwashed
451 Health Sciences Dr
Davis
USA
University of California Davis
Danielle,G,Lemay
Basecalls performed using Illumina software,Reads mapped to the genome using TopHat with these options: tophat -G hg19.gtf -o tophat -p 4 -r 0,Mapped reads were indexed using samtools: samtools index tophat/accepted_hits.bam,Normalized transcript abundances determined using Cufflinks: cufflinks -u -b hg19.fa -G hg19.gtf -p 4 -o cufflinks tophat/accepted_hits.bam,Genome_build: hg19,Supplementary_files_format_and_content: Compressed tab-delimited text files contain transcript abundance measurements (FPKM) summarized at the gene level
Soft Spin: Whole milk samples were centrifuged at 300 g for 10 min at 4 degrees C. The milk fat layers from three, 2.0 mL aliquots were transferred into a single new tube to which 500 µL TRIzol® was added and stored at -80 degrees C,Hard Spin: Whole milk samples were centrifuged at 15000 g for 10 min at 4 degrees C. The milk fat layers from three, 2.0 mL aliquots were transferred into a single new tube to which 500 µL TRIzol® was added and stored at -80 degrees C,Wash: After a hard spin at a warmer temperature, (15,000 g at 12 degrees C) the milk fat layers were transferred to a clean set of 3 tubes and re-suspended in 1 mL PBS+10µM EDTA. After centrifuging again (15,000 g at 12 degrees C), the milk fat layers from all 3 tubes were transferred to a single tube, re-suspended in 1 mL PBS, and centrifuged a final time (15,000 g at 12 degrees C). The remaining milk fat layer was transferred into a single new tube to which 500 µL TRIzol® was added and stored at -80 degrees C.,RNA Isolation: Total RNA was extracted and purified in batches of 16 using the PROMEGA Maxwell 16™ integrated system (Promega Corporation, Madison, WI).,RNA libraries were prepared for sequencing using the Illumina TruSeq RNA Kit and standard Illumina Protocols
GSM1111646
Illumina HiSeq 2000
May 15 2019
cDNA
transcriptomic
RNA-Seq
polyA RNA
Homo sapiens
GPL11154
SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX258169,BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN01996054
GSM1111646
GSE45669
0.006163
Milk Fat Layer
Public on Jul 22 2013
Apr 01 2013
9606
154-D_RNA_c0_0
SRA
https://www.ncbi.nlm.nih.gov/sra?term=SRX258169
https://www.ncbi.nlm.nih.gov/biosample/SAMN01996054
1
subject id: 179,lactation stage: Mature,extraction protocol: Hard spin, Washed twice
451 Health Sciences Dr
Davis
USA
University of California Davis
Danielle,G,Lemay
Basecalls performed using Illumina software,Reads mapped to the genome using TopHat with these options: tophat -G hg19.gtf -o tophat -p 4 -r 0,Mapped reads were indexed using samtools: samtools index tophat/accepted_hits.bam,Normalized transcript abundances determined using Cufflinks: cufflinks -u -b hg19.fa -G hg19.gtf -p 4 -o cufflinks tophat/accepted_hits.bam,Genome_build: hg19,Supplementary_files_format_and_content: Compressed tab-delimited text files contain transcript abundance measurements (FPKM) summarized at the gene level
Soft Spin: Whole milk samples were centrifuged at 300 g for 10 min at 4 degrees C. The milk fat layers from three, 2.0 mL aliquots were transferred into a single new tube to which 500 µL TRIzol® was added and stored at -80 degrees C,Hard Spin: Whole milk samples were centrifuged at 15000 g for 10 min at 4 degrees C. The milk fat layers from three, 2.0 mL aliquots were transferred into a single new tube to which 500 µL TRIzol® was added and stored at -80 degrees C,Wash: After a hard spin at a warmer temperature, (15,000 g at 12 degrees C) the milk fat layers were transferred to a clean set of 3 tubes and re-suspended in 1 mL PBS+10µM EDTA. After centrifuging again (15,000 g at 12 degrees C), the milk fat layers from all 3 tubes were transferred to a single tube, re-suspended in 1 mL PBS, and centrifuged a final time (15,000 g at 12 degrees C). The remaining milk fat layer was transferred into a single new tube to which 500 µL TRIzol® was added and stored at -80 degrees C.,RNA Isolation: Total RNA was extracted and purified in batches of 16 using the PROMEGA Maxwell 16™ integrated system (Promega Corporation, Madison, WI).,RNA libraries were prepared for sequencing using the Illumina TruSeq RNA Kit and standard Illumina Protocols
GSM1111658
Illumina HiSeq 2000
May 15 2019
cDNA
transcriptomic
RNA-Seq
polyA RNA
Homo sapiens
GPL11154
SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX258181,BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN01996066
GSM1111658
GSE45669
0.063019
Milk Fat Layer
Public on Jul 22 2013
Apr 01 2013
9606
179-C_RNA_m2_2
SRA
https://www.ncbi.nlm.nih.gov/sra?term=SRX258181
https://www.ncbi.nlm.nih.gov/biosample/SAMN01996066
1
tissue: blood,fraction: exosome
8701 Watertown Plank Rd.
Milwaukee
USA
Medical College of Wisconsin
Liang,,Wang
Perl Scripts were developed to process data from RNA sequencing. Raw reads were firstly extracted from FASTQ files, and trimmed with sequencing quality control of Q > 13 , and then cleaned up 3’ adaptor sequences within read sequences. Those prepared sequences filtered with the length ≥16 nt were combined into a FASTA file and aligned against human miRNA sequences downloaded from miRBase (Release 19, 2043 entries) and human genome reference sequences downloaded from NCBI ftp site (Release 103) with Bowtie (version 0.12.8) , of which the parameters for alignment were -m 3 -n 1 -f -a -best --strata. Normalization of miRNA profiling was the read counts of a target miRNA by million bases versus the sum of read counts of all mappable miRNAs on human miRNA sequences.,Genome_build: miRNA from miRBase(release19),Supplementary_files_format_and_content: Data frame of normalized miRNA transcription level in *.txt
we selected plasma samples (samples A, B and C) from 3 anonymous blood donors and split each sample into two for technical replication.,We tested the six samples (A1 and A2, B1 and B2, C1 and C2) using two small RNA library preparation kits: NEBNext Multiplex Small RNA library Prep Set from New England Biolab (NEB) and NEXTflex Small RNA Sequencing Kit from Bioo Scientific (BS). We also tested Illumina’s TrueSeq Small RNA Sample Preparation Kit (ILMN) in sample A1 and A2. Together, we tested these plasma samples by sequencing 14 indexed libraries.,Human plasma samples were obtained from Mayo Clinic and stored at -80°C before use. Exosomes were isolated from 250 µL of plasma prepared from whole blood using the ExoQuick Exosome Precipitation Solution (SBI) according to the manufacturer’s instructions with minor modifications. Briefly, the plasma was incubated with Thromboplastin D (Thermo) for 15 min at 37oC. After centrifugation at 10,000 rpm for 5 min, the supernatant was mixed with 75 µL of ExoQuick Solution and RNase A (Sigma) at final concentration of 10 µg/mL. The mixture was kept at 4oC overnight and then further mixed with 150 units/mL of murine RNase inhibitor (NEB) before centrifugation at 1500 g for 30 min. The exosome pellet was dissolved in 25 µL 1×PBS, 2 µL of which was reserved for evaluation of exosome size and concentration using NanoSight LM 10 instrument (Particle Characterization Laboratories). The remainder was subjected to RNA extraction immediately. The usage of human biospecimen for this study was approved by Institutional Review Board of Medical College of Wisconsin and Mayo Clinic.,RNA was prepared by using miRNeasy Micro Kit (QIAGEN). Twenty-three µL of exosome suspension was mixed with 700 µL QIAzol Lysis buffer, and was processed by the standard protocol from the manufacturer. The extracted RNA was eluted with 14 µL of RNase-free water. The quantity and quality of the RNA were determined by Agilent Bioanalyzer 2100 with Small RNA Chip and RNA 6000 Pico Kit as indicated (Agilent Technologies).,The concentration and the size distribution of isolated exosomes were measured using NanoSight. Prior to sampling, the sample solutions were homogenized by vortexing, followed by serial dilution to the final dilution of 1:100,000 in 0.2 µm-filtered 1x PBS. NIST (National Institute of Standards and Technology) traceable 97 nm ± 3 nm polystyrene latex standards were added and analyzed in conjunction with the diluted exosome solution to validate the operation of the instrumentation. A blank 0.2 µm-filtered 1x PBS sample was also run as a negative control. Each sample analysis was conducted for 90 seconds. The Nanosight’s automatic analysis settings (High Sensitivity, Blue laser [405 nm, 645 mW]) were utilized for the processing of the data. All samples were evaluated in triplicates.
GSM1112869
Illumina HiSeq 2000
May 15 2019
size fractionation
transcriptomic
RNA-Seq
total RNA
Homo sapiens
GPL11154
SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX258926,BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN01997249
GSM1112869
GSE45722
0.561508
microRNA from sample A constructed by the kit from Bioo scientific
Public on May 15 2013
Apr 03 2013
9606
microRNA from sample A constructed by the kit from Bioo scientific [LW_AB_1]
SRA
https://www.ncbi.nlm.nih.gov/sra?term=SRX258926
https://www.ncbi.nlm.nih.gov/biosample/SAMN01997249
1
tissue: blood,fraction: exosome
8701 Watertown Plank Rd.
Milwaukee
USA
Medical College of Wisconsin
Liang,,Wang
Perl Scripts were developed to process data from RNA sequencing. Raw reads were firstly extracted from FASTQ files, and trimmed with sequencing quality control of Q > 13 , and then cleaned up 3’ adaptor sequences within read sequences. Those prepared sequences filtered with the length ≥16 nt were combined into a FASTA file and aligned against human miRNA sequences downloaded from miRBase (Release 19, 2043 entries) and human genome reference sequences downloaded from NCBI ftp site (Release 103) with Bowtie (version 0.12.8) , of which the parameters for alignment were -m 3 -n 1 -f -a -best --strata. Normalization of miRNA profiling was the read counts of a target miRNA by million bases versus the sum of read counts of all mappable miRNAs on human miRNA sequences.,Genome_build: miRNA from miRBase(release19),Supplementary_files_format_and_content: Data frame of normalized miRNA transcription level in *.txt
we selected plasma samples (samples A, B and C) from 3 anonymous blood donors and split each sample into two for technical replication.,We tested the six samples (A1 and A2, B1 and B2, C1 and C2) using two small RNA library preparation kits: NEBNext Multiplex Small RNA library Prep Set from New England Biolab (NEB) and NEXTflex Small RNA Sequencing Kit from Bioo Scientific (BS). We also tested Illumina’s TrueSeq Small RNA Sample Preparation Kit (ILMN) in sample A1 and A2. Together, we tested these plasma samples by sequencing 14 indexed libraries.,Human plasma samples were obtained from Mayo Clinic and stored at -80°C before use. Exosomes were isolated from 250 µL of plasma prepared from whole blood using the ExoQuick Exosome Precipitation Solution (SBI) according to the manufacturer’s instructions with minor modifications. Briefly, the plasma was incubated with Thromboplastin D (Thermo) for 15 min at 37oC. After centrifugation at 10,000 rpm for 5 min, the supernatant was mixed with 75 µL of ExoQuick Solution and RNase A (Sigma) at final concentration of 10 µg/mL. The mixture was kept at 4oC overnight and then further mixed with 150 units/mL of murine RNase inhibitor (NEB) before centrifugation at 1500 g for 30 min. The exosome pellet was dissolved in 25 µL 1×PBS, 2 µL of which was reserved for evaluation of exosome size and concentration using NanoSight LM 10 instrument (Particle Characterization Laboratories). The remainder was subjected to RNA extraction immediately. The usage of human biospecimen for this study was approved by Institutional Review Board of Medical College of Wisconsin and Mayo Clinic.,RNA was prepared by using miRNeasy Micro Kit (QIAGEN). Twenty-three µL of exosome suspension was mixed with 700 µL QIAzol Lysis buffer, and was processed by the standard protocol from the manufacturer. The extracted RNA was eluted with 14 µL of RNase-free water. The quantity and quality of the RNA were determined by Agilent Bioanalyzer 2100 with Small RNA Chip and RNA 6000 Pico Kit as indicated (Agilent Technologies).,The concentration and the size distribution of isolated exosomes were measured using NanoSight. Prior to sampling, the sample solutions were homogenized by vortexing, followed by serial dilution to the final dilution of 1:100,000 in 0.2 µm-filtered 1x PBS. NIST (National Institute of Standards and Technology) traceable 97 nm ± 3 nm polystyrene latex standards were added and analyzed in conjunction with the diluted exosome solution to validate the operation of the instrumentation. A blank 0.2 µm-filtered 1x PBS sample was also run as a negative control. Each sample analysis was conducted for 90 seconds. The Nanosight’s automatic analysis settings (High Sensitivity, Blue laser [405 nm, 645 mW]) were utilized for the processing of the data. All samples were evaluated in triplicates.
GSM1112870
Illumina HiSeq 2000
May 15 2019
size fractionation
transcriptomic
RNA-Seq
total RNA
Homo sapiens
GPL11154
SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX258927,BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN01997250
GSM1112870
GSE45722
0.676602
microRNA from sample A constructed by the kit from Bioo scientific
Public on May 15 2013
Apr 03 2013
9606
microRNA from sample A constructed by the kit from Bioo scientific [LW_AB_2]
SRA
https://www.ncbi.nlm.nih.gov/sra?term=SRX258927
https://www.ncbi.nlm.nih.gov/biosample/SAMN01997250
1
tissue: blood,fraction: exosome
8701 Watertown Plank Rd.
Milwaukee
USA
Medical College of Wisconsin
Liang,,Wang
Perl Scripts were developed to process data from RNA sequencing. Raw reads were firstly extracted from FASTQ files, and trimmed with sequencing quality control of Q > 13 , and then cleaned up 3’ adaptor sequences within read sequences. Those prepared sequences filtered with the length ≥16 nt were combined into a FASTA file and aligned against human miRNA sequences downloaded from miRBase (Release 19, 2043 entries) and human genome reference sequences downloaded from NCBI ftp site (Release 103) with Bowtie (version 0.12.8) , of which the parameters for alignment were -m 3 -n 1 -f -a -best --strata. Normalization of miRNA profiling was the read counts of a target miRNA by million bases versus the sum of read counts of all mappable miRNAs on human miRNA sequences.,Genome_build: miRNA from miRBase(release19),Supplementary_files_format_and_content: Data frame of normalized miRNA transcription level in *.txt
we selected plasma samples (samples A, B and C) from 3 anonymous blood donors and split each sample into two for technical replication.,We tested the six samples (A1 and A2, B1 and B2, C1 and C2) using two small RNA library preparation kits: NEBNext Multiplex Small RNA library Prep Set from New England Biolab (NEB) and NEXTflex Small RNA Sequencing Kit from Bioo Scientific (BS). We also tested Illumina’s TrueSeq Small RNA Sample Preparation Kit (ILMN) in sample A1 and A2. Together, we tested these plasma samples by sequencing 14 indexed libraries.,Human plasma samples were obtained from Mayo Clinic and stored at -80°C before use. Exosomes were isolated from 250 µL of plasma prepared from whole blood using the ExoQuick Exosome Precipitation Solution (SBI) according to the manufacturer’s instructions with minor modifications. Briefly, the plasma was incubated with Thromboplastin D (Thermo) for 15 min at 37oC. After centrifugation at 10,000 rpm for 5 min, the supernatant was mixed with 75 µL of ExoQuick Solution and RNase A (Sigma) at final concentration of 10 µg/mL. The mixture was kept at 4oC overnight and then further mixed with 150 units/mL of murine RNase inhibitor (NEB) before centrifugation at 1500 g for 30 min. The exosome pellet was dissolved in 25 µL 1×PBS, 2 µL of which was reserved for evaluation of exosome size and concentration using NanoSight LM 10 instrument (Particle Characterization Laboratories). The remainder was subjected to RNA extraction immediately. The usage of human biospecimen for this study was approved by Institutional Review Board of Medical College of Wisconsin and Mayo Clinic.,RNA was prepared by using miRNeasy Micro Kit (QIAGEN). Twenty-three µL of exosome suspension was mixed with 700 µL QIAzol Lysis buffer, and was processed by the standard protocol from the manufacturer. The extracted RNA was eluted with 14 µL of RNase-free water. The quantity and quality of the RNA were determined by Agilent Bioanalyzer 2100 with Small RNA Chip and RNA 6000 Pico Kit as indicated (Agilent Technologies).,The concentration and the size distribution of isolated exosomes were measured using NanoSight. Prior to sampling, the sample solutions were homogenized by vortexing, followed by serial dilution to the final dilution of 1:100,000 in 0.2 µm-filtered 1x PBS. NIST (National Institute of Standards and Technology) traceable 97 nm ± 3 nm polystyrene latex standards were added and analyzed in conjunction with the diluted exosome solution to validate the operation of the instrumentation. A blank 0.2 µm-filtered 1x PBS sample was also run as a negative control. Each sample analysis was conducted for 90 seconds. The Nanosight’s automatic analysis settings (High Sensitivity, Blue laser [405 nm, 645 mW]) were utilized for the processing of the data. All samples were evaluated in triplicates.
GSM1112871
Illumina HiSeq 2000
May 15 2019
size fractionation
transcriptomic
RNA-Seq
total RNA
Homo sapiens
GPL11154
SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX258928,BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN01997251
GSM1112871
GSE45722
0.341471
microRNA from sample A constructed by the kit from NEB
Public on May 15 2013
Apr 03 2013
9606
microRNA from sample A constructed by the kit from NEB [LW_AN_1]
SRA
https://www.ncbi.nlm.nih.gov/sra?term=SRX258928
https://www.ncbi.nlm.nih.gov/biosample/SAMN01997251
1
tissue: blood,fraction: exosome
8701 Watertown Plank Rd.
Milwaukee
USA
Medical College of Wisconsin
Liang,,Wang
Perl Scripts were developed to process data from RNA sequencing. Raw reads were firstly extracted from FASTQ files, and trimmed with sequencing quality control of Q > 13 , and then cleaned up 3’ adaptor sequences within read sequences. Those prepared sequences filtered with the length ≥16 nt were combined into a FASTA file and aligned against human miRNA sequences downloaded from miRBase (Release 19, 2043 entries) and human genome reference sequences downloaded from NCBI ftp site (Release 103) with Bowtie (version 0.12.8) , of which the parameters for alignment were -m 3 -n 1 -f -a -best --strata. Normalization of miRNA profiling was the read counts of a target miRNA by million bases versus the sum of read counts of all mappable miRNAs on human miRNA sequences.,Genome_build: miRNA from miRBase(release19),Supplementary_files_format_and_content: Data frame of normalized miRNA transcription level in *.txt
we selected plasma samples (samples A, B and C) from 3 anonymous blood donors and split each sample into two for technical replication.,We tested the six samples (A1 and A2, B1 and B2, C1 and C2) using two small RNA library preparation kits: NEBNext Multiplex Small RNA library Prep Set from New England Biolab (NEB) and NEXTflex Small RNA Sequencing Kit from Bioo Scientific (BS). We also tested Illumina’s TrueSeq Small RNA Sample Preparation Kit (ILMN) in sample A1 and A2. Together, we tested these plasma samples by sequencing 14 indexed libraries.,Human plasma samples were obtained from Mayo Clinic and stored at -80°C before use. Exosomes were isolated from 250 µL of plasma prepared from whole blood using the ExoQuick Exosome Precipitation Solution (SBI) according to the manufacturer’s instructions with minor modifications. Briefly, the plasma was incubated with Thromboplastin D (Thermo) for 15 min at 37oC. After centrifugation at 10,000 rpm for 5 min, the supernatant was mixed with 75 µL of ExoQuick Solution and RNase A (Sigma) at final concentration of 10 µg/mL. The mixture was kept at 4oC overnight and then further mixed with 150 units/mL of murine RNase inhibitor (NEB) before centrifugation at 1500 g for 30 min. The exosome pellet was dissolved in 25 µL 1×PBS, 2 µL of which was reserved for evaluation of exosome size and concentration using NanoSight LM 10 instrument (Particle Characterization Laboratories). The remainder was subjected to RNA extraction immediately. The usage of human biospecimen for this study was approved by Institutional Review Board of Medical College of Wisconsin and Mayo Clinic.,RNA was prepared by using miRNeasy Micro Kit (QIAGEN). Twenty-three µL of exosome suspension was mixed with 700 µL QIAzol Lysis buffer, and was processed by the standard protocol from the manufacturer. The extracted RNA was eluted with 14 µL of RNase-free water. The quantity and quality of the RNA were determined by Agilent Bioanalyzer 2100 with Small RNA Chip and RNA 6000 Pico Kit as indicated (Agilent Technologies).,The concentration and the size distribution of isolated exosomes were measured using NanoSight. Prior to sampling, the sample solutions were homogenized by vortexing, followed by serial dilution to the final dilution of 1:100,000 in 0.2 µm-filtered 1x PBS. NIST (National Institute of Standards and Technology) traceable 97 nm ± 3 nm polystyrene latex standards were added and analyzed in conjunction with the diluted exosome solution to validate the operation of the instrumentation. A blank 0.2 µm-filtered 1x PBS sample was also run as a negative control. Each sample analysis was conducted for 90 seconds. The Nanosight’s automatic analysis settings (High Sensitivity, Blue laser [405 nm, 645 mW]) were utilized for the processing of the data. All samples were evaluated in triplicates.
GSM1112872
Illumina HiSeq 2000
May 15 2019
size fractionation
transcriptomic
RNA-Seq
total RNA
Homo sapiens
GPL11154
SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX258929,BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN01997252
GSM1112872
GSE45722
0.465001
microRNA from sample A constructed by the kit from NEB
Public on May 15 2013
Apr 03 2013
9606
microRNA from sample A constructed by the kit from NEB [LW_AN_2]
SRA
https://www.ncbi.nlm.nih.gov/sra?term=SRX258929
https://www.ncbi.nlm.nih.gov/biosample/SAMN01997252
1
tissue: blood,fraction: exosome
8701 Watertown Plank Rd.
Milwaukee
USA
Medical College of Wisconsin
Liang,,Wang
Perl Scripts were developed to process data from RNA sequencing. Raw reads were firstly extracted from FASTQ files, and trimmed with sequencing quality control of Q > 13 , and then cleaned up 3’ adaptor sequences within read sequences. Those prepared sequences filtered with the length ≥16 nt were combined into a FASTA file and aligned against human miRNA sequences downloaded from miRBase (Release 19, 2043 entries) and human genome reference sequences downloaded from NCBI ftp site (Release 103) with Bowtie (version 0.12.8) , of which the parameters for alignment were -m 3 -n 1 -f -a -best --strata. Normalization of miRNA profiling was the read counts of a target miRNA by million bases versus the sum of read counts of all mappable miRNAs on human miRNA sequences.,Genome_build: miRNA from miRBase(release19),Supplementary_files_format_and_content: Data frame of normalized miRNA transcription level in *.txt
we selected plasma samples (samples A, B and C) from 3 anonymous blood donors and split each sample into two for technical replication.,We tested the six samples (A1 and A2, B1 and B2, C1 and C2) using two small RNA library preparation kits: NEBNext Multiplex Small RNA library Prep Set from New England Biolab (NEB) and NEXTflex Small RNA Sequencing Kit from Bioo Scientific (BS). We also tested Illumina’s TrueSeq Small RNA Sample Preparation Kit (ILMN) in sample A1 and A2. Together, we tested these plasma samples by sequencing 14 indexed libraries.,Human plasma samples were obtained from Mayo Clinic and stored at -80°C before use. Exosomes were isolated from 250 µL of plasma prepared from whole blood using the ExoQuick Exosome Precipitation Solution (SBI) according to the manufacturer’s instructions with minor modifications. Briefly, the plasma was incubated with Thromboplastin D (Thermo) for 15 min at 37oC. After centrifugation at 10,000 rpm for 5 min, the supernatant was mixed with 75 µL of ExoQuick Solution and RNase A (Sigma) at final concentration of 10 µg/mL. The mixture was kept at 4oC overnight and then further mixed with 150 units/mL of murine RNase inhibitor (NEB) before centrifugation at 1500 g for 30 min. The exosome pellet was dissolved in 25 µL 1×PBS, 2 µL of which was reserved for evaluation of exosome size and concentration using NanoSight LM 10 instrument (Particle Characterization Laboratories). The remainder was subjected to RNA extraction immediately. The usage of human biospecimen for this study was approved by Institutional Review Board of Medical College of Wisconsin and Mayo Clinic.,RNA was prepared by using miRNeasy Micro Kit (QIAGEN). Twenty-three µL of exosome suspension was mixed with 700 µL QIAzol Lysis buffer, and was processed by the standard protocol from the manufacturer. The extracted RNA was eluted with 14 µL of RNase-free water. The quantity and quality of the RNA were determined by Agilent Bioanalyzer 2100 with Small RNA Chip and RNA 6000 Pico Kit as indicated (Agilent Technologies).,The concentration and the size distribution of isolated exosomes were measured using NanoSight. Prior to sampling, the sample solutions were homogenized by vortexing, followed by serial dilution to the final dilution of 1:100,000 in 0.2 µm-filtered 1x PBS. NIST (National Institute of Standards and Technology) traceable 97 nm ± 3 nm polystyrene latex standards were added and analyzed in conjunction with the diluted exosome solution to validate the operation of the instrumentation. A blank 0.2 µm-filtered 1x PBS sample was also run as a negative control. Each sample analysis was conducted for 90 seconds. The Nanosight’s automatic analysis settings (High Sensitivity, Blue laser [405 nm, 645 mW]) were utilized for the processing of the data. All samples were evaluated in triplicates.
GSM1112873
Illumina HiSeq 2000
May 15 2019
size fractionation
transcriptomic
RNA-Seq
total RNA
Homo sapiens
GPL11154
SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX258930,BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN01997253
GSM1112873
GSE45722
0.630554
microRNA from sample A constructed by the kit from Illumina
Public on May 15 2013
Apr 03 2013
9606
microRNA from sample A constructed by the kit from Illumina [LW_AI_1]
SRA
https://www.ncbi.nlm.nih.gov/sra?term=SRX258930
https://www.ncbi.nlm.nih.gov/biosample/SAMN01997253
1
tissue: blood,fraction: exosome
8701 Watertown Plank Rd.
Milwaukee
USA
Medical College of Wisconsin
Liang,,Wang
Perl Scripts were developed to process data from RNA sequencing. Raw reads were firstly extracted from FASTQ files, and trimmed with sequencing quality control of Q > 13 , and then cleaned up 3’ adaptor sequences within read sequences. Those prepared sequences filtered with the length ≥16 nt were combined into a FASTA file and aligned against human miRNA sequences downloaded from miRBase (Release 19, 2043 entries) and human genome reference sequences downloaded from NCBI ftp site (Release 103) with Bowtie (version 0.12.8) , of which the parameters for alignment were -m 3 -n 1 -f -a -best --strata. Normalization of miRNA profiling was the read counts of a target miRNA by million bases versus the sum of read counts of all mappable miRNAs on human miRNA sequences.,Genome_build: miRNA from miRBase(release19),Supplementary_files_format_and_content: Data frame of normalized miRNA transcription level in *.txt
we selected plasma samples (samples A, B and C) from 3 anonymous blood donors and split each sample into two for technical replication.,We tested the six samples (A1 and A2, B1 and B2, C1 and C2) using two small RNA library preparation kits: NEBNext Multiplex Small RNA library Prep Set from New England Biolab (NEB) and NEXTflex Small RNA Sequencing Kit from Bioo Scientific (BS). We also tested Illumina’s TrueSeq Small RNA Sample Preparation Kit (ILMN) in sample A1 and A2. Together, we tested these plasma samples by sequencing 14 indexed libraries.,Human plasma samples were obtained from Mayo Clinic and stored at -80°C before use. Exosomes were isolated from 250 µL of plasma prepared from whole blood using the ExoQuick Exosome Precipitation Solution (SBI) according to the manufacturer’s instructions with minor modifications. Briefly, the plasma was incubated with Thromboplastin D (Thermo) for 15 min at 37oC. After centrifugation at 10,000 rpm for 5 min, the supernatant was mixed with 75 µL of ExoQuick Solution and RNase A (Sigma) at final concentration of 10 µg/mL. The mixture was kept at 4oC overnight and then further mixed with 150 units/mL of murine RNase inhibitor (NEB) before centrifugation at 1500 g for 30 min. The exosome pellet was dissolved in 25 µL 1×PBS, 2 µL of which was reserved for evaluation of exosome size and concentration using NanoSight LM 10 instrument (Particle Characterization Laboratories). The remainder was subjected to RNA extraction immediately. The usage of human biospecimen for this study was approved by Institutional Review Board of Medical College of Wisconsin and Mayo Clinic.,RNA was prepared by using miRNeasy Micro Kit (QIAGEN). Twenty-three µL of exosome suspension was mixed with 700 µL QIAzol Lysis buffer, and was processed by the standard protocol from the manufacturer. The extracted RNA was eluted with 14 µL of RNase-free water. The quantity and quality of the RNA were determined by Agilent Bioanalyzer 2100 with Small RNA Chip and RNA 6000 Pico Kit as indicated (Agilent Technologies).,The concentration and the size distribution of isolated exosomes were measured using NanoSight. Prior to sampling, the sample solutions were homogenized by vortexing, followed by serial dilution to the final dilution of 1:100,000 in 0.2 µm-filtered 1x PBS. NIST (National Institute of Standards and Technology) traceable 97 nm ± 3 nm polystyrene latex standards were added and analyzed in conjunction with the diluted exosome solution to validate the operation of the instrumentation. A blank 0.2 µm-filtered 1x PBS sample was also run as a negative control. Each sample analysis was conducted for 90 seconds. The Nanosight’s automatic analysis settings (High Sensitivity, Blue laser [405 nm, 645 mW]) were utilized for the processing of the data. All samples were evaluated in triplicates.
GSM1112874
Illumina HiSeq 2000
May 15 2019
size fractionation
transcriptomic
RNA-Seq
total RNA
Homo sapiens
GPL11154
SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX258931,BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN01997254
GSM1112874
GSE45722
0.52746
microRNA from sample A constructed by the kit from Illumina
Public on May 15 2013
Apr 03 2013
9606
microRNA from sample A constructed by the kit from Illumina [LW_AI_2]
SRA
https://www.ncbi.nlm.nih.gov/sra?term=SRX258931
https://www.ncbi.nlm.nih.gov/biosample/SAMN01997254
1
tissue: blood,fraction: exosome
8701 Watertown Plank Rd.
Milwaukee
USA
Medical College of Wisconsin
Liang,,Wang
Perl Scripts were developed to process data from RNA sequencing. Raw reads were firstly extracted from FASTQ files, and trimmed with sequencing quality control of Q > 13 , and then cleaned up 3’ adaptor sequences within read sequences. Those prepared sequences filtered with the length ≥16 nt were combined into a FASTA file and aligned against human miRNA sequences downloaded from miRBase (Release 19, 2043 entries) and human genome reference sequences downloaded from NCBI ftp site (Release 103) with Bowtie (version 0.12.8) , of which the parameters for alignment were -m 3 -n 1 -f -a -best --strata. Normalization of miRNA profiling was the read counts of a target miRNA by million bases versus the sum of read counts of all mappable miRNAs on human miRNA sequences.,Genome_build: miRNA from miRBase(release19),Supplementary_files_format_and_content: Data frame of normalized miRNA transcription level in *.txt
we selected plasma samples (samples A, B and C) from 3 anonymous blood donors and split each sample into two for technical replication.,We tested the six samples (A1 and A2, B1 and B2, C1 and C2) using two small RNA library preparation kits: NEBNext Multiplex Small RNA library Prep Set from New England Biolab (NEB) and NEXTflex Small RNA Sequencing Kit from Bioo Scientific (BS). We also tested Illumina’s TrueSeq Small RNA Sample Preparation Kit (ILMN) in sample A1 and A2. Together, we tested these plasma samples by sequencing 14 indexed libraries.,Human plasma samples were obtained from Mayo Clinic and stored at -80°C before use. Exosomes were isolated from 250 µL of plasma prepared from whole blood using the ExoQuick Exosome Precipitation Solution (SBI) according to the manufacturer’s instructions with minor modifications. Briefly, the plasma was incubated with Thromboplastin D (Thermo) for 15 min at 37oC. After centrifugation at 10,000 rpm for 5 min, the supernatant was mixed with 75 µL of ExoQuick Solution and RNase A (Sigma) at final concentration of 10 µg/mL. The mixture was kept at 4oC overnight and then further mixed with 150 units/mL of murine RNase inhibitor (NEB) before centrifugation at 1500 g for 30 min. The exosome pellet was dissolved in 25 µL 1×PBS, 2 µL of which was reserved for evaluation of exosome size and concentration using NanoSight LM 10 instrument (Particle Characterization Laboratories). The remainder was subjected to RNA extraction immediately. The usage of human biospecimen for this study was approved by Institutional Review Board of Medical College of Wisconsin and Mayo Clinic.,RNA was prepared by using miRNeasy Micro Kit (QIAGEN). Twenty-three µL of exosome suspension was mixed with 700 µL QIAzol Lysis buffer, and was processed by the standard protocol from the manufacturer. The extracted RNA was eluted with 14 µL of RNase-free water. The quantity and quality of the RNA were determined by Agilent Bioanalyzer 2100 with Small RNA Chip and RNA 6000 Pico Kit as indicated (Agilent Technologies).,The concentration and the size distribution of isolated exosomes were measured using NanoSight. Prior to sampling, the sample solutions were homogenized by vortexing, followed by serial dilution to the final dilution of 1:100,000 in 0.2 µm-filtered 1x PBS. NIST (National Institute of Standards and Technology) traceable 97 nm ± 3 nm polystyrene latex standards were added and analyzed in conjunction with the diluted exosome solution to validate the operation of the instrumentation. A blank 0.2 µm-filtered 1x PBS sample was also run as a negative control. Each sample analysis was conducted for 90 seconds. The Nanosight’s automatic analysis settings (High Sensitivity, Blue laser [405 nm, 645 mW]) were utilized for the processing of the data. All samples were evaluated in triplicates.
GSM1112875
Illumina HiSeq 2000
May 15 2019
size fractionation
transcriptomic
RNA-Seq
total RNA
Homo sapiens
GPL11154
SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX258932,BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN01997255
GSM1112875
GSE45722
0.528227
microRNA from sample B constructed by the kit from Bioo scientific
Public on May 15 2013
Apr 03 2013
9606
microRNA from sample B constructed by the kit from Bioo scientific [LW_BB_1]
SRA
https://www.ncbi.nlm.nih.gov/sra?term=SRX258932
https://www.ncbi.nlm.nih.gov/biosample/SAMN01997255
1
tissue: blood,fraction: exosome
8701 Watertown Plank Rd.
Milwaukee
USA
Medical College of Wisconsin
Liang,,Wang
Perl Scripts were developed to process data from RNA sequencing. Raw reads were firstly extracted from FASTQ files, and trimmed with sequencing quality control of Q > 13 , and then cleaned up 3’ adaptor sequences within read sequences. Those prepared sequences filtered with the length ≥16 nt were combined into a FASTA file and aligned against human miRNA sequences downloaded from miRBase (Release 19, 2043 entries) and human genome reference sequences downloaded from NCBI ftp site (Release 103) with Bowtie (version 0.12.8) , of which the parameters for alignment were -m 3 -n 1 -f -a -best --strata. Normalization of miRNA profiling was the read counts of a target miRNA by million bases versus the sum of read counts of all mappable miRNAs on human miRNA sequences.,Genome_build: miRNA from miRBase(release19),Supplementary_files_format_and_content: Data frame of normalized miRNA transcription level in *.txt
we selected plasma samples (samples A, B and C) from 3 anonymous blood donors and split each sample into two for technical replication.,We tested the six samples (A1 and A2, B1 and B2, C1 and C2) using two small RNA library preparation kits: NEBNext Multiplex Small RNA library Prep Set from New England Biolab (NEB) and NEXTflex Small RNA Sequencing Kit from Bioo Scientific (BS). We also tested Illumina’s TrueSeq Small RNA Sample Preparation Kit (ILMN) in sample A1 and A2. Together, we tested these plasma samples by sequencing 14 indexed libraries.,Human plasma samples were obtained from Mayo Clinic and stored at -80°C before use. Exosomes were isolated from 250 µL of plasma prepared from whole blood using the ExoQuick Exosome Precipitation Solution (SBI) according to the manufacturer’s instructions with minor modifications. Briefly, the plasma was incubated with Thromboplastin D (Thermo) for 15 min at 37oC. After centrifugation at 10,000 rpm for 5 min, the supernatant was mixed with 75 µL of ExoQuick Solution and RNase A (Sigma) at final concentration of 10 µg/mL. The mixture was kept at 4oC overnight and then further mixed with 150 units/mL of murine RNase inhibitor (NEB) before centrifugation at 1500 g for 30 min. The exosome pellet was dissolved in 25 µL 1×PBS, 2 µL of which was reserved for evaluation of exosome size and concentration using NanoSight LM 10 instrument (Particle Characterization Laboratories). The remainder was subjected to RNA extraction immediately. The usage of human biospecimen for this study was approved by Institutional Review Board of Medical College of Wisconsin and Mayo Clinic.,RNA was prepared by using miRNeasy Micro Kit (QIAGEN). Twenty-three µL of exosome suspension was mixed with 700 µL QIAzol Lysis buffer, and was processed by the standard protocol from the manufacturer. The extracted RNA was eluted with 14 µL of RNase-free water. The quantity and quality of the RNA were determined by Agilent Bioanalyzer 2100 with Small RNA Chip and RNA 6000 Pico Kit as indicated (Agilent Technologies).,The concentration and the size distribution of isolated exosomes were measured using NanoSight. Prior to sampling, the sample solutions were homogenized by vortexing, followed by serial dilution to the final dilution of 1:100,000 in 0.2 µm-filtered 1x PBS. NIST (National Institute of Standards and Technology) traceable 97 nm ± 3 nm polystyrene latex standards were added and analyzed in conjunction with the diluted exosome solution to validate the operation of the instrumentation. A blank 0.2 µm-filtered 1x PBS sample was also run as a negative control. Each sample analysis was conducted for 90 seconds. The Nanosight’s automatic analysis settings (High Sensitivity, Blue laser [405 nm, 645 mW]) were utilized for the processing of the data. All samples were evaluated in triplicates.
GSM1112876
Illumina HiSeq 2000
May 15 2019
size fractionation
transcriptomic
RNA-Seq
total RNA
Homo sapiens
GPL11154
SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX258933,BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN01997256
GSM1112876
GSE45722
0.630344
microRNA from sample B constructed by the kit from Bioo scientific
Public on May 15 2013
Apr 03 2013
9606
microRNA from sample B constructed by the kit from Bioo scientific [LW_BB_2]
SRA
https://www.ncbi.nlm.nih.gov/sra?term=SRX258933
https://www.ncbi.nlm.nih.gov/biosample/SAMN01997256
1
tissue: blood,fraction: exosome
8701 Watertown Plank Rd.
Milwaukee
USA
Medical College of Wisconsin
Liang,,Wang
Perl Scripts were developed to process data from RNA sequencing. Raw reads were firstly extracted from FASTQ files, and trimmed with sequencing quality control of Q > 13 , and then cleaned up 3’ adaptor sequences within read sequences. Those prepared sequences filtered with the length ≥16 nt were combined into a FASTA file and aligned against human miRNA sequences downloaded from miRBase (Release 19, 2043 entries) and human genome reference sequences downloaded from NCBI ftp site (Release 103) with Bowtie (version 0.12.8) , of which the parameters for alignment were -m 3 -n 1 -f -a -best --strata. Normalization of miRNA profiling was the read counts of a target miRNA by million bases versus the sum of read counts of all mappable miRNAs on human miRNA sequences.,Genome_build: miRNA from miRBase(release19),Supplementary_files_format_and_content: Data frame of normalized miRNA transcription level in *.txt
we selected plasma samples (samples A, B and C) from 3 anonymous blood donors and split each sample into two for technical replication.,We tested the six samples (A1 and A2, B1 and B2, C1 and C2) using two small RNA library preparation kits: NEBNext Multiplex Small RNA library Prep Set from New England Biolab (NEB) and NEXTflex Small RNA Sequencing Kit from Bioo Scientific (BS). We also tested Illumina’s TrueSeq Small RNA Sample Preparation Kit (ILMN) in sample A1 and A2. Together, we tested these plasma samples by sequencing 14 indexed libraries.,Human plasma samples were obtained from Mayo Clinic and stored at -80°C before use. Exosomes were isolated from 250 µL of plasma prepared from whole blood using the ExoQuick Exosome Precipitation Solution (SBI) according to the manufacturer’s instructions with minor modifications. Briefly, the plasma was incubated with Thromboplastin D (Thermo) for 15 min at 37oC. After centrifugation at 10,000 rpm for 5 min, the supernatant was mixed with 75 µL of ExoQuick Solution and RNase A (Sigma) at final concentration of 10 µg/mL. The mixture was kept at 4oC overnight and then further mixed with 150 units/mL of murine RNase inhibitor (NEB) before centrifugation at 1500 g for 30 min. The exosome pellet was dissolved in 25 µL 1×PBS, 2 µL of which was reserved for evaluation of exosome size and concentration using NanoSight LM 10 instrument (Particle Characterization Laboratories). The remainder was subjected to RNA extraction immediately. The usage of human biospecimen for this study was approved by Institutional Review Board of Medical College of Wisconsin and Mayo Clinic.,RNA was prepared by using miRNeasy Micro Kit (QIAGEN). Twenty-three µL of exosome suspension was mixed with 700 µL QIAzol Lysis buffer, and was processed by the standard protocol from the manufacturer. The extracted RNA was eluted with 14 µL of RNase-free water. The quantity and quality of the RNA were determined by Agilent Bioanalyzer 2100 with Small RNA Chip and RNA 6000 Pico Kit as indicated (Agilent Technologies).,The concentration and the size distribution of isolated exosomes were measured using NanoSight. Prior to sampling, the sample solutions were homogenized by vortexing, followed by serial dilution to the final dilution of 1:100,000 in 0.2 µm-filtered 1x PBS. NIST (National Institute of Standards and Technology) traceable 97 nm ± 3 nm polystyrene latex standards were added and analyzed in conjunction with the diluted exosome solution to validate the operation of the instrumentation. A blank 0.2 µm-filtered 1x PBS sample was also run as a negative control. Each sample analysis was conducted for 90 seconds. The Nanosight’s automatic analysis settings (High Sensitivity, Blue laser [405 nm, 645 mW]) were utilized for the processing of the data. All samples were evaluated in triplicates.
GSM1112877
Illumina HiSeq 2000
May 15 2019
size fractionation
transcriptomic
RNA-Seq
total RNA
Homo sapiens
GPL11154
SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX258934,BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN01997257
GSM1112877
GSE45722
0.346684
microRNA from sample B constructed by the kit from NEB
Public on May 15 2013
Apr 03 2013
9606
microRNA from sample B constructed by the kit from NEB [LW_BN_1]
SRA
https://www.ncbi.nlm.nih.gov/sra?term=SRX258934
https://www.ncbi.nlm.nih.gov/biosample/SAMN01997257
1
tissue: blood,fraction: exosome
8701 Watertown Plank Rd.
Milwaukee
USA
Medical College of Wisconsin
Liang,,Wang
Perl Scripts were developed to process data from RNA sequencing. Raw reads were firstly extracted from FASTQ files, and trimmed with sequencing quality control of Q > 13 , and then cleaned up 3’ adaptor sequences within read sequences. Those prepared sequences filtered with the length ≥16 nt were combined into a FASTA file and aligned against human miRNA sequences downloaded from miRBase (Release 19, 2043 entries) and human genome reference sequences downloaded from NCBI ftp site (Release 103) with Bowtie (version 0.12.8) , of which the parameters for alignment were -m 3 -n 1 -f -a -best --strata. Normalization of miRNA profiling was the read counts of a target miRNA by million bases versus the sum of read counts of all mappable miRNAs on human miRNA sequences.,Genome_build: miRNA from miRBase(release19),Supplementary_files_format_and_content: Data frame of normalized miRNA transcription level in *.txt
we selected plasma samples (samples A, B and C) from 3 anonymous blood donors and split each sample into two for technical replication.,We tested the six samples (A1 and A2, B1 and B2, C1 and C2) using two small RNA library preparation kits: NEBNext Multiplex Small RNA library Prep Set from New England Biolab (NEB) and NEXTflex Small RNA Sequencing Kit from Bioo Scientific (BS). We also tested Illumina’s TrueSeq Small RNA Sample Preparation Kit (ILMN) in sample A1 and A2. Together, we tested these plasma samples by sequencing 14 indexed libraries.,Human plasma samples were obtained from Mayo Clinic and stored at -80°C before use. Exosomes were isolated from 250 µL of plasma prepared from whole blood using the ExoQuick Exosome Precipitation Solution (SBI) according to the manufacturer’s instructions with minor modifications. Briefly, the plasma was incubated with Thromboplastin D (Thermo) for 15 min at 37oC. After centrifugation at 10,000 rpm for 5 min, the supernatant was mixed with 75 µL of ExoQuick Solution and RNase A (Sigma) at final concentration of 10 µg/mL. The mixture was kept at 4oC overnight and then further mixed with 150 units/mL of murine RNase inhibitor (NEB) before centrifugation at 1500 g for 30 min. The exosome pellet was dissolved in 25 µL 1×PBS, 2 µL of which was reserved for evaluation of exosome size and concentration using NanoSight LM 10 instrument (Particle Characterization Laboratories). The remainder was subjected to RNA extraction immediately. The usage of human biospecimen for this study was approved by Institutional Review Board of Medical College of Wisconsin and Mayo Clinic.,RNA was prepared by using miRNeasy Micro Kit (QIAGEN). Twenty-three µL of exosome suspension was mixed with 700 µL QIAzol Lysis buffer, and was processed by the standard protocol from the manufacturer. The extracted RNA was eluted with 14 µL of RNase-free water. The quantity and quality of the RNA were determined by Agilent Bioanalyzer 2100 with Small RNA Chip and RNA 6000 Pico Kit as indicated (Agilent Technologies).,The concentration and the size distribution of isolated exosomes were measured using NanoSight. Prior to sampling, the sample solutions were homogenized by vortexing, followed by serial dilution to the final dilution of 1:100,000 in 0.2 µm-filtered 1x PBS. NIST (National Institute of Standards and Technology) traceable 97 nm ± 3 nm polystyrene latex standards were added and analyzed in conjunction with the diluted exosome solution to validate the operation of the instrumentation. A blank 0.2 µm-filtered 1x PBS sample was also run as a negative control. Each sample analysis was conducted for 90 seconds. The Nanosight’s automatic analysis settings (High Sensitivity, Blue laser [405 nm, 645 mW]) were utilized for the processing of the data. All samples were evaluated in triplicates.
GSM1112878
Illumina HiSeq 2000
May 15 2019
size fractionation
transcriptomic
RNA-Seq
total RNA
Homo sapiens
GPL11154
SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX258935,BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN01997258
GSM1112878
GSE45722
0.566353
microRNA from sample B constructed by the kit from NEB
Public on May 15 2013
Apr 03 2013
9606
microRNA from sample B constructed by the kit from NEB [LW_BN_2]
SRA
https://www.ncbi.nlm.nih.gov/sra?term=SRX258935
https://www.ncbi.nlm.nih.gov/biosample/SAMN01997258
1
tissue: blood,fraction: exosome
8701 Watertown Plank Rd.
Milwaukee
USA
Medical College of Wisconsin
Liang,,Wang
Perl Scripts were developed to process data from RNA sequencing. Raw reads were firstly extracted from FASTQ files, and trimmed with sequencing quality control of Q > 13 , and then cleaned up 3’ adaptor sequences within read sequences. Those prepared sequences filtered with the length ≥16 nt were combined into a FASTA file and aligned against human miRNA sequences downloaded from miRBase (Release 19, 2043 entries) and human genome reference sequences downloaded from NCBI ftp site (Release 103) with Bowtie (version 0.12.8) , of which the parameters for alignment were -m 3 -n 1 -f -a -best --strata. Normalization of miRNA profiling was the read counts of a target miRNA by million bases versus the sum of read counts of all mappable miRNAs on human miRNA sequences.,Genome_build: miRNA from miRBase(release19),Supplementary_files_format_and_content: Data frame of normalized miRNA transcription level in *.txt
we selected plasma samples (samples A, B and C) from 3 anonymous blood donors and split each sample into two for technical replication.,We tested the six samples (A1 and A2, B1 and B2, C1 and C2) using two small RNA library preparation kits: NEBNext Multiplex Small RNA library Prep Set from New England Biolab (NEB) and NEXTflex Small RNA Sequencing Kit from Bioo Scientific (BS). We also tested Illumina’s TrueSeq Small RNA Sample Preparation Kit (ILMN) in sample A1 and A2. Together, we tested these plasma samples by sequencing 14 indexed libraries.,Human plasma samples were obtained from Mayo Clinic and stored at -80°C before use. Exosomes were isolated from 250 µL of plasma prepared from whole blood using the ExoQuick Exosome Precipitation Solution (SBI) according to the manufacturer’s instructions with minor modifications. Briefly, the plasma was incubated with Thromboplastin D (Thermo) for 15 min at 37oC. After centrifugation at 10,000 rpm for 5 min, the supernatant was mixed with 75 µL of ExoQuick Solution and RNase A (Sigma) at final concentration of 10 µg/mL. The mixture was kept at 4oC overnight and then further mixed with 150 units/mL of murine RNase inhibitor (NEB) before centrifugation at 1500 g for 30 min. The exosome pellet was dissolved in 25 µL 1×PBS, 2 µL of which was reserved for evaluation of exosome size and concentration using NanoSight LM 10 instrument (Particle Characterization Laboratories). The remainder was subjected to RNA extraction immediately. The usage of human biospecimen for this study was approved by Institutional Review Board of Medical College of Wisconsin and Mayo Clinic.,RNA was prepared by using miRNeasy Micro Kit (QIAGEN). Twenty-three µL of exosome suspension was mixed with 700 µL QIAzol Lysis buffer, and was processed by the standard protocol from the manufacturer. The extracted RNA was eluted with 14 µL of RNase-free water. The quantity and quality of the RNA were determined by Agilent Bioanalyzer 2100 with Small RNA Chip and RNA 6000 Pico Kit as indicated (Agilent Technologies).,The concentration and the size distribution of isolated exosomes were measured using NanoSight. Prior to sampling, the sample solutions were homogenized by vortexing, followed by serial dilution to the final dilution of 1:100,000 in 0.2 µm-filtered 1x PBS. NIST (National Institute of Standards and Technology) traceable 97 nm ± 3 nm polystyrene latex standards were added and analyzed in conjunction with the diluted exosome solution to validate the operation of the instrumentation. A blank 0.2 µm-filtered 1x PBS sample was also run as a negative control. Each sample analysis was conducted for 90 seconds. The Nanosight’s automatic analysis settings (High Sensitivity, Blue laser [405 nm, 645 mW]) were utilized for the processing of the data. All samples were evaluated in triplicates.
GSM1112879
Illumina HiSeq 2000
May 15 2019
size fractionation
transcriptomic
RNA-Seq
total RNA
Homo sapiens
GPL11154
SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX258936,BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN01997259
GSM1112879
GSE45722
0.564652
microRNA from sample C constructed by the kit from Bioo scientific
Public on May 15 2013
Apr 03 2013
9606
microRNA from sample C constructed by the kit from Bioo scientific [LW_CB_1]
SRA
https://www.ncbi.nlm.nih.gov/sra?term=SRX258936
https://www.ncbi.nlm.nih.gov/biosample/SAMN01997259
1
tissue: blood,fraction: exosome
8701 Watertown Plank Rd.
Milwaukee
USA
Medical College of Wisconsin
Liang,,Wang
Perl Scripts were developed to process data from RNA sequencing. Raw reads were firstly extracted from FASTQ files, and trimmed with sequencing quality control of Q > 13 , and then cleaned up 3’ adaptor sequences within read sequences. Those prepared sequences filtered with the length ≥16 nt were combined into a FASTA file and aligned against human miRNA sequences downloaded from miRBase (Release 19, 2043 entries) and human genome reference sequences downloaded from NCBI ftp site (Release 103) with Bowtie (version 0.12.8) , of which the parameters for alignment were -m 3 -n 1 -f -a -best --strata. Normalization of miRNA profiling was the read counts of a target miRNA by million bases versus the sum of read counts of all mappable miRNAs on human miRNA sequences.,Genome_build: miRNA from miRBase(release19),Supplementary_files_format_and_content: Data frame of normalized miRNA transcription level in *.txt
we selected plasma samples (samples A, B and C) from 3 anonymous blood donors and split each sample into two for technical replication.,We tested the six samples (A1 and A2, B1 and B2, C1 and C2) using two small RNA library preparation kits: NEBNext Multiplex Small RNA library Prep Set from New England Biolab (NEB) and NEXTflex Small RNA Sequencing Kit from Bioo Scientific (BS). We also tested Illumina’s TrueSeq Small RNA Sample Preparation Kit (ILMN) in sample A1 and A2. Together, we tested these plasma samples by sequencing 14 indexed libraries.,Human plasma samples were obtained from Mayo Clinic and stored at -80°C before use. Exosomes were isolated from 250 µL of plasma prepared from whole blood using the ExoQuick Exosome Precipitation Solution (SBI) according to the manufacturer’s instructions with minor modifications. Briefly, the plasma was incubated with Thromboplastin D (Thermo) for 15 min at 37oC. After centrifugation at 10,000 rpm for 5 min, the supernatant was mixed with 75 µL of ExoQuick Solution and RNase A (Sigma) at final concentration of 10 µg/mL. The mixture was kept at 4oC overnight and then further mixed with 150 units/mL of murine RNase inhibitor (NEB) before centrifugation at 1500 g for 30 min. The exosome pellet was dissolved in 25 µL 1×PBS, 2 µL of which was reserved for evaluation of exosome size and concentration using NanoSight LM 10 instrument (Particle Characterization Laboratories). The remainder was subjected to RNA extraction immediately. The usage of human biospecimen for this study was approved by Institutional Review Board of Medical College of Wisconsin and Mayo Clinic.,RNA was prepared by using miRNeasy Micro Kit (QIAGEN). Twenty-three µL of exosome suspension was mixed with 700 µL QIAzol Lysis buffer, and was processed by the standard protocol from the manufacturer. The extracted RNA was eluted with 14 µL of RNase-free water. The quantity and quality of the RNA were determined by Agilent Bioanalyzer 2100 with Small RNA Chip and RNA 6000 Pico Kit as indicated (Agilent Technologies).,The concentration and the size distribution of isolated exosomes were measured using NanoSight. Prior to sampling, the sample solutions were homogenized by vortexing, followed by serial dilution to the final dilution of 1:100,000 in 0.2 µm-filtered 1x PBS. NIST (National Institute of Standards and Technology) traceable 97 nm ± 3 nm polystyrene latex standards were added and analyzed in conjunction with the diluted exosome solution to validate the operation of the instrumentation. A blank 0.2 µm-filtered 1x PBS sample was also run as a negative control. Each sample analysis was conducted for 90 seconds. The Nanosight’s automatic analysis settings (High Sensitivity, Blue laser [405 nm, 645 mW]) were utilized for the processing of the data. All samples were evaluated in triplicates.
GSM1112880
Illumina HiSeq 2000
May 15 2019
size fractionation
transcriptomic
RNA-Seq
total RNA
Homo sapiens
GPL11154
SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX258937,BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN01997260
GSM1112880
GSE45722
0.577046
microRNA from sample C constructed by the kit from Bioo scientific
Public on May 15 2013
Apr 03 2013
9606
microRNA from sample C constructed by the kit from Bioo scientific [LW_CB_2]
SRA
https://www.ncbi.nlm.nih.gov/sra?term=SRX258937
https://www.ncbi.nlm.nih.gov/biosample/SAMN01997260
1
tissue: blood,fraction: exosome
8701 Watertown Plank Rd.
Milwaukee
USA
Medical College of Wisconsin
Liang,,Wang
Perl Scripts were developed to process data from RNA sequencing. Raw reads were firstly extracted from FASTQ files, and trimmed with sequencing quality control of Q > 13 , and then cleaned up 3’ adaptor sequences within read sequences. Those prepared sequences filtered with the length ≥16 nt were combined into a FASTA file and aligned against human miRNA sequences downloaded from miRBase (Release 19, 2043 entries) and human genome reference sequences downloaded from NCBI ftp site (Release 103) with Bowtie (version 0.12.8) , of which the parameters for alignment were -m 3 -n 1 -f -a -best --strata. Normalization of miRNA profiling was the read counts of a target miRNA by million bases versus the sum of read counts of all mappable miRNAs on human miRNA sequences.,Genome_build: miRNA from miRBase(release19),Supplementary_files_format_and_content: Data frame of normalized miRNA transcription level in *.txt
we selected plasma samples (samples A, B and C) from 3 anonymous blood donors and split each sample into two for technical replication.,We tested the six samples (A1 and A2, B1 and B2, C1 and C2) using two small RNA library preparation kits: NEBNext Multiplex Small RNA library Prep Set from New England Biolab (NEB) and NEXTflex Small RNA Sequencing Kit from Bioo Scientific (BS). We also tested Illumina’s TrueSeq Small RNA Sample Preparation Kit (ILMN) in sample A1 and A2. Together, we tested these plasma samples by sequencing 14 indexed libraries.,Human plasma samples were obtained from Mayo Clinic and stored at -80°C before use. Exosomes were isolated from 250 µL of plasma prepared from whole blood using the ExoQuick Exosome Precipitation Solution (SBI) according to the manufacturer’s instructions with minor modifications. Briefly, the plasma was incubated with Thromboplastin D (Thermo) for 15 min at 37oC. After centrifugation at 10,000 rpm for 5 min, the supernatant was mixed with 75 µL of ExoQuick Solution and RNase A (Sigma) at final concentration of 10 µg/mL. The mixture was kept at 4oC overnight and then further mixed with 150 units/mL of murine RNase inhibitor (NEB) before centrifugation at 1500 g for 30 min. The exosome pellet was dissolved in 25 µL 1×PBS, 2 µL of which was reserved for evaluation of exosome size and concentration using NanoSight LM 10 instrument (Particle Characterization Laboratories). The remainder was subjected to RNA extraction immediately. The usage of human biospecimen for this study was approved by Institutional Review Board of Medical College of Wisconsin and Mayo Clinic.,RNA was prepared by using miRNeasy Micro Kit (QIAGEN). Twenty-three µL of exosome suspension was mixed with 700 µL QIAzol Lysis buffer, and was processed by the standard protocol from the manufacturer. The extracted RNA was eluted with 14 µL of RNase-free water. The quantity and quality of the RNA were determined by Agilent Bioanalyzer 2100 with Small RNA Chip and RNA 6000 Pico Kit as indicated (Agilent Technologies).,The concentration and the size distribution of isolated exosomes were measured using NanoSight. Prior to sampling, the sample solutions were homogenized by vortexing, followed by serial dilution to the final dilution of 1:100,000 in 0.2 µm-filtered 1x PBS. NIST (National Institute of Standards and Technology) traceable 97 nm ± 3 nm polystyrene latex standards were added and analyzed in conjunction with the diluted exosome solution to validate the operation of the instrumentation. A blank 0.2 µm-filtered 1x PBS sample was also run as a negative control. Each sample analysis was conducted for 90 seconds. The Nanosight’s automatic analysis settings (High Sensitivity, Blue laser [405 nm, 645 mW]) were utilized for the processing of the data. All samples were evaluated in triplicates.
GSM1112881
Illumina HiSeq 2000
May 15 2019
size fractionation
transcriptomic
RNA-Seq
total RNA
Homo sapiens
GPL11154
SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX258938,BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN01997261
GSM1112881
GSE45722
0.834073
microRNA from sample C constructed by the kit from NEB
Public on May 15 2013
Apr 03 2013
9606
microRNA from sample C constructed by the kit from NEB [LW_CN_1]
SRA
https://www.ncbi.nlm.nih.gov/sra?term=SRX258938
https://www.ncbi.nlm.nih.gov/biosample/SAMN01997261
1
tissue: blood,fraction: exosome
8701 Watertown Plank Rd.
Milwaukee
USA
Medical College of Wisconsin
Liang,,Wang
Perl Scripts were developed to process data from RNA sequencing. Raw reads were firstly extracted from FASTQ files, and trimmed with sequencing quality control of Q > 13 , and then cleaned up 3’ adaptor sequences within read sequences. Those prepared sequences filtered with the length ≥16 nt were combined into a FASTA file and aligned against human miRNA sequences downloaded from miRBase (Release 19, 2043 entries) and human genome reference sequences downloaded from NCBI ftp site (Release 103) with Bowtie (version 0.12.8) , of which the parameters for alignment were -m 3 -n 1 -f -a -best --strata. Normalization of miRNA profiling was the read counts of a target miRNA by million bases versus the sum of read counts of all mappable miRNAs on human miRNA sequences.,Genome_build: miRNA from miRBase(release19),Supplementary_files_format_and_content: Data frame of normalized miRNA transcription level in *.txt
we selected plasma samples (samples A, B and C) from 3 anonymous blood donors and split each sample into two for technical replication.,We tested the six samples (A1 and A2, B1 and B2, C1 and C2) using two small RNA library preparation kits: NEBNext Multiplex Small RNA library Prep Set from New England Biolab (NEB) and NEXTflex Small RNA Sequencing Kit from Bioo Scientific (BS). We also tested Illumina’s TrueSeq Small RNA Sample Preparation Kit (ILMN) in sample A1 and A2. Together, we tested these plasma samples by sequencing 14 indexed libraries.,Human plasma samples were obtained from Mayo Clinic and stored at -80°C before use. Exosomes were isolated from 250 µL of plasma prepared from whole blood using the ExoQuick Exosome Precipitation Solution (SBI) according to the manufacturer’s instructions with minor modifications. Briefly, the plasma was incubated with Thromboplastin D (Thermo) for 15 min at 37oC. After centrifugation at 10,000 rpm for 5 min, the supernatant was mixed with 75 µL of ExoQuick Solution and RNase A (Sigma) at final concentration of 10 µg/mL. The mixture was kept at 4oC overnight and then further mixed with 150 units/mL of murine RNase inhibitor (NEB) before centrifugation at 1500 g for 30 min. The exosome pellet was dissolved in 25 µL 1×PBS, 2 µL of which was reserved for evaluation of exosome size and concentration using NanoSight LM 10 instrument (Particle Characterization Laboratories). The remainder was subjected to RNA extraction immediately. The usage of human biospecimen for this study was approved by Institutional Review Board of Medical College of Wisconsin and Mayo Clinic.,RNA was prepared by using miRNeasy Micro Kit (QIAGEN). Twenty-three µL of exosome suspension was mixed with 700 µL QIAzol Lysis buffer, and was processed by the standard protocol from the manufacturer. The extracted RNA was eluted with 14 µL of RNase-free water. The quantity and quality of the RNA were determined by Agilent Bioanalyzer 2100 with Small RNA Chip and RNA 6000 Pico Kit as indicated (Agilent Technologies).,The concentration and the size distribution of isolated exosomes were measured using NanoSight. Prior to sampling, the sample solutions were homogenized by vortexing, followed by serial dilution to the final dilution of 1:100,000 in 0.2 µm-filtered 1x PBS. NIST (National Institute of Standards and Technology) traceable 97 nm ± 3 nm polystyrene latex standards were added and analyzed in conjunction with the diluted exosome solution to validate the operation of the instrumentation. A blank 0.2 µm-filtered 1x PBS sample was also run as a negative control. Each sample analysis was conducted for 90 seconds. The Nanosight’s automatic analysis settings (High Sensitivity, Blue laser [405 nm, 645 mW]) were utilized for the processing of the data. All samples were evaluated in triplicates.
GSM1112882
Illumina HiSeq 2000
May 15 2019
size fractionation
transcriptomic
RNA-Seq
total RNA
Homo sapiens
GPL11154
SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX258939,BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN01997262
GSM1112882
GSE45722
0.645251
microRNA from sample C constructed by the kit from NEB
Public on May 15 2013
Apr 03 2013
9606
microRNA from sample C constructed by the kit from NEB [LW_CN_2]
SRA
https://www.ncbi.nlm.nih.gov/sra?term=SRX258939
https://www.ncbi.nlm.nih.gov/biosample/SAMN01997262
1
cell line: MCF7,cell type: breast cancer cells,transfection: control siRNA
450 Brookline Ave
Boston
USA
Dana-Farber Cancer Institute
Kornelia,,Polyak
Basecalls performed using CASAVA version 1.7 or 1.8.,RNA-Seq raw data was mapped by Tophat to hg19.,Read counting and differential gene expression analysis were done using GFold using significance cutoff = 0.05.,Genome_build: hg19,Supplementary_files_format_and_content: Text file (.cnt) of mapped read counts was generated using Gfold.
Total RNA was isolated from cells using RNeasy Mini Kit (Qiagen) following the manufacturer’s protocol. Then polyA RNA were purified using the MACS mRNA isolation kit (Miltenyi Biotec).,PolyA RNA was fragmented by RNA fragmentation reagent (Ambion), and subjected to first strand synthesis by using SupeScript II (Invitrogen) and random hexamer oligos. The second strand was synthesized, and then subjected to end repair, A-tailing, ligation of Illumia paired end adaptor. Following PCR amplification for 18 cycles, the final library underwent gel purification.
GSM1113298
Illumina HiSeq 2000
May 15 2019
cDNA
transcriptomic
RNA-Seq
polyA RNA
Homo sapiens
GPL11154
SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX259553,BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN01997737
GSM1113298
GSE45732,GSE46073
0.051349
breast cancer cells
Public on Jun 17 2014
Apr 03 2013
9606
MCF7_RNAseq_Control
SRA
https://www.ncbi.nlm.nih.gov/sra?term=SRX259553
https://www.ncbi.nlm.nih.gov/biosample/SAMN01997737
1
cell line: MCF7,cell type: breast cancer cells,transfection: siJARID1B
450 Brookline Ave
Boston
USA
Dana-Farber Cancer Institute
Kornelia,,Polyak
Basecalls performed using CASAVA version 1.7 or 1.8.,RNA-Seq raw data was mapped by Tophat to hg19.,Read counting and differential gene expression analysis were done using GFold using significance cutoff = 0.05.,Genome_build: hg19,Supplementary_files_format_and_content: Text file (.cnt) of mapped read counts was generated using Gfold.
Total RNA was isolated from cells using RNeasy Mini Kit (Qiagen) following the manufacturer’s protocol. Then polyA RNA were purified using the MACS mRNA isolation kit (Miltenyi Biotec).,PolyA RNA was fragmented by RNA fragmentation reagent (Ambion), and subjected to first strand synthesis by using SupeScript II (Invitrogen) and random hexamer oligos. The second strand was synthesized, and then subjected to end repair, A-tailing, ligation of Illumia paired end adaptor. Following PCR amplification for 18 cycles, the final library underwent gel purification.
GSM1113299
Illumina HiSeq 2000
May 15 2019
cDNA
transcriptomic
RNA-Seq
polyA RNA
Homo sapiens
GPL11154
SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX259554,BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN01997738
GSM1113299
GSE45732,GSE46073
0.048785
breast cancer cells
Public on Jun 17 2014
Apr 03 2013
9606
MCF7_RNAseq_siJARID1B
SRA
https://www.ncbi.nlm.nih.gov/sra?term=SRX259554
https://www.ncbi.nlm.nih.gov/biosample/SAMN01997738